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Langerin and the DC Asialoglycoprotein-Receptor: Two Closely Related Endocytic
Type-II Lectins with Divergent Functions in Dendritic Cells
S. Saeland
Schering-Plough Laboratory for Immunological Research, Dardilly, France
Immature dendritic cells (DC) are highly specialized in antigen capture, notably via a number of
endocytic receptors. These include type-I lectins, such as the mannose-receptor and DEC205,
with multiple Ca++-dependent (C-type) carbohydrate recognition domains (CRD). The
important role of type-II lectins with a single CRD in DC endocytosis has been more recently
realized. Langerin is a mannose-binding type-II lectin that we cloned from DC supplemented with
TGFb. Langerin is expressed on Langerhans cells of the epidermis and epithelia. Strikingly,
Langerin routes extracellular ligand into Birbeck granules (BG), the unique organelles of
Langerhans-type cells. This process is paralelled by an active role of Langerin in the formation of
BG by membrane superimposition and zippering when expressed in cell lines. Of note, the
intracellular portion of Langerin contains a proline-rich (WPREPPP) domain but lacks the
tyrosine-based internalization motif used by a number of other endocytic receptors. Mouse
Langerin shares key features of its human counterpart, including a similar genomic organization.
Langerin is most closely related to the rodent Kuppfer cell receptors, constituting a subfamily of C-
type lectins characterized by an a-helical coil-coiled stalk between the transmembrane domain and
the CRD. Studies with deleted and mutant forms of Langerin have shown that the CRD is
essential for BG formation. Also, mouse Langerin in which a single conserved residue was modi®ed
within the CRD did not give rise to BG but to a different type of superimposed membranes similar
to the cored tubules described in mouse Langerhans cells. We have also identi®ed several isoforms
of an asialoglycoprotein receptor (DC-ASGPR) on human DC. These represent splice-variants of
the macrophage lectin HML, a galactose-speci®c type-II Ca++-dependent lectin highly related to
Langerin. However, in contrast to Langerin, the DC-ASGPR/HML is expressed by interstitial DC
but not by Langerhans cells. The DC-ASGPR, which features an intracellular tyrosine-motif,
internalizes extracellular ligand into DC with similar rapid kinetics as Langerin. However, the DC-
ASGPR localizes to DC early endosomes indicative of a recycling receptor, and its expression in
cell lines does not result in BG formation. Also, whereas Langerin does not intersect with the
routing of MHC-II molecules, antigen targeted to the DC-ASGPR reaches the MHC-II pathway
resulting in highly ef®cient presentation to T cells. Our data demonstrate that structurally closely-
related endocytic receptors can have highly divergent functions in DC. Furthermore, as illustrated
by Langerin, we speculate that a given receptor could have considerable plasticity in the routing of
extracellular ligands, by generating distinct subcellular compartments upon endocytosis. Recent
availability of mice with disrupted Langerin genes should be important to further understand the
functional consequences of the diversity of type-II lectin endocytic receptors in DC.
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In¯ammatory Chemokine Transport and Presentation in HEV: A Remote Control
Mechanism for Monocyte Recruitment to Lymph Nodes in In¯amed Tissues
R. T. Palframan, S. Jung, G. Cheng, W. Weninger, Y. Luo, M. Dorf, D. R. Littman, B. J. Rollins,
H. Zweerink, A. Rot and U. H. von Andrian
Center for Blood Research, Harvard University, Boston, Massachusetts
Interstitial ¯uid is constantly drained into lymph nodes (LN) via afferent lymph vessels. This
conduit enables monocyte-derived macrophages and dendritic cells to access LN from peripheral
tissues. We show that during in¯ammation in the skin, a second recruitment pathway is evoked
that recruits large numbers of blood-borne monocytes to LN via high endothelial venules (HEV).
Inhibition of monocyte chemoattractant protein-1 (MCP-1) blocked this in¯ammation-induced
monocyte homing to LN. MCP-1 mRNA in in¯amed skin was over 100-fold up-regulated and
paralleled MCP-1 protein levels, whereas in draining LN MCP-1 mRNA induction was much
weaker and occurred only after a pronounced rise in MCP-1 protein. Thus, MCP-1 in draining
LN was primarily derived from in¯amed skin. In MCP-1-/± mice, intracutaneously injected
MCP-1 accumulated rapidly in the draining LN where it enhanced monocyte recruitment.
Intravital microscopy showed that skin-derived MCP-1 was transported via the lymph to the
luminal surface of HEV where it triggered integrin dependent arrest of rolling monocytes. These
®ndings demonstrate that in¯amed peripheral tissues project their local chemokine pro®le to HEV
in draining LN and thereby exert ``remote control'' over the composition of leukocyte populations
that home to these organs from the blood.
003
CCR7 Controls De®ned Stages of Dendritic Cell Mobilization and Localization
R. FoÈrster, L. Ohl, G. Henning, and M. Mohaupt*
Clinic for Surgery, Department for Experimental Surgery and Immunology, Erlangen, Germany; *Max-
Delbruck-Center for Molecular Medicne, Berlin, Germany
We recently identi®ed the chemokine receptor CCR7 as an important organizer of the immune
response. Due to the impaired migration of lymphocytes, CCR7-de®cient mice reveal profound
morphological and functional alterations in all secondary lymphoid organs. We now analyzed the
role of CCR7 during the process of activation and mobilization of dendritic cells (DCs). We show
that CCR7 is required at least at three different steps of the migratory process of dc. I) Langerhans
cells need this receptor to migrate within the dermis towards the lymphatic vessels. II) Once these
cells have been arrived within the marginal sinus of the draining lymph nodes they exploit CCR7
to make their way into the T cell-rich areas. III) Finally, both lymphoid- and myeloid-derived DCs
require the interaction of CCR7 with its ligands to stay within their characteristic
microenvironments within lymphoid organs. Within lymphoid organs CCR7-de®cient DCs are
dislocated to distinct areas where other homeostatic chemokines are highly expressed. Thus, our
data also suggest that a hierarchy of chemotactic gradients within lymphoid organs controls the
dynamic reorganization of lymphoid organs during an adoptive immune response.
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Basic Research in Langerhans Cell Histiocytosis
K. L. McClain
Baylor College of Medicine, Texas Children's Cancer Center, Houston, Texas
Until recently discoveries in the basic biology of Langerhans cell histiocytosis (LCH) have
progressed at a slow pace as compared to the rapid advances in dendritic cell (DC) biology. My talk
will summarize the work of several investigators in bringing new understanding to the
pathobiology of LCH. The application of reagents used in DC research has provided better
characterization of how the diseased Langerhans cells (LC) ®t into the scheme of DC lineage and
maturation. A major question has been whether the LC of LCH are mature or immature DC.
Indeed the LC from LCH patient lesions are immature having no expression of CD83, CD86, or
DC-Lamp and only intracellular expression of Class II antigens. These LC may be in¯uenced by
surrounding macrophages which that IL-10 and TGF-b could inhibit LC maturation. When LC
from LCH lesions are put in culture they can be matured by cultivation with CD40. These
important ®ndings will be discussed in the context of previous understanding about the clonal
proliferation of the LC in LCH that has perplexed investigators since no morphologic or
cytogenetic markers of malignancy occur in this disease. Furthermore the etiology of elevated
cytokine expression in LCH has not been elucidated although increased CD40L on surrounding T
cells and CD40 on the LC in LCH has been identi®ed along with TGF-b expression in
macrophages. The multiple locations of LCH in patients suggests there are aberrations of the
integrins or other cell surface proteins guiding LC migration. Low expression of E-cadherin has
been associated with disseminated disease. Presence of CD2, CD11a and CD11b on LC has been
hypothesized to show that they may contribute to migration of the LC. The complex interactions
of lymphocytes and macrophages surrounding LC need to be dissected to determine the pivotal005
Dendritic Cells and Peripheral Tolerance
R. M. Steinman
The Rockefeller University, New York, New York
Dendritic cells (DCs) are best known for their immunogenic capacities. DCs have several known
roles in the innate response and provide a direct link between innate and adaptive immunity. After
initiating adaptive responses by CD4 and CD8 T cells, DCs also control T cell differentiation, such
as the rapid polarization to Th1 type CD4 T cells and high af®nity CD8 T cells. Much of the
experimental work in the past has involved ex vivo derived DCs matured with different microbial
and in¯ammatory stimuli. Together with the laboratories of Michel Nussenzweig and Kayo Inaba,
we now ®nd that a major function of DCs in vivo, in the unperturbed or steady state, is to induce
peripheral T cell tolerance. DCs have been proposed to have tolerogenic capacities in the past, but
we set out to assess this with DCs in vivo. We will ®rst review evidence that DCs are continually
capturing cells and soluble proteins in the steady state in vivo, and yet no autoimmunity or chronic
in¯ammation is induced. When cellular and protein antigens are targeted selectively to DCs in vivo,
the corresponding antigen-speci®c T cells undergo deletion, and the animals become tolerant or
speci®cally unresponsive to antigenic challenge, even on mature immunogenic DCs. In contrast, if
the DCs are simultaneously exposed to antigen and a maturation stimulus, immunity results, with
an expansion of T cell numbers and a differentiation to effector T cells. We propose that the
tolerogenic role of DCs is a vital part of their immunogenic function. When DCs are called upon
to immunize an animal, they must capture antigen and respond to a maturation stimulus.
Simultaneously however, e.g. during a microbial infection, the DCs must be capturing self antigens
from dying infected cells as well as normal environmental antigens, such as proteins in the airway
and intestine. If on the other hand in the steady state, i.e. prior to infection, DCs capture and
induce tolerance to the peptides that can be extracted from cells dying during normal cell turnover
or from nonpathogenic environmental proteins, then a subsequent exposure to an infection will
lead preferentially to anti-microbial immunity and not autoimmunity or chronic in¯ammation.
Therefore, the tolerizing role of DCs is not an occasional event. Rather it is a critical day-to-day
role of DCs during their traf®c through peripheral tissues and lymphoid organs in the steady state.
The tolerizing and immunizing functions of DCs therefore seem critical for understanding the
perplexing but essential capacity of the immune system to distinguish self from, as Janeway has
stated it, ``infectious nonself''.
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CD14+ CD1a± Dermal Migratory Cells Acquire the Characteristics of Langerhans After
Short-Term Culture in GM-CSF, TGFb-1 and IL-4
A. T. Larregina, A. E. Morelli, L. A. Spencer, S. C. Watkins, A. W. Thomson, and L. D. Falo Jr
Departments of Dermatology, Cell Biology and Surgery. University of Pittsburgh, School of Medicine,
Pittsburgh, Pennsylvania
It has been postulated that Langerhans cells (LC) precursors might be a skin-resident cell
population; however, no data exist con®rming this hypothesis. In the present work, we have
characterized a population of human dermal-resident CD14+ CD1a± cells that migrates
``spontaneously'' from human skin explants. After short-term culture in GM-CSF + TGFb-
1 + IL-4 these cells acquire morphology, phenotype and function characteristic of epidermal LC.
CD14+ CD1a± cells did not adhere to plastic, expressed langerin, the myeloid markers CD13 and
CD33, MHC-I and ±II molecules, moderate levels of the costimulatory molecules CD80, CD86,
and CD40 but they were negative for the maturation molecule CD83. CD14+ CD1a± cells were
positive for the intracytoplasmic markers protein S-100 and CD68, they showed a very weak
expression of factor XIIIa and they lacked Birbeck granules (BG). In addition, CD14+ CD1a±
expressed CCR6 and migrated in a dose dependent manner in response to MIP-3a in chemotaxis
assays. CD14+ CD1a± cells were highly endocytic, and exhibited a weak stimulatory capacity for
allogenic naive T cells. After short-term culture in GM-CSF + TGFb-1 + IL-4, CD14+ CD1a±
cells: i) expressed de novo CD1a and E-cadherin, ii) decreased langerin and CCR6 expression, iii)
lost CD14 positivity, iv) acquired BG, and v) became a strong stimulators of allogeneic T cells. Our
results show that skin migratory CD14+ CD1a+ cells might constitute a reserve pool of LC
precursors resident in the dermis that are able to differentiate into epidermal LC in the appropriate
cytokine environment.
C2
Neonatal Murine Dendritic Epidermal Cells Do Not Acquire the Phenotypic and
Functional Characteristics of Adult Langerhans Cells Upon In Vitro Culture
A. Elbe-BuÈrger, S. Olt, S. Chang-Rodriguez, G. Stingl
DIAID, Department of Dermatology, VIRCC, Vienna, Austria
In epidermal sheets of adult mice, Langerhans cells (LC) exhibit a pronounced anti-MHC class II
reactivity. Dendritic leukocytes of neonatal epidermis (NDL), in contrast, express only modest
amounts of these proteins. To determine the differentiation and maturation potential of these cells,
epidermal cell suspensions from newborn (£10 h old) and adult whole body skin were prepared
and highly puri®ed (395%) for CD45+/MHC class II+ cells. Subsequently, the puri®ed populations
were cultured for three days in RPMI medium supplemented with FCS and GM-CSF. During
culture, adult LC became highly dendritic and formed numerous homotypic clusters, while NDL
remained round to polygonal and created only few small-sized clusters. After culture, both cell
types were CD3± and exhibited similar intensity in surface expression of CD45, F4/80, and
CD11b. NDL, however, expressed slightly more MHC class I, less CD40, considerably less MHC
class II, CD54, CD80 and CD86, and were CD25±/CD205±. Functionally, cultured NDL were
signi®cantly weaker stimulators of naive, allogeneic CD4+ and CD8+ T cells than adult LC.
Furthermore, freshly isolated NDL were twice as ef®cient as adult LC in the uptake of FITC-
conjugated ovalbumin, but were not able to present ovalbumin to antigen-speci®c T cell
hybridomas. In summary, we have shown that CD45+/CD3± NDL do not acquire the
morphology and phenotype typical of in vitro cultured adult LC, and are greatly impaired in their
capacity to activate antigen-speci®c T cell proliferative responses. The ®nding that certain dendritic
cells of neonatal mice do apparently not possess the molecular machinery needed for the initiation
of productive T cell responses should facilitate the search for molecules involved and engaged in T
cell activation.
C3
Anatomical Location and T Cell Stimulatory Functions of Mouse Dendritic Cell Subsets
De®ned by CD4 and CD8 Expression
A. D. McLellan, M. Kapp,* A. Eggert, C. Linden, E.-B. BroÈcker, U. KaÈmmerer,* and E.
KaÈmpgen
Depts of Dermatology and *Gynecology, University of WuÈrzburg, Germany
Mouse spleen contains three subsets of CD4+, CD8a+ and CD4±/CD8a± dendritic cells (DC) in a
2 : 1 : 1 ratio. An analysis of over 60 surface and cytoplasmic antigens revealed several differences in
adhesion molecule and costimulator expression between the three subsets. Immunohistochemical
analysis revealed that both CD4 and CD8-expressing DC were present in the T cell areas, but large
numbers of both subsets were also apparent in the splenic marginal zones. All three DC subsets
showed similar migratory capacity in collagen lattices and were similar in their ability to stimulate
unfractionated, allogeneic CD4+ T cells. However, CD8a+ DC were very weak stimulators of
highly puri®ed allogeneic resting or CTL CD8+ T cells, even at high stimulator to responder ratios.
Neither LPS nor CD40 treatment signi®cantly improved the stimulatory capacity of the CD8+ DC
subset. In contrast CD8a+ DC did ef®ciently stimulate NP68 peptide±speci®c CD8+ F5 transgenic
T cells, but this required higher DC: T cell ratios and peptide concentrations. The turnover rate of
class I/peptide complexes CD8a+ DC was similar to the CD8a± subsets, suggesting that a rapid loss
of antigenic complexes from CD8a+ DC was not responsible for their poor CD8+ T cell
stimulation. Mixing experiments showed that CD8a+ DC could not down-regulate the ability of
the other DC subsets to stimulate resting CD8+ T cell proliferation. Therefore CD8a+ DC are
poor stimulators of resting CD8+ T cells, and do not appear to tolerise, induce apoptosis, or
otherwise interfere with the proliferative ability of CD8+ T cells.
C4
The Migration of Langerhans Cells is Closely Associated with the Expression of the
Actin Bundling Protein Fascin
K. West,*² M. Al-Alwan,* P. Colp,² G. De. Pan®lis,³ L. R. Braathen, G. Rowden²
Department of Medicine, *Microbiology & Immunology, and ²Pathology, Dalhousie University, Halifax,
Canada and ³Dermatology, Spedali Civili, Brescia, Italy and Dermatology, Bern, Switzerland
We have demonstrated that the DC actin bundling protein fascin is involved in the development of
dendrites and plays a critical role in activating T cells. In this study we evaluated the regulation of
fascin expression in migrating LC in vivo.
Normal skin and lymph node were obtained from mice and human and double stained for fascin
and MHC Class II. Fascin expression was quantitated using Matlab software. Isolated human
epidermal cell suspensions were further evaluated for fascin and MHC Class II staining by ¯ow
cytometry. Human lymph cells were examined for fascin and MHC Class II expression. Suprabasal
LC in the epidermis did not stain for fascin. However, basal LC were fascin positive and had a
more rounded appearance. Strong staining for fascin of a dermal DC population was seen. The
fascin positive DC were frequently clustered around lymphatics suggesting that these are migrating
DC. Human lymphatic DC also expressed fascin. Numerous DCs were noted in the marginal
sinuses and paracortical zones of the lymph nodes. Fascin expression quantitatively increased from
the dermis into the T cell areas of the lymph node. Fascin expression was con®ned to migrating
LC. Similar results were seen in mouse and human indicating an important conserved function.
This distribution pattern of fascin expression suggests an important role for its expression in the
migration of LC. An increase in fascin expression in lymph node DC suggests a second function of
fascin, possibly in the interaction of DC and T cells.
C5
Selective and Transient Accumulation of Polyubiquinated Proteins During Dendritic
Cell Maturation
H. Lelouard, E. Gatti, F. Capello, and Ph. Pierre
Centre d'Immunologie de Marseille-Luminy CNRS-INSERM-Univ Med. Campus de Luminy, Marseille,
France
Dendritic cells (DCs) are antigen presenting cells (APCs) with the unique capacity to initiate
primary and secondary immune responses. DCs acquire antigens in peripheral tissues and migrate
to lymphoid organs where they present processed peptides to T-cells. DCs have a remarkable
pattern of differentiation (maturation) that is accompanied by striking changes in morphology,
organization and function. In particular, DCs exhibit unique mechanisms to control antigen
presentation by regulating the transport and the loading of MHC class I and II molecules. MHC
class I molecules function to present peptides eight to 10 residues long to CD8 + cytotoxic T cells.
These peptides are mostly derived from cytosolic proteins which in turn have to be ubiquinated
and degraded by the proteasome, the major cytosolic protease complex. Here we show, that upon
in¯ammatory stimulation, Langerhans cells accumulate ubiquitinated proteins in large cytosolic
structures reminiscent of aggresomes or inclusion bodies observed in many amyloid or
neurogenerative diseases. Interestingly, these Dendritic cell Aggresome Like Induced Structures
(DALIS) are transient and require continuous protein synthesis for their existence. Our
observations suggest the existence of an organized prioritization of protein degradation in
maturing DCs, likely to be important for maturation and regulating MHC class I presentation
during this necessary functional switch.
C6
Crosspresentation of Antigens on MHC Class I Molecules by Dendritic Cells after
Endocytosis via DEC-205 In Vivo
K. Mahnke,*² M. Rivera,² L. Bonifaz,² D. Bonnyay,² M. Pack,² A. Enk,* and R. M. Steinman²
Dept. of Dermatology, Univ. of Mainz, Germany and Rockefeller Univ. New York, New York
Dendritic cells (DCs), including Langerhans cells, express a distinct receptor for adsorptive
endocytosis, DEC-205. The receptor contains 10 contiguous C-type lectin domains (it is a
DECalectin), but its ligands are not yet known. Therefore, we are using anti-DEC-205 antibodies
as surrogate ligands for this receptor. Previously, we found that DEC-205 greatly enhances the
ef®ciency of ligand presentation to CD4+ T cells in culture. We now are asking if DEC-205
mediated uptake can be exploited for the targeting of antigens to DCs in mice. In fact, anti DEC-
205 antibodies ef®ciently target to DCs in the T cell areas of lymph node. To begin to establish that
this targeting gives rise to MHC-peptide complexes, we coupled the model antigen ovalbumin
(OVA) to anti-DEC-205 and control Abs. After s.c. injection, CD11c + ve lymph node DCs were
isolated and tested for presentation to MHC class I restricted (OT-1) and MHC class II restricted
(OT-II) T cell receptor transgenic cells. The CD11c + ve DCs induced strong proliferative
responses from both CD8 + and CD4 + T cells, with the presentation on MHC class I (``exogenous
pathway'' or ``cross presentation'') being TAP dependent. The presentation of OVA following
injection of DEC-205 OVA conjugate was at least 100-fold more potent than control antibody
OVA conjugates. Also the CD11c + ve DCs were at least 30 fold more potent than the CD11c ±ve
nonDCs. These results show that the DEC-205 receptor ef®ciently delivers antigens to DCs in vivo
for presentation on MHC class I and II products.
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C7
A Dendritic Cell-Restricted Mechanism for the Phagocytosis of Apoptotic Cells
M. L. Albert and R. B. Birge
The Rockefeller University, New York City, New York
The typical fate for apoptotic cells is rapid engulfment and degradation by phagocytes. Previously,
we described a novel pathway in which dendritic cells (DCs) phagocytose apoptotic material via
the avb5 integrin receptor and generate MHC I peptide epitopes from the internalized material,
thus allowing for the activation of antigen-speci®c CTLs. Notably, the avb5 integrin is not found
on macrophages and may account in part for the unique nature by which DCs handle internalized
apoptotic material. Despite the signi®cance of the cellular events associated with phagocytosis of
apoptotic cells via this receptor, little is known about the molecular events involved. We now
show that apoptotic cells are recognized and internalized via the avb5 integrin receptor, with an
absolute requirement for the cytoplasmic tail of the b5 integrin. Notably, this constitutes the ®rst
demonstration that integrin receptors play a direct role in phagosome formation, and do not simply
serve to ``stick'' the apoptotic material to the phagocyte as was originally predicted. We have also
demonstrated that activation of avb5 results in phosphorylation of p130
cas and recruitment of both
CrkII and Dock180. Upon phagocytosis, Dock180 activates Rac1 and which is the proposed
trigger for cytoskeletal rearrangement. Interestingly, Dock180 expression is restricted to DCs as
compared to macrophages, which employ the avb3 integrin receptor and the Dock-M protein (a
family member of Dock180). Additionally, we ®nd that Dock180 is markedly down-regulated
during DC maturation, consistent with its role in antigen capture. Present studies are focused on
identifying additional molecules that distinguish the mechanism by which DCs capture and traf®c
apoptotic material. By uncovering the molecular events involved in the phagocytosis of apoptotic
cells, we hope to better understand the mechanism of antigen traf®cking and cross-presentation by
DCs.
C8
Heat Shock Proteins 70 and 60 Share Common Receptors which are Expressed on
Human Monocyte-Derived But Not Epidermal Dendritic Cells
D. Lipsker, U. Ziylan, D. Spehner, H. Bausinger, J.-P. Cazenave,* D. Hanau, and H. de la Salle
INSERM EP99-08 and *U311, EFS-Alsace, Strasbourg, France
Priming of CTLs by means of heat shock proteins (hsps) is dependent on APCs, which present the
hsp-associated peptides, via their cell surface MHC class I molecules, to CD8+ T cells. It has not yet
been established how human (hu)hsp70 interacts with the major (hu)APCs, the dendritic cells
(DCs). Here we show that (hu)hsp70 is speci®cally internalized into CD14± Toll-like receptor 4-
monocyte-derived (hu)DCs by receptor-mediated endocytosis. We further demonstrate that
(hu)hsp70 and (hu)hsp60 share the same putative receptors. Both molecules as well as MHC class I
molecules are spontaneously internalized and reach the MHC class II enriched compartments.
Finally, freshly isolated Langerhans cells (LCs), as well as CD34+-derived LCs, do not bind hsp60
or hsp70. Given the immunological importance of the internalization of hsp70 by APCs, in the
induction of the immune responses, the ®nding that hsp60 and hsp70 are internalized through the
same receptor(s) may explain why microbial hsp60 represents a major T cell antigen. This may
rationalize the use of microbial hsp60 to prime immune responses against microbes. Finally, the
lack of hsp60/70 receptors on LCs raises the crucial question as to whether absence of priming of
the skin and mucosal immune systems by hsp-polypeptide complexes could account for some tissue
speci®c diseases.
C9
Functional Analysis of Dendritic Cells Generated In Vitro from Blood Monocytes and
CD34+ Progenitors and In Vivo with FLT3 Ligand
T. Luft, M. Jefford, H. Hochrein,* M. Rizkalla, K.-A. Masterman, C. Maliszewski,²
K. Shortman,* J. Cebon, and E. Maraskovsky
Ludwig Institute for Cancer Research, Melbourne, Australia; *The Walter and Eliza Hall Institute of
Medical Research, Melbourne, Australia; ²Immunex Corporation, Seattle
The successful use of DC as cellular vaccine adjuvants in immunotherapy of cancer is dependent on
clearly understanding DC subsets and their functional diversity. DC can be generated from either
monocytes (McDC) or from CD34+ progenitors (CD34+DC) or expanded in vivo with Flt3 ligand
(FL). We evaluated the ability of these DC subsets to respond to 3 classes of stimuli. (1) pro-
in¯ammatory mediators; (2) T cell-derived signals (CD40L) and (3) pathogen-derived signals. All 3
types of DC responded to pro-in¯ammatory mediators, CD40L or bacterial signals and DC
stimulated with any one class of stimuli were phenotypically indistinguishable. However, these
phenotypically similar DC were found to be functionally distinct. A putative dichotomy in DC
functions was identi®ed. Immature DC that encounter pro-in¯ammatory cytokines acquire
migratory capacity towards chemokines and secrete low levels of cytokines. Conversely, immature
DC that encounter pathogens or CD40L in the absence of pro-in¯ammatory mediators (and
presence of IL-10) are activated into pro-in¯ammatory, cytokine secreting cells which are poor
migratory cells. Finally, CD40L-mediated cytokine secretion requires the presence of both T cell-
derived cytokines (e.g. IL-4 and IFN-g) as well as cytokines produced by non-T cells (IL-1b and
IFN-a) suggesting dual roles for CD40L function in the lymph nodes and periphery. It appears
therefore that not all mature DC nor all DC subsets are destined to migrate to lymphoid organs and
that the sequence in which stimuli are encountered signi®cantly affects which functions are
expressed. This highlights that immature DC may have multiple developmental options once
recruited from the resting precursor pool in the periphery.
C10
Identi®cation of a Clinical Grade Maturation Factor for Dendritic Cells
A. Nardin, C. Boccaccio, A. Kaiser, S. Jacod, A. Boyer, and J.-P. Abastado
Immuno-Designed Molecules (IDM), 15 rue de l'Ecole de Medecine, Paris, France
Dendritic cells are essential for the generation of primary adaptive immune responses, but their full
immuno-stimulatory capacities are reached only upon maturation. Despite a growing interest for
the use of antigen-loaded DC in immunotherapy, few effective activating agents compatible with
clinical use have been identi®ed so far. In this study, several bacteria-derived adjuvants were
compared for their ability to induce phenotypic maturation and cytokine secretion (IL-12, IL-10)
by monocyte-derived dendritic cells (DendritophagesTM, DF) differentiated with GM-CSF and IL-
13 in single-use cell processors (VacCellq). Ef®ciency in the induction of MelanA-speci®c T cell
responses by mature DF was evaluated using 51Cr-release assay, ELISPOT, and tetramers.
Although MonophosphorylLipidA, BCG, and Ribomunyl, all appeared to be able to provide the
signal necessary for initiation of DF maturation, Ribomunyl (composed by membrane and
ribosomal bacterial fractions) was more ef®cient than MonophosphorylLipidA and did not imply
an active cellular infection as does BCG. Addition of IFN-g at the onset of maturation modulated
both quantitatively and qualitatively cytokine secretion, allowing higher levels of IL-12
concomitant with lower levels of IL-10. Moreover, contact of DF with Ribomunyl (6 IFN-g)
for 6 h was suf®cient to trigger a maturation process that would proceed and complete
spontaneously. MelanA-speci®c CTL responses could be ef®ciently induced in vitro by Ribomunyl
+ IFN-g-treated DF even in the absence of exogenous cytokines. Thus, Ribomunyl in association
with IFN-g represents a suitable agent for the ex vivo production of mature monocyte-derived DC
for use as cellular vaccines. DF matured with Ribomunyl and IFN-g will be tested in a melanoma
clinical trial.
C11
A Costimulatory Role of Hyaluronan in Dendritic Cell±T Cell Interaction
M. E. Mummert and A. Takashima
UT South-western Medical Center, Dallas, Texas
Hyaluronan (HA), a high molecular weight glycosaminoglycan expressed abundantly in
extracellular and pericellular matrices, is thought to be involved in a variety of cellular functions
including leukocyte migration and activation. Most studies on HA function have employed
inhibitors of CD44, a cell surface glycoprotein that binds HA. Because CD44 binds many ligands,
these studies failed to examine the function of HA directly. To better de®ne physiological roles of
HA, we developed an HA-binding peptide (GAHWQFNALTVR), termed Pep-1, that
speci®cally binds to HA and inhibits leukocyte adhesion to HA (J Exp Med 192 : 769, 2000).
Based on the reported costimulatory role of CD44 in mitogen-induced T cell activation, we
investigated the contribution of HA in dendritic cell (DC)±T cell interaction using Pep-1. First,
the XS52 DC line was cultured with a KLH-reactive CD4+ Th1 clone (HDK-1) with antigen
(KLH). Pep-1 inhibited in a dose-dependent manner the secretion of TNFa (by XS52 and HDK-1
cells), IL-6 (by both cell types) and IFN (by HDK-1 cells). To study the impact of HA on primary
T cell activation, we employed a second system. Splenic DC freshly isolated from BALB/c mice
pulsed with OVA323-339 peptide and cocultured with CD4
+ T cells isolated from DO11.10
transgenic mice expressing transgenic TCR a and b chains speci®c for the OVA peptide. Pep-1,
but not a control peptide, inhibited DC-dependent and antigen-speci®c activation of naive T cells.
Based on these results, we propose a previously unrecognized function of HA in antigen
presentation.
C12
The Expression of Serotonin Receptors by Murine Langerhans Cells
T. Hideshi, M. Hiroshi,* and T. Kunihiko*
Department of Dermatology, University of Tokyo Branch Hospital and *University of Tokyo, Tokyo, Japan
Serotonin has been known to show various physiological and pharmacological activities through its
speci®c receptors in the nervous, vascular, and gastrointestinal systems. Moreover, it has been
reported to regulate the cytokine production and the expression of surface molecules including
MHC class II by the immunocompetent cells such as macrophages and monocytes, suggesting that
it also plays an role in the immune system. Seven families of serotonin receptors (5-HT1~5-HT7),
some of which include several subtypes, have been identi®ed so far. The expression of serotonin
receptors and the effect of serotonin on Langerhans cells (LC) were investigated. Murine LC were
enriched from BALB/c epidermal cell suspension by panning method using anti I-Ad antibody and
the high purity (~95%) achieved by this procedure was con®rmed by ¯ow cytometry. Reverse
transcriptase-polymerase chain reaction revealed the expression of mRNA for 5-HT1A, 5-HT2A,
and 5-HT2B by LC. The expression of 5-HT2A was con®rmed by Western blot analysis. In order
to study the function of the serotonin receptors on LC, the effect of serotonin on the expression of
I-Ad, B7-1 and B7-2 was further examined. Although the expression of B7-1 and B7-2 on LC was
unchanged, I-Ad expression was suppressed by 1 mg/ml serotonin, suggesting the LC function was,
at least in part, regulated by serotonin through its speci®c receptors.
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C13
Dendritic Cells are Induced to Proliferate In Vivo by Interaction with Microparticles of
Speci®c Size
A. Gamvrellis, Th. Fi®s, J. Li, C. Osinski, I. McKenzie, and M. Plebanski
Vaccine Development and Infectious Disease Unit, The Austin Research Institute, Studley Road, Victoria,
Australia
Microparticles are readily taken up by phagocytic antigen presenting cells (APC) and have been
used to target antigen to these cells for vaccine development. A new phenomenon is presented by
which stimulation with microparticles in vivo induces proliferation of cells expressing dendritic cell
(DC) and Langerhans cell markers. Our results suggest that microparticles may provide a danger
signal to the immune system manifested by ampli®cation of cellular responses including expansion
in the number of potent APC types. The optimal microparticle size and composition capable of
stimulating these proliferative responses was determined and the mechanism by which DC were
induced to expand was explored by testing this phenomenon in a series of lymphokine de®cient
knockout mice.
C14
CD1a Positive Dendritic Cells Intracellularly Transport Antigen from the Skin to the
Regional Lymph Nodes in the Induction Phase of Allergic Contact Dermatitis
R.E. Hunger,* N. Yawalkar,*² Ch. U. Brand,* and L.R. Braathen*
*Dermatological Clinic, and ²Clinic for Rheumatology and Clinical Immunology/Allergology, University of
Berne, Switzerland
Dendritic cells are potent stimulators of T cell-mediated immune responses. In contact
hypersensitivity reactions in animals dendritic cells have been reported to pick up antigens in
the skin and migrate to the regional lymph node. In this study we analysed whether skin-derived
dendritic cells transport contact antigens via the afferent lymph in humans. By means of
microsurgical technique lymph cells were collected after painting a de®ned skin region on the leg
of 10 volunteers with the sensitizing agent 2,4 dinitrochlorobenzene 2%. Interestingly, in the
collected skin lymph speci®cally draining this painted area there was no signi®cant change in ¯ow,
output or composition of cells after antigen painting. Using ¯ow cytometric analysis we were able
to detect the antigen in CD1a+ dendritic cells of the afferent lymph 15-25 h after antigen
application. However, the antigen could only be detected after permeabilizing the dendritic cells,
indicating that the main part of the antigen is transported intracellularly and not on the surface of
these cells. Further analysis of cell surface antigens such as CD80, CD86, HLA-DR, CD11a,
CD14, CD23, CD25 and CD54 revealed that in the course of cutaneous sensitization the
phenotype of the dendritic cells does not seem to be altered in the afferent lymph. These results
provide direct evidence that during the induction phase of an allergic contact dermatitis in humans
antigen-bearing dendritic cells internalize the antigen and migrate from the skin via the afferent
lymph vessels to the lymph node.
C15
Osteopontin is Involved in the Initiation of Cutaneous Contact Hypersensitivity by
Inducing Langerhans and Dendritic Cell Migration to Lymph Nodes
A. C. Renkl,* M. Kimmig, L. Liaw,² Th. Ahrens,* H. Hotta,³ T. Uede,³ J. C. Simon,* and J. M.
Weiss*
*Department of Dermatology, University of Freiburg, Germany; ²Institute for Genetic Med. Hokkaido
University, Japan; ³Center of Mol. Med., Maine Med. Center Research Institute, Portland, Maine
Osteopontin (OPN) is a chemotactic protein that attracts in¯ammatory cells. The sensitization
phase of cutaneous CHS is dependent upon the migration of antigen-carrying Langerhans cells/
dendritic cells (LC/DC) from the skin to draining lymph nodes (LN). We investigated the
expression of OPN in the sensitization phase of CHS and found that OPN mRNA is up-regulated
both in the TNCB hapten sensitized skin and in LN draining such skin after hapten application.
Within skin especially endothelial cells expressed OPN. Speculating that OPN expression could be
a crucial factor in attracting DC to lymphatic organs, we investigated the role of OPN in DC
traf®cking. Migration-assays revealed that OPN-induced DC migration in a chemotactic manner.
In vivo s.c. injected OPN initiated LC emigration from the epidermis and OPN injected in close
proximity to LN draining the skin attracted DC into these nodes. The OPN receptors CD44 and
avb3 integrin are known mediators of OPN induced cell migration. We found both receptors on
DC upon their maturation in bone-marrow cultures. Antibodies against av and CD44 partially
blocked OPN mediated LC/DC migration in vitro and in vivo. When ultimately investigating OPN
function in vivo we found that OPN de®cient mice had a signi®cantly reduced CHS response to
TNCB. Furthermore, when wild type DC were injected into OPN de®cient mice, migration of
DC to regional LN was reduced dramatically compared to wild type mice. In conclusion we
demonstrate that OPN is a crucial factor in the initiation of CHS by guiding DC from skin into
lymphatic organs.
C16
Interleukin-18 is a Key Cytokine in the Initiation of Langerhans Cell Migration and
Contact Hypersensitivity Response in Mice
C. Antonopoulos, M. Cumberbatch,* J. B. Mee, R. J. Dearman,* F. Y. Liew,² I. Kimber,* and
R. W. Groves
Centre for Dermatology, University College London, UK; *Syngenta Central Toxicology Laboratory,
Maccles®eld, UK; ²Department of Immunology and Bacteriology, University of Glasgow, UK
Following skin sensitisation, Langerhans cells (LC) are stimulated to migrate from the epidermis via
afferent lymphatics to draining lymph nodes where they accumulate as immunostimulatory
dendritic cells. It has been demonstrated previously that interleukin (IL)-1b and tumour necrosis
factor-a (TNF-a) provide important signals for the initiation of LC migration. In the present study,
the ability of IL-18 to regulate LC migration and contact hypersensitivity (CHS) was examined
using IL-18 de®cient mice. Thus, IL-18±/± and control (wild type; WT) mice were sensitised
epicutaneously on abdominal skin with 1% oxazolone (OX) and challenged on the dorsum of the
ear with 0.5% OX 5 days later. Although WT mice responded with vigorous ear swelling,
signi®cant suppression (36%, n = 3; p < 0.05) of this response was observed in IL-18±/± mice.
Local pre-treatment of mice by intradermal injection of IL-18 (50 ng) prior to sensitisation with
OX, restored completely the CHS response in IL-18±/± mice (n = 3 experiments). To investigate
the in¯uence of IL-18 in allergen-induced LC migration, epidermal LC numbers were determined
following exposure of IL-18±/± and WT mice to 1% OX. Topical application of the contact
allergen resulted in a signi®cant decrease in the frequency of epidermal MHC class II+ LC 4 h after
exposure (26%, n = 3; p < 0.05) in control mice, as expected. However, this decrease was absent in
IL-18±/± mice. We next examined the response of LC in WT and IL-18±/± mice to intradermal
injection of IL-1b, TNF-a and IL-18. All three cytokines caused a signi®cant decline in epidermal
LC numbers 4 h (IL-1b and IL-18) or 30 min (TNF-a) after exposure in both WT and IL-18±/±
mice (n = 3 experiments) indicating that IL-18±/± LC are capable of migration when provided
with the appropriate cytokine stimuli. Taken together these data demonstrate that IL-18 is a critical
proximal mediator of contact allergen-induced LC migration and CHS and suggest that this
cytokine may be a key mediator of cutaneous immune responses.
C17
Differential Kinetics of Langerhans Cell Migration Stimulated in Mice by Chemical
Contact and Respiratory Allergens
M. Cumberbatch, R. J. Dearman, and I. Kimber
Syngenta Central Toxicology Laboratory, Alderley Park, Maccles®eld, UK
We have demonstrated previously, that repeated topical exposure of BALB/c strain mice to
chemical contact and respiratory allergens results in the selective activation of T helper 1 (Th1)-
and Th2-type cells, respectively. Thus, under conditions of exposure that induce equivalent levels
of immunogenicity with respect to IgG antibody production and draining lymph node cell (LNC)
proliferation, only treatment of mice with respiratory allergens elicits IgE antibody production and
a Th2-type cytokine secretion pro®le by LNC. We have now investigated the migration of
Langerhans cells (LC) from the epidermis and the accumulation of dendritic cells (DC) in draining
lymph nodes (DLN) induced following topical exposure of mice to the contact allergens
dinitrochlorobenzene (DNCB; 1%) and oxazolone (Ox; 0.5%). These responses were compared
with those provoked by trimellitic anhydride (TMA; 25%) and ¯uorescein isothiocyanate (FITC;
1%); sensitizers that stimulate a Th2 type cytokine pro®le. We demonstrate that whereas both Ox
and DNCB provoke signi®cant reductions in epidermal MHC class II+ LC frequencies within 4 hr
of exposure, the response to TMA reached signi®cance only after 17 hr. DC accumulation was also
more vigorous, with DNCB and Ox inducing approximately 5-fold increases in the accumulation
of DC in DLN compared with 2- to 2.5-fold increases for TMA and FITC. These data
demonstrate that under conditions of similar immunogenicity, chemical contact and respiratory
allergens display differential kinetics of LC migration. Such differences may ultimately in¯uence
the selective activation of Th cell subpopulations by these classes of chemical allergen.
C18
Poly I:C-Exposed Human Keratinocytes Acquire the Ability to Induce Type-1 Polarized
Phenotype in Dendritic Cells (DC1)
M. C. Lebre,*² J. C. Antons,*³ P. Kalinski,* M. L. Kapsenberg,*² and E. C. de Jong*²
Depts of *Cell Biology and Histology, ²Dermatology, ³Pulmunology, AMC, UvA, The Netherlands
Epidermal epithelial cells, keratinocytes (KC), represent the major constituent of the skin and
participate actively in the skin immune system by producing, constitutively or upon stimulation,
various soluble mediators. Immature dendritic cells (iDC) reside in the epithelia in close contact
with KC. Upon activation iDC undergo ®nal maturation and migrate toward secondary lymphoid
tissues, where they prime naive Th cells. Amongst others, IL-1b and TNF-a, which are produced
by KC, can induce iDC to mature. Therefore, we questioned whether the products of
differentially activated KC could induce DC polarization. To this aim, KC were pulsed with poly
I:C and or with IL-1b/TNF-a and KC-derived supernatants (50%, v/v) were added to iDC.
Exposure of maturing DC to poly I:C-activated keratinocyte supernatants enhanced their
expression of CD83. Neutralization of TNF-a reduced the phenotypic maturation of monocyte-
derived DC induced by poly I:C-exposed KC supernatants suggesting that TNF-a produced by
poly I:C-activated KC induced DC maturation. DC matured in the presence of poly I:C-activated
KC were able to induce the differentiation of polarized Th1 cells, although IL-12p70 production
was not affected. In contrast, DC mature in the presence of IL-1b/TNF-a-activated KC induce
the differentiation of a mixed population of Th1 and Th2 cells. Our results indicate that activated
KC may initiate speci®c immune responses by direct activation and polarization of DC.
1006 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
C19
Psoriatic Lesional Keratinocytes Promote the Maturation of Human Monocyte-Derived
Langerhans Cells
Yizhi Yu,1 Ling Tang,1* Minghui Zhang, ShuXun Liu, Wenya Wang, Maorong Zheng,* SuJiang
Tao,* and Xuetao Cao
Institute of Immunology, Second Military Medical University, Shanghai, P.R. China; *Department of
Dermatology, Changhai Hospital, Second Military Medical University, Shanghai, P.R. China
Langerhans cells (LCs) are a kind of important antigen-presenting cells in epidermis and may play a
key role in the pathogenesis of psoriasis. It has been proved that LCs isolated from psoriasis are
abnormal. However, the reason of the abnormality of LCs from psoriasis has not been reported so
far. In the present study, we investigated the effect of psoriatic lesional keratinocytes on the
maturation of LCs. At ®rst, the monocytes isolated from the healthy peripheral blood could
differentiate into LCs in the presence of GM-CSF, IL-4 and TGF-b1 for 5 days. Then the human
monocyte-derived LCs were cultured with the supernatants from psoriatic lesional keratinocytes
for another 2 days. Their phenotypes and phagocytic capacity were analyzed by ¯ow cytometry.
IL-12 secreted by the LCs was determined by ELISA. Their immunostimulatory capacity was also
detected by mixed lymphocyte reaction (MLR). The results showed that the supernatants from
psoriatic lesional keratinocytes could up-regulate the expression of HLA-DR and CD86 on LCs
more signi®cantly than the supernatants from healthy keratinocytes, but less powerfully than LPS.
Their immunostimulatory capacity was enhanced markedly and the levels of IL-12 secreted from
LCs also increased. But the expression of CD1a on LCs and their phagocytic capacity were
reduced. The results demonstrated that human monocyte-derived LCs cultured with the
supernatants from psoriatic lesional keratinocytes displayed the characteristics of maturation. It
suggests that psoriatic lesional keratinocytes might secrete some factors that could promote the
maturation of LCs, which may play important roles on immune reaction correlated to psoriasis.
1Yizhi Yu and Ling Tang contributed equally to this work.
C20
``Tracking & Tracing'' of Migrating Langerhans Cells
S. Holzmann, P. Stoitzner, H. StoÈssel, J. Valladeau,* S. Saeland,* S. Lebecque,* F. Koch, and N.
Romani
Department of Dermatology, University of Innsbruck, Innsbruck, Austria; *Laboratory for Immunological
Research, Schering-Plough, Dardilly, France
In response to in¯ammatory stimuli, Langerhans cells migrate from the epidermis to draining
lymph nodes and, if charged with antigen, generate T cell immunity there. Dermal dendritic cells
behave alike. In order to learn about the relative contributions of these two types of cutaneous
dendritic cells we studied migration in a murine skin explant model and in vivo using a novel
antibody recognizing the mouse homologue of Langerin. This allowed us to distinguish
Langerhans cells from dermal dendritic cells. Migrating dendritic cells in lymphatic vessels
(``cords'') consisted of both Langerhans cells and dermal dendritic cells in roughly equal
proportions. This was also true for dendritic cells that emigrated into the culture medium.
Numbers of Langerin-expressing cells in the lymph nodes increased upon epicutaneous application
of a contact sensitizer (FITC). These Langerin-positive cells in the nodes were also FITC-positive
indicating that they carried the antigen. A substantial proportion of Langerin-negative but FITC-
containing cells was also detected. This would emphasize an important role for dermal dendritic
cells in antigen carriage from the skin and, speci®cally, in contact hypersensitivity. Our data also
suggest that Langerin is a reliable Langerhans cell marker in vivo, as opposed to epidermal cell
cultures where it disappears during culture.
C21
Regulation of CCR6 Expression in Langerhans Cell Precursors: Suppression by IL-4 and
IFN-g and Induction by IL-10
M.-C. Dieu-Nosjean,*² C. Massacrier,* B. Vanbervliet,* W.-H. Fridman,² and C. Caux*
*Schering-Plough, Laboratory for Immunological Research, France and ²Laboratory of Cellular and Clinical
Immunology, INSERM U255, Curie Institute, France
Immune responses are initiated by Dendritic Cells (DC) that form a network comprising different
populations. In particular, Langerhans cells (LC) appear as a unique population of cells colonizing
epithelial surfaces. We have recently shown that MIP-3a/CCL20, a chemokine secreted by
epithelial cells, induces the selective migration of LC among DC populations. Here we studied the
effects of cytokines on the expression of the MIP-3a receptor, CCR6, during differentiation of
LC. We found that both IFNg and IL-4 blocked the expression of CCR6 and MIP-3a
responsiveness when added during LC development. In addition, when added on CCR6+
differentiated LC precursors, both cytokines down-regulated CCR6 expression and antagonized
their migration in response to MIP-3a. The IFNg induced down-regulation of CCR6 was
irreversible, in contrast, when IL-4 was withdrawn from the culture both CCR6 expression and
MIP-3a responsiveness were recovered. When other cytokines involved in DC and T cell
differentiation were tested, we found that IL-10, unlike IL-4 and IFNg, maintained CCR6
expression. The effect of IL-10 was reversible and upon IL-10 withdrawn, CCR6 was lost
concomitantly to ®nal LC differentiation. In addition, IL-10 induced the expression of CCR6 and
responsiveness to MIP-3a in differentiated monocytes. Finally TGF-b which induces LC
differentiation, did not alter early CCR6 expression but triggered its irreversible down-regulation,
in parallel to terminal LC differentiation. Taken together these results suggest that the recruitment
of LC at epithelial surface might be suppressed during Th-1 and Th-2 immune responses, and
ampli®ed during regulatory immune responses involving IL-10 and TGF-b.
C22
In¯ammatory Stimuli Promote Differentiation of Langerin+ Immature LC Type Cells
In Vitro, and the Recruitment of Immature LC within the Draining Lymph Node In Vivo
F. Geissmann, Y. Lepelletier, M.-C. Dieu-Nosjean,* C. Dezutter-Dambuyant,² S. Kayal, M.
Leborgne, C. Chalouni,³ J. Valladeau,§ S. Saeland,§ N. Brousse, and J. Davoust*
Pathology and Microbiology Departments and UMR CNRS 8603, IFR Necker-Enfants Malades, Paris
France; *U255 INSERM, Paris, France; ²U346 INSERM, Lyon France; ³Baylor Institute for
Immunology, Dallas, Texas; §Schering Plough Laboratory for Immunology Research, Dardilly, France
Maturation of dendritic cells (DC), i.e. switching from low to high expression of MHCII antigen
complexes and costimulatory molecules, is a critical event in the induction of immunity. DC
maturation in the periphery and DC migration to draining lymph nodes are thought to be
coordinated, but little is known regarding these events for Langerhans cells (LC). Using LC-type
cells cultured in the presence of TGFb1, we found that in¯ammatory stimuli such as TNFa and
bacterial products induce expression of Langerin-a LC speci®c C-type lectin- in up to 60% of
immature DCs. TNFa also induces LC migration towards lymph node chemokines. Although
these in¯ammatory stimuli induce the maturation of interstitial type DC they did not induce the
maturation of LC type cells in vitro. As an in vivo counterpart, we examined a series of in¯amed-skin
human draining lymph nodes. Strikingly, these lymph nodes selectively exhibited a massive
recruitment of immature LCs in T cell areas. Our results show that Langerhans cells can migrate to
secondary lymphoid organs in an immature stage in response to in¯ammation. Therefore stimuli
that induce maturation of LC appear to be distinct from those leading to their accumulation in
lymph nodes. The role of LC in the regulation of immune responses should thus be re-evaluated,
since antigen bearing LCs can either transmit antigen to bystander DCs within lymph nodes,
undergo maturation, or induce tolerance in absence of maturation.
C23
Dendritic Cells Exposed to Extracellular ATP Acquire the Migratory Properties of
Mature Dendritic Cells and Reduce the Capacity to Attract Type 1 T Lymphocytes
A. la Sala, S. Sebastiani, D. Ferrari,* A. Cavani, M. Izdko,² J. Norgauer,² F. Di Virgilio,* and G.
Girolomoni
Lab. of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy; *Department of
Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; ²Department of Experimental
Dermatology, Freiburg, Germany
We recently reported that chronic stimulation with low, noncytotoxic doses of extracellular ATP,
induced a distorted maturation of dendritic cells (DCs) with reduced production of TNF-a and
IL-12 but unchanged release of IL-10. As a result, DCs matured in the presence of ATP showed an
impaired capacity to initiate Th1 responses in vitro. Here we examined the effects of ATP on the
chemokine receptor asset of DCs. As shown by FACS analysis and RNase protection assay, ATP
strongly induced CXCR4 expression both in immature and in LPS-stimulated DCs. Moreover,
CCR7 was slightly up-regulated mainly in mature DCs. In contrast, ATP reduced CCR5
expression on immature DCs. ATP increased migration and intracellular calcium transients of
immature and mature DCs to SDF-1 and MIP-3b, while responses to MIP-1b were reduced.
Mature DCs are an important source of chemokines in¯uencing the recruitment of distinct T
lymphocyte subsets. ATP signi®cantly reduced LPS-induced production of IP-10 and RANTES,
but did not affect the release of MDC and TARC. Consistent with this ®nding, supernatants from
mature DCs exposed to ATP attracted less ef®ciently Th1 and Tc1 cells, whereas migration of Th2
and Tc2 cells was not affected. In aggregate our data suggest that ATP provides a signal for lymph
node localization of DCs and impairs their capacity to attract type 1 T lymphocytes.
C24
The CD1a+CD11c+ Langerhans Cell Precursors are the Most Susceptible Blood
Leucocytes for HIV Infection
P. U. Cameron, A. Handley, D. C. Baylis, J. C. Reece, S. R. Lewin, and D. F. Purcell
Department of Microbiology and Immunology, University of Melbourne Grattan St, Parkville, Victoria,
Australia
Using skin explants we have previously shown HIV-1 entry into Langerhans cells and preferential
transmission of macrophage tropic HIV-1 after virus exposure. Primate studies have mostly
supported this role for DCs however, recent studies of SIV in macaques have shown CD4 T cells
are the ®rst to express HIV-1 at the site of entry. Models based on initial infection of T cells or on
lectin binding and carriage by DC do not allow for HIV-1 selection. Since CCR5 is involved in
HIV-1 selection and viral entry whatever the route of infection we have examined directly isolated
blood leucocytes to determine if initial entry is via the different DC subpopulations. DCs,
identi®ed as lin- [CD3-, 14-, 16-, 19-] HLA-DR+ cells were sorted into subpopulations using the
additional markers CD123, CD11c and CD1a. After exposure of sorted uncultured blood
leucocytes for 2 h HIV-1 entry was determined using quantitative realtime PCR at 24 h. The
highest frequency of infection was found in the CD1a+CD11c+ Langerhans cell precursors. The
CD11c+CD1a- and CD11c- DCs were infected at a lower frequency and the CD14+ and CD16+
monocytes and lymphocytes were infrequently infected. A similar preferential entry of HIV-1 into
the CD11c+ DCs was found if the whole PBMCs were infected and cultured for 0, 12, 36 h before
determining entry into the sorted sub-populations. Ef®cient virus production occurred after DC
infection and coculture with T cells but only low levels of virus production occured after infection
of the monocytes or T cells.
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C25
Correlation Between CD123+ (Lymphoid) Dendritic Cell Recovery and Better Infection
Control in Primary HIV Infection
A. Hosmalin,1 S. Kahi,1 J. Pacanowski, M. Baillet, P. Lebon,* C. Deveau,² C. Goujard,³ L.
Meyer,² and M. Sinet§
INSERM 445, ICGM, Paris, *Virology, St-Vincent de Paul Hospital, Paris, ²INSERM 292,
³PRIMO Cohort, Internal Medicine, and §CRI 9612, BiceÃtre Hospital, Kremlin-BiceÃtre, France; 1both
contributed equally.
Successful immunological control of HIV infection is only achieved in rare individuals. Dendritic
Cells (DCs) are required for speci®c antigen presentation to naive T lymphocytes and for antiviral,
type I Interferon secretion. We have previously found a decreased proportion of blood CD11c+
(myeloid) DCs in chronic HIV+ patients. In this study, we have used rare event analysis of three-
colour ¯ow cytometry data. We have studied longitudinally 13 patients during primary infection,
before and after highly active antiretroviral therapy. Twenty six to 57 days after contamination,
CD123+ (lymphoid) and CD11c+ DC numbers were dramatically reduced in the 13 HIV+ patients
compared to 13 controls (p = 0.0002 and 0.001, respectively). After 6-12 months of highly active
antiretroviral therapy, DC subpopulation average numbers remained low, but CD123+ DC
numbers increased again in 5/13 patients. A strong correlation was found between this increase and
CD4 T cell count increase (p = 0.0009) and plasmatic viral load decrease (p = 0.009). DC number
restoration may be predictive of immune restoration and may be a goal for immunotherapy to
enhance viral control in a larger proportion of patients.
C26
Comparative Inhibition of R5 HIV Infection in Epidermal Langerhans Cells by Novel
Chemically Modi®ed RANTES Analogues
T. Kawamur and A. Blauvelt
Dermatology Branch, NCI, Bethesda, Maryland
Initial biologic events that underlie sexual transmission of HIV are poorly understood, although it is
believed that mucosal Langerhans cells (LC) are initial targets for virus. It is also known that the
majority of transmitted viruses utilize CCR5 as a co-receptor for entry into cells (i.e. R5 viruses).
To model these events, we recently reported that LC within epithelial tissue explants could be
preferentially infected with R5 HIV isolates (Kawamura et al, J Exp Med, 2000). Here, to help
elucidate a potent inhibitor of HIV infection in LC, we directly compared the HIV blocking ability
of four novel chemically modi®ed chemokines that bind CCR5 (AOP-RANTES, NNY-
RANTES, PSC-RANTES, and UCB-RANTES) using our explant model. As quanti®ed by
intracellular HIV p24 staining of LC and ¯ow cytometry, all analogues could block R5 HIV in a
dose-dependent manner (1-100 nM) when pre-incubated with explant tissue for 20 min prior to
HIV exposure. Furthermore, all analogues could inhibit LC-mediated HIV infection of CD4+ T
cells that were co-cultured with LC. Interestingly, the newer analogues, especially PSC-RANTES
and UCB-RANTES, performed signi®cantly better than AOP-RANTES at a dose of 10 nM
(p < 0.01). In summary, we document R5 HIV infection in single LC following exposure to virus
within epithelial tissue and show that this infection can be blocked by pre-incubation of tissue with
drugs that compete with virus binding and entry into cells. The fact that RANTES analogues could
also block transmission of virus to T cells suggests that LC infection, and not virus bound to LC via
a C-type lectin, is the most important mechanism by which LC transmit HIV to T cells.
Importantly, these results suggest that a topical microbicide containing a chemically modi®ed
RANTES analogue may be useful in blocking sexual transmission of HIV.
C27
CD40-Ligation In Vivo Promotes Activation and Migration of Dendritic Cells and
Enhances Resistance to Infection with Mycobacterium tuberculosis
S. Jolles,* R. Tascon, G. Klaus,* A. Ager,* and M. J. Colston
Divisions of Cellular Immunology* and Mycobacterial Research, The National Institute for Medical Research,
The Ridgeway, Mill Hill, London, UK
Adaptive immune responses begin after antigen bearing dendritic cells (DCs) traf®c from peripheral
tissues to lymph nodes where they play a key role in the initiation of speci®c T-cell responses.
Ligation of CD40 is known to be an important signal in the activation and migration of Langerhans
cells (LC). Furthermore the importance of CD40 ligation in the generation of protective immune
responses against infectious agents (Leishmania major, Trypansoma cruzi) and tumors has been
demonstrated in a number of studies. M.tuberculosis has been shown to use a number of evasion
strategies to avoid an effective immune response including impairment of antigen presentation and
down-regulation of CD40 ligand. We investigated whether there is an impairment of Langerhans
cell migration in M.tuberculosis infected mice and whether ligation of CD40 using an anti CD40
mAb could overcome any antigen processing/presentation defect in M.tuberculosis infected mice
and result in increased immunity against M. tuberculosis infection. We have demonstrated that
CD40 ligation in vivo results in Langerhans cell migration from the epidermis with virtual clearing
of LC by day 7 following anti-CD40 mAb. Epidermal LC have a more mature phenotype and
dendritic cells accumulate in the draining nodes of anti-CD40 treated mice. M.tuberculosis infected
mice were treated with either anti-CD40 or control antibody. The colony counts of M.tuberculosis
in the lungs and spleens showed a 10-100 fold reduction in viable M.tuberculosis. This effect is
greater than any other immunological therapy to date (including dendritic cell immunotherapy and
DNA vaccination) and suggests potential new approaches in multidrug resistant M.tuberculosis and
vaccine design.
C28
DermaVir: A Langerhans Cell-Mediated DNA Immunization Technology for the
Induction of Cellular Immune Responses
J. Lisziewicz, J. Xu, J. Trocio, L. Whitman, G. Varga, P. Erbacher,* C. Fox,² R. Woodward,³ P.
Markham,³ S. Arya,§ J.-P. Behr,* and F. Lori
Research Institute for Genetic and Human Therapy (RIGHT), Washington DC; *Laboratoire de Chimie
Genetique, Faculte de Pharmacie, Illkirch, France; ² Advanced BioScience Laboratories, Inc., Rockville,
Maryland; ³ Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arizona; §
NIH, NCI, USA
A practical, non-invasive transcutaneous gene transfer technology has been developed to
genetically engineer large numbers of lymph node dendritic cells in order to induce potent T cell-
mediated immune responses. Plasmid DNA was formulated with mannosylated polyethylenimine
(PEIm) in a glucose-water solution to transduce Langerhans cells in the epidermis. DNA-
expressing Langerhans cells migrated to the T cells area of the draining lymph node, interdigitated
as dendritic cells and presented DNA-derived antigens to T cells. The unprecedented high ef®cacy
of this approach was demonstrated in a non-human primate model where 0.025 mg DNA applied
on the surface of the skin resulted in ca. 20 000 gene-expressing dendritic cells in one draining
lymph node. Large number of SIV-speci®c T cells were detected in monkeys immunized on the
surface of the skin with a SHIV expression plasmid (DermaVirSHIV). This novel technology is
expected to provide a new, general scheme for developing therapeutic and preventive vaccines
against viral and neoplastic diseases.
C29
Active Migration of Human Monocyte-Derived Dendritic Cells from Skin to Regional
Lymph Nodes Depends on their Stage of Maturation
P. Keikavoussi, W. Becker,* E. Werner,² A. Opitz,³ E. -B. BroÈcker, J. Becker, P. Friedl, and E.
KaÈmpgen
Department of Dermatology, University of WuÈrzburg; *Department of Nuclear Medicine, University of
GoÈttingen, ²Department of Nuclear Medicine, University of WuÈrzburg; ³Department of Transfusion
Medicine, University of WuÈrzburg, Germany
The feasibility to produce high numbers of dendritic cells (DC) from human monocytes (moDC)
has stimulated increasing interest in DC based immunotherapy of tumor patients. Whereas a high
T cell stimulatory property of moDC has clearly been shown in vitro, reliable data on their in vivo
migratory capacities are lacking. To determine the in vivo migratory capacity of moDC, 2 Mio
moDC indium-111 labeled cells were injected intra- and subcutaneously in a voluntary patient,
who as a physician was himself interested in these data. Imaging over the injection sites and
draining lymph nodes was obtained at 4, 24, 48 and 96 h and the percentage of clearance for each
area of interest calculated. Immature DC, obtained from monocytes by a 7d culture with GM-CSF
and IL-4 were bad migrators: only following i.c. injection a small amount of the injected activity
was found in the draining inguinal and iliacal lymph nodes. In contrast, ic. and sc. injections of
moDC that were further matured over 3d with a cocktail of in¯ammatory cytokines (IL-1, IL-6,
TNF, PGE2) yielded 8-12% activity within regional nodes. No nodal activity was detected when
matured DC were ethanol ®xed prior injection. This is the ®rst in vivo proof that human monocyte
derived DC, if properly matured, do actively and ef®ciently migrate from peripheral injection sites
to draining lymph organs. Thus there is no need for dif®cult intranodal injections of DC in
patients, which even bear the risk of damaging the lymph node architecture.
C30
Generation of Optimal Monocyte-Derived Dendritic Cells for Immunotherapy:
In¯uence of Maturation Conditions on Antigen Presentation
M. L. Bosch, P. Crosby, A.-A. Elgamal, T. Howard, H. Kelley, T. Lake, D. Lin, A. Lodge, J.
McEarchern, S. Monahan, M. Salgaller, G. Shankar, B. Tjoa, L. Trimble, A. Turner, and Y. Zhou
North-west Biotherapeutics, Inc., Bothell, Washington
Monocyte derived dendritic cells (MODC) are increasingly used for immunotherapy of cancer.
For human clinical trials, U.S. regulatory agencies dictate that the cells must be generated under
Good Manufacturing Practice (GMP) conditions, using no animal-derived products.
Consequently, we have established serum-free culture conditions for human MODC that result
in a highly puri®ed preparation. These cells ef®ciently take up different antigenic preparations,
including recombinant proteins, inactivated virus, and whole tumor cells, and can stimulate speci®c
responses to these antigens in vitro. To induce maturation, we use heat-killed Baccille Calmette-
Guerin (BCG), or BCG + gamma interferon (IFNg). Inclusion of IFN. during maturation induces
the production of high levels of interleukin 12 and tumor necrosis factor (TNFa), and down-
regulation of interleukin 10. Both immature MODC, as well as cells matured with BCG alone or
with BCG + IFNg are able to stimulate peptide-speci®c T cell lines, whereas especially MODC
matured with BCG + IFNg effectively stimulate CD4+ and CD8+ primary T cell responses. For
immunotherapy of hormone refractory prostate cancer patients, we prepared MODC loaded with
prostate speci®c membrane antigen (PSMA). Upon injection into the patients, these cells generated
signi®cant humoral and cellular immune responses. A current update of clinical data from this trial,
including CT scans, bone scans and PSA values, will be presented and discussed.
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IL-12-Secreting Dendritic Cells are Required for Optimal Activation of Human
Secondary Lymphoid Tissue T-Cells: Implication for Anti-Tumoral Vaccination
Protocols
H. Rouard, J. Marquet, A. LeÂon, C. Haioun, C. Copie, A. Plonquet, J.-P. Farcet, and M.-H.
Delfau-Larue
Departments of Immunology, Cellular Therapy, Pathology and Clinical Hematology of Henri Mondor
hospital, Assistance Publique-HoÃpitaux de Paris, Etablissement FrancËais du Sang and University of Paris
XII, CreÂteil, France
Successful antitumor immunization requires that mature dendritic cells (mDC) prime T cells in
secondary lymphoid tissue (LT). However, in contrast to peripheral blood T-cells, multiple
costimulatory signals are required for triggering LT T-cell activation. This study was designed to
optimize mDC immunogenicity in accordance with lymphoid tissue T-cell requirements.
Monocyte-derived DC differentiated in GM-CSF/IL-13 were matured for 24 h with soluble
CD40Ligand (sCD40L-mDC) or IFN-g combined with sCD40L (sCD40L/IFNg-mDC). T cells
from secondary lymphoid tissues were puri®ed from spleen, tonsil and lymph node samples by
immunomagnetic selection. We report here that 1) Although mDC expressed similar membrane
phenotype including CD83 expression, only sCD40L/IFNg signaling induce high levels of IL-
12p70 secretion by mDC. 2) sCD40L/IFNg-mDC increased allogeneic LT T-cell proliferative
responses as compared with sCD40L-mDC. IL-12 neutralizing antibody prevented the effect of
IFN-g addition. 3) IL-12-secreting DC promote IFN-g production from LT CD4+ cells. LT T-
cells IFN-g release was partially inhibited by neutralizing IL-12 antibody. 4) sCD40L/IFNg-mDC
enhanced the cytotoxic CD8+ generation from lymphoid tissue T-cells. In conclusion, IL-12-
secreting DC are required for optimal proliferation, IFN-g secretion and cytotoxic responses of LT
T-cells. DC to be used for immunization protocols should be characterized by their IL-12
secretion as an additional costimulatory signal potentially critical for the triggering of an antitumor
immune response by LT T-cells.
C32
Autologous MUC-1 Pulsed Dendritic Cells are a Safe, Feasible Treatment Approach in
Patients with Cancer and are Associated with Cellular Immune Responses
F. Nussey,* M. Waterfall,* K. Samuel,² A. Atkinson,² R. Leonard,* and M. Turner*²
*University of Edinburgh, Department of Oncology, Edinburgh; ²Scottish National Blood Transfusion
Service, Cellular Therapeutics Group, Western General Hospital, Edinburgh
Dendritic cells (DC) are professional antigen presenting cells capable of inducing MHC restricted
antigen speci®c CD4 and CD8 T cells in vitro when pulsed with tumor antigens. DC function in
patients with malignancy is de®cient and re-administration of ex-vivo cultured DC may reverse this.
MUC-1 is a trans-membrane glycoprotein aberrantly glycosylated in some human cancers soan
occult epitope is exposed, providing an immuno-therapeutic target. A phase 1 clinical trial of
MUC-1 pulsed DC began in July 1999. 12 patients with various primary cancers have been
treated. DC were generated from adherent peripheral blood mononuclear cells using GM-CSF and
IL4, and pulsed with a liposomal preparation of a 25-mer peptide from MUC-1 (BLP-25, Biomira
Inc) before re-administration by subcutaneous injection. Patients received between 0.075 3 106
and 1.0 3 106 dc per kg body weight in one or two doses. Followed up for toxicity, immune
response and clinical effects at days 1, 7, 14, 28 and 90. 11 patients are assessable, more than 28 days
from treatment. Minor, grade 1 toxicitites reported by 8 patients. Grade 2 fatigue seen in 2, myalgia
in 1 and anaemia in 1. No grade 3 or 4 toxicities. 4 patients had stable disease radiologically and
clinically at 28 days, but all progressed by 3 months. Immunologically a small but signi®cant
increase occurred in proliferative response to the muc-1 antigen in patients over time compared
with controls (n = 6). Increased responses seen to repeated skin testing with ppd, a recall antigen,
following the dc therapy (n = 9). Patients mean pre-treatment value was 3.2mm, post treatment
13mm (p = 0.03, students t test), controls (n = 5), showed no response to re-testing over the same
time period (initial test mean 17.6mm, repeated test mean 23.6mm, p = 0.13, students t test). This
phase 1 trial demonstrates a safe, feasible treatment approach with biological effects in patients with
a range of malignancies.
C33
Accumulation of Langerhans Cells in the Skin of Epithelium-Speci®c PTEN Knockout
Mice
B. Wang, S. A. Backman, I. Freed, Q. C. Cai, H. Watanabe, B. G. Howell, W. Kalair, S. Shahid,
B. Tuvel, T. W. Mak, and D. N. Sauder
Division of Dermatology, Sunnybrook & Women's College Health Science Centre, Toronto; and Amgen
Institute, Toronto, Canada
The PTEN gene is a highly mutated tumor suppressor gene. Somatic deletions or mutations of this
gene have been identi®ed in a wide range of tumors such as gliomas, endothelial, prostate and
breast cancers. The PTEN tumor suppressor plays a critical role in cell programming apoptosis and
cell cycle arrest. In addition, in vitro studies have demonstrated that PTEN may participate in the
regulation of T cell survival and TCR signaling, implicating a potential role of PTEN in immunity.
However, in vivo studies have been impeded by the embryonic lethality of the homozygous PTEN
knockout mice. To directly address the role of PTEN in skin immunity, we have recently
developed epithelium-speci®c PTEN knockout mice (PTEN WAP±/±). These mutant mice are
viable and demonstrate a speci®c PTEN de®ciency in the epidermis. Intriguingly, PTEN WAP±/±
mice spontaneously developed chronic cutaneous in¯ammation in the trunk, head and ears.
Clinically, the dermatitis was characterized by the thickened and reddened skin, as well as abnormal
hairs. Histologically, lesional skin demonstrated hyperkeratosis, acanthosis, dermal thickening and
mixed cellular in®ltration. Most interestingly, Langerhans cells were dramatically increased in the
epidermis and follicular epithelium, suggesting a potential role of PTEN in differentiation and/or
activation programs of cutaneous dendritic cells. Collectively, our data demonstrate a signi®cant
role of PTEN in the cutaneous in¯ammatory and immune response.
C34
High Numbers of In®ltrating Langerhans Cells in the Absence of MHC IIhigh
Macrophages is Associated with Skin Tumour Regression
S. N. Byrne and G. M. Halliday
Department of Medicine (Dermatology), The University of Sydney at Royal Prince Alfred Hospital, Sydney,
Australia
Dendritic cells (DC) such as Langerhans cells (LC) are important in the induction of anti-tumour
immunity and are currently being used in clinical trials. To address their interaction with tumour
cells, UV-radiation induced skin cancers which spontaneously regress upon transplantation into
syngeneic mice because they activate the immune system were compared to progressing skin
tumours which evade immunological destruction. Flow cytometric analysis revealed that regressing
tumours were in®ltrated by greater numbers of mature DC (CD11c+CD45+) compared to
progressing skin tumours. DC derived from both tumour groups had an ``activated'' phenotype
compared to in vitro matured epidermal LC, with high surface expression of MHC II, CD80,
CD86 and Fas. However in contrast to both fresh and matured epidermally-derived LC which
expressed moderate levels of the chemokine receptors CCR5 and CXCR4, skin tumour derived
DC had no surface expression of these receptors. Thus, it is possible that there is a dysregulation in
the ability of DC from both tumour groups to respond to chemokines. DC derived from both
tumours were ``myeloid-related'' with high levels of Mac-1 and F4/80 but no CD4. No
``lymphoid-related'' CD8a+ DC could be detected in either tumour type. Progressing but not
regressing skin tumours were heavily in®ltrated by MHC IIhigh macrophages. Thus, it is possible
that the larger number of DC in regressor tumours stimulates immunity, although they may not be
able to migrate from the tumour as they failed to express chemokine receptors. In contrast the
macrophages present in progressor tumours may inhibit the induction of immunity.
C35
Blood-Derived Myeloid and Plasmacytoid Dendritic Cells Differ in Responsiveness to
Pathogenic Compounds and Expression of Toll-Like Receptors
E. C. de Jong,* R. M. Bleijswijk,* J. H. N. Schuitemaker,* and M. L. Kapsenberg*²
*Department of Cell Biology and Histology and ²Department of Dermatology, Academic Medical Center,
University of Amsterdam, Amsterdam, The Netherlands
Speci®c immunity to pathogens requires activation of sentinel dendritic cells (DC). Distinct subsets
from different lineages, e.g. myeloid DC and plasmacytoid DC, have been described. Using newly
described antibodies (BDCA1-4) we have isolated three distinct DC-subsets from peripheral blood
and analysed these subsets for their responsiveness to different pathogenic compounds and their
Toll-like receptor (TLR) expression. Myeloid BDCA1+ or BDCA3+ DC produced IL-12p70,
IL-6 and TNF-a but no IFN-a in response to LPS or dsRNA, whereas plasmacytoid
BDCA2+ DC produced high levels of IFN-a, TNF-a and IL-6 but no IL-12p70 in response to
bacterial CpG-motifs but not to LPS or dsRNA. To our surprise also myeloid BDCA3+ DC
responded to CpG motifs with the production of IFN-a, TNF-a and IL-6 but no IL-12p70.
Analysing the mRNA expression of TLR1-9 we found that TLR2 and 4, the receptors for LPS,
were expressed by all 3 subsets, which is not in line with their LPS-responsiveness. However, as
expected from the responsiveness to CpG motifs, the receptor for CpG, e.g. TLR9 was found in
BDCA2+ and BDCA3+ DC but not in BDCA1+ DC. This study suggest that reactivity to
pathogenic compounds is mediated by distinct subsets of DC with different cytokines pro®les and
expression of TLR.
C36
BDCA-2, a Novel Plasmacytoid Dendritic Cell-Speci®c C-Type Lectin Type II
Transmembrane Protein: Molecular Cloning and Functional Characterization
J. Schmitz,1 A. Dzionek,2 Y. Sohma,2* J. Nagafune,2* M. Cella,² M. Colonna,² and Y.
Yamaguchi1*
Miltenyi Biotec GmbH, Germany; *Kirin Brewery, Co., Ltd, Japan; ²Basel Institute for Immunology,
Switzerland; 1share senior authorship, 2contributed equally to this work
Plasmacytoid dendritic cells (PDCs, also known as interferon (IFN)-a/b-producing cells or type-2
pre-dendritic cells) are present in lymphoid and non-lymphoid tissue and contribute substantially
to both innate and adaptive immunity. Recently, we have described several mAbs that recognize a
PDC-speci®c antigen which we have termed BDCA-2. Molecular cloning of BDCA-2 revealed
that BDCA-2 is a novel C-type lectin type II transmembrane protein with 50% identity and 69%
homology at the amino acid level to human DCIR. Anti BDCA-2 mAbs are rapidly internalized
and ef®ciently presented to T-cells indicating that BDCA-2 can function in ligand internalization
and presentation. Furthermore, ligation of BDCA-2 suppresses both in¯uenza virus-induced and
DNA/anti dsDNA mAb complex-induced IFN-a/b production by PDCs, presumably by a
mechanism dependent on calcium mobilization and protein-tyrosine phosphorylation by Src-
family protein-tyrosine kinases. Inasmuch as production of IFN-a/b by PDCs is believed to be a
key pathophysiological factor in systemic lupus erythematosus (SLE), BDCA-2 represents an
attractive target for blocking production of IFN-a/b in SLE patients.
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Rapid Chemokine-Mediated Binding of T Cells to Dendritic Cells (DC) Under Dynamic
Conditions
M. Wu, H. Fang, and S. T. Hwang
Dermatology Branch, NCI. Bethesda, Maryland
The binding of a T cell to an antigen-laden DC is a critical step of the acquired immune response.
Activated DC synthesize a variety of chemokines including CCL22 (a CCR4 ligand) that can
attract T cells. Herein, we address whether DC-produced CCL22 can induce the arrest of T cells
to DC. Maturing bone marrow-derived DC were allowed to adhere to anti-CD40 pre-coated
plastic tissue culture plates at high density. Within a parallel plate ¯ow chamber, shear-dependent
arrest of B 9.1 T cell hybridoma cells was observed with maximal arrest at or below 0.2 dynes/cm2.
Arrest of B 9.1 cells was inhibited by > 85% with anti-CCL22 or anti-CD18 (but not anti-
CXCL13) antibodies (Ab), pretreatment of B 9.1 cells with CCL22 (but not CCL5 or CXCL10)
or pertussis toxin (PTX) (p < 0.01). At 0.2 dynes/cm2, ovalbumin-immunized (memory) T cells
(mTC) from DO11.10 mice showed 3-fold more ef®cient binding to DC than did naõÈve T cells
(nTC) although nTC demonstrated consistent binding to DC. mTC (but not nTC) binding to DC
was inhibited (> 80%, p < 0.01) by anti-CCL22 antibodies, PTX, and CCR4 desensitization with
CCL22. mTC to DC arrest occurred in less that 0.5 s. Our results demonstrate that DC-produced
CCL22 induces rapid binding of T cells under dynamic conditions and that mTC and nTC
fundamentally differ with respect to chemokine-dependent binding to DC.
C38
Regulation of Immune Responses by Interleukin-10 Treated Dendritic Cells In Vivo
A. MuÈller and A. Enk
Dermatology, Johannes Gutenberg-University, Mainz, Germany
Interleukin-10 (IL-10) is an immuno-modulatory cytokine expressed by various immune cells as
well as tumor cells. IL-10 treatment of dendritic cells (DC) affects the expression of MHC and
costimulatory molecules such as CD80 and CD86. It was shown in vitro that IL-10 treated human
blood-derived DC induce anergy in CD4+ and CD8+ clonal or naive T cells. In this study we
analysed the effect of IL-10 treated DC in vivo using the OVA-TCR transgenic and the murine
experimental autoimmune encephalopathy (EAE) system, a model system for multiple sklerosis. In
the OVA-TCR transgenic system dendritic cells not only prevented OVA-speci®c immune
responses in naive mice but also inhibited immunity in previously sensitized mice. This inhibition
was detected by antigen speci®c proliferation ex vivo and by DTH reactions in vivo. The effect was
long lasting and could not be reversed by subsequent antigen stimulation. In the EAE model mice
injected with IL-10 treated DC prior to EAE induction developed no clinical symptoms. DC
injection 5 days past EAE induction also prevented disease-onset. In the EAE system the inhibitory
effect of IL-10 treated DC was not antigen-speci®c. As IL-10 treated DC represent a population of
immature DC which have been shown to induce regulatory T cells we are currently studying
whether induction of regulatory cells might account for the effects seen in both systems.
C39
Immature Langerhans Cells: Central Role in Tolerance Induction in Carcinogen-
Treated and Neonatal Skin
H. K. Muller, K. V. Doherty, A. L. Dewar, Y. P. Chen, B. H. Toh, and G. M. Woods
University of Tasmania, Discipline of Pathology, Hobart, Tasmania, Australia
Antigen presented across dimethylbenzanthracene (DMBA)-treated BALB/c skin results in the
induction of antigen speci®c tolerance rather than immunity. DMBA treatment of skin triggers the
enhanced migration of Langerhans cells (LC) to draining lymph nodes and epidermal replacement
by immature LC. Morphologically, these new arrivals are small rounded cells with poorly formed
dendrites. These immature cells carry less antigen to lymph nodes, have a reduced costimulatory
molecule expression and impaired capacity to induce T cell proliferation. Comparative analysis in
4 day old neonatal skin revealed that the LC were small and rounded with poor dendrite formation.
Likewise they have an impaired ability to transport antigen to the draining lymph nodes. They
have reduced costimulatory molecule expression, fail to express DEC205 and are unable to induce
T cell proliferation. Antigen applied across such skin also results in antigen speci®c tolerance. By
day 14 the LC of neonatal skin have a typical dendritic morphology and antigen applied across this
skin results in a positive immune response. We are now using immature LC as an approach to
down-regulate the development of autoimmune gastritis. In short, the active antigenic peptide
associated with this disease, when presented across neonatal skin, curtails the development of the
autoantibody against parietal cells and the pathological lesions. It is concluded that pulsing
immature LC with autoantigens offers a strategy to prevent the development of autoimmune
disease.
C40
Inhibition of Epidermal Langerhans Cells in Early Events of Murine Schistosomiasis
V. Angeli, C. Faveeuw, J. Fontaine, M. Capron, and F. Trottein
*Centre d'Immunologie et de Biologie Parasitaire, INSERM U 547, Institut Pasteur de Lille, France
Epidermal Langerhans cells (LCs) play a key role in immune defence mechanisms and in numerous
immunological disorders. We show that percutaneous infection of C57BL/6 mice with the
helminth parasite Schistosoma mansoni leads to the activation of LCs but, surprisingly, to their
retention in the epidermis. Moreover, using an experimental model of LC migration induced by
TNFa, we show that parasites transiently impair the departure of LCs from the epidermis and their
subsequent accumulation as dendritic cells in the draining lymph nodes. The inhibitory effect is
mediated by soluble lipophilic factors released by the parasites and not by host-derived anti-
in¯ammatory cytokines. We ®nd that prostaglandin (PG)D2, but not the other major eicosanoids
produced by the parasites, speci®cally impedes the TNFa-triggered migration of LCs through the
adenylate cyclase-coupled PGD2 receptor (DP receptor). Moreover, the potent DP receptor
antagonist BW A868C restores LC migration in infected mice. Finally, in a model of contact
allergen-induced LC migration, we show that activation of the DP receptor not only inhibits LC
emigration but also dramatically reduces the contact hypersensitivity responses after challenge.
Taken together, we propose that the inhibition of LC migration could represent an additional
stratagem for the schistosomes to escape the host immune system and that PGD2 may play a key
role in the control of cutaneous immune responses. The putative ef®ciency of PGD2 analogues in
diseases where reduction of immune cutaneous response is sought (dermatitis) or, conversely, in
diseases where stimulation of LC migration would be bene®cial (carcinomas, infectious
pathologies) will be discussed.
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Ontogeny of Langerin Expression in Mouse Skin
C. Tripp, S. Holzmann, P. Stoitzner, J. Valladeau,* S. Saeland,* S. Lebecque,* F. Koch, and N.
Romani
Department of Dermatology, University of Innsbruck, Innsbruck, Austria, and *Laboratory for Immunological
Research, Schering-Plough, Dardilly, France
As Langerhans cells populate the epidermis in fetal and neonatal life, they acquire surface molecules
in a stepwise fashion. In the mouse, ATPase-expressing and CD45-positive cells of dendritic
morphology appear in late fetal life. These cells do not yet express MHC class II molecules, neither
on the suface nor intracellularly. MHC class II expressing cells show up only after birth, they
increase in numbers and by the 5th postnatal day virtually all Langerhans cells express MHC class II.
It has not been systematically studied when in ontogeny Birbeck granules arise. Therefore, we
made use of a newly developed mAb recognizing the murine homologue of Langerin. Epidermal
sheets were prepared from the skin of late fetal (i.e. fetal days 9-19) and postnatal (i.e. day of birth,
days 1, 5, 18, and adult) BALB/c mice. They were labelled with anti-Langerin mAb and visualized
with FITC-conjugated second-step antibodies.
We found that Langerin expression was very low or absent on Langerhans cells from mice 5 days
after birth. In contrast, Langerhans cells from mice on day 18 after birth were like Langerhans cells
from adult mice: There was an almost 100% overlap of HC class II and Langerin. We conclude that
Birbeck granules appear relatively late in the development of Langerhans cells. It appears that in vivo
Langerhans cell precursor cells do not yet possess Birbeck granules.
P2
The Concept of Lymphoid Versus Myeloid Dendritic Cell Lineages Revisited: Both
CD8a± and CD8a+ Dendritic Cells are Generated from CD4low Lymphoid-Committed
Precursors
C. ArdavõÂn, P. MartõÂn, G. MartõÂnez del Hoyo, C. FernaÂndez Arias, and F. AnjueÁre
Department of Cell Biology, Faculty of Biology, Complutense University, Madrid, Spain
Two dendritic cell (DC) subsets have been identi®ed in the murine system on the basis of their
differential CD8a expression. CD8a+ DCs and CD8a± DCs are considered as lymphoid- and
myeloid-derived, respectively, because CD8a+ but not CD8a± splenic DCs were generated from
lymphoid CD4low precursors, devoid of myeloid reconstitution potential. Although CD8a± DCs
were ®rst described as negative for CD4, our results demonstrate that around 70% of them are
CD4+. Besides CD4± CD8a± and CD4+ CD8a± DCs displayed a similar phenotype and T cell
stimulatory potential in MLR, although among CD8a± DCs, the CD4+ subset appear to have a
higher endocytic capacity. Finally, experiments of DC reconstitution after irradiation in which, in
contrast to previous studies, donor-type DCs were analyzed without depleting CD4+ cells,
revealed that both CD8a+ DCs and CD8a± DCs were generated after transfer of CD4low
precursors. These data suggest that both CD8a+ and CD8a± DCs derive from a common
precursor, and hence do not support the concept of the CD8a+ lymphoid-derived and CD8a±
myeloid-derived DC lineages. However, since this has to be con®rmed at the clonal level, it
remains possible that CD8a± DCs arise from a myeloid precursor within the CD4low precursor
population, or alternatively that both CD8a+ and CD8a± DCs derive from an independent non-
lymphoid, non-myeloid, DC precursor. In conclusion, although we favor the hypothesis that both
CD8a+ and CD8a± DCs derive from a lymphoid-committed precursor, a precise study of the
differentiation process of CD8a+ and CD8a± DCs is required to de®ne conclusively their origin.
P3
Langerhans Cells Develop from a Lymphoid-Committed Precursor
C. ArdavõÂn, G. MartõÂnez del Hoyo, P. MartõÂn, C. FernaÂndez Arias, and F. AnjueÁre
Department of Cell Biology, Faculty of Biology, Complutense University, Madrid, Spain
Langerhans cells (LCs) are specialized dendritic cells (DCs) strategically located in strati®ed
epithelia, such as those of the skin, oral cavity, pharynx, oesophagus, upper airways, urethra and
female reproductive tract, which are exposed to a wide variety of microbial pathogens. LCs play an
essential role in the induction of T lymphocyte responses against viruses, bacteria and parasites
which gain access to those epithelial surfaces, due to their high antigen capture and processing
potential and their capacity to present antigen peptides to T cells upon migration to the lymph
nodes. Although LCs have been classically considered of myeloid origin, recent reports
demonstrating the existence of lymphoid DCs derived from multipotent lymphoid precursors
devoid of myeloid differentiation potential, raise the question of the lymphoid or myeloid origin of
LCs. Here we show that mouse lymphoid-committed CD4low precursors, with capacity to
generate T cells, B cells, CD8+ lymphoid DCs and NK cells, also generate epidermal LCs upon
intravenous transfer, supporting the view that LCs belong to the lymphoid lineage.
P4
Pro-In¯ammatory Skin-Derived Cytokines Play a Critical Role in the Regulation and/
or Maintenance of Langerin Expression Induced on Monocytes in Synergy with IL-13/
TGFb
N. Bechetoille,*³ F. Geissmann,² S. Dumont,* V. AndreÂ,³ S. MareÂchal,* J. Valladeau,§ S.
Saeland, D. Schmitt,* E. Perrier,³ and C. Dezutter-Dambuyant*
*INSERM U.346, Ed. Herriot Hospital, Lyon, France; ²The Skirball Institute of Biomolecular Medicine,
New York, New York; ³COLETICA, Gerland, France; §INSERM U.520, Institut Curie, Paris,
France; Schering-Plough, Dardilly, France
Keratinocytes (KC) are activated by environmental stimuli such as UV to produce a variety of
cytokines (TNFa, GM-CSF, TGFb,¼) that can affect the immune responses as well as the cell
growth and differentiation of skin cells and mononuclear cells which have recently colonized the
epidermis. Furthermore, other cells present in the dermis such as IL-13-secreting mast cells, IL-15-
secreting endothelial cells or IL-13-/IL-4-secreting activated T cells may also contribute to the
differentiation of the mononuclear cells while they enter the skin. The epidermal dendritic cells
(DC) termed Langerhans cells speci®cally express the type II lectin, Langerin. In this study we
showed that the addition of TNFa to peripheral CD14+ monocytes cultured for 6 days in presence
of IL-13 in combination with GM-CSF, TGFb optimized the generation of Langerin+ DC which
were similar to the Lag+ Langerhans-like cells generated in presence of IL-4 (Geissmann et al, J.
Exp. Med, 1998). We further demonstrated that a short incubation with TNFa (< 10-18h) up-
regulated the membrane expression of Langerin on the monocytes after 6 days of culture whereas a
longer incubation with TNFa (> 24h-48h) led to : (i) the phenotype of activated mature DC
correlated to the up-regulation of characteristic markers such as CD86, CD83, DC-LAMP and
CCR7; (ii) the translocation of MHC-class II onto the membrane of Langerin+ DC; (iii) the
internalization of membrane Langerin. It is noteworthy that in absence of TNFa, the up-
regulation of the Langerin was dramatically reduced on the plasma membrane. Taken together,
these results suggest that the generation of a Langerhans cell phenotypic pro®le from peripheral
monocytes which colonize epidermis is dependent on a large amount of pro-in¯ammatory
cytokines, i.e. IL-13, TGFb and TNFa.
P5
Peripheral Homeostasis of Immature Dendritic Cells Mediated through TRANCE±
RANK Interaction
I. Cremer, M.-C. Dieu-Nosjean, C. SauteÁs-Fridman, W. H. Fridman, and C. G. Mueller
Laboratoire d'Immunologie Cellulaire et Clinique, INSERM U255, Institut Curie, Paris, France
TRANCE (tumor necrosis factor-related activation-induced cytokine) and its receptor RANK
(receptor activator of NF-kB) are required for bone homeostasis and lymph-node organogenesis
and are involved in cell survival. Factor XIIIa+ CD14+ CD1a± interstitial dermal DC are present in
the skin, where they capture antigen and thereafter, migrate to draining lymph nodes where they
present it to T cells. We have generated immature dermal DC in vitro using M-CSF and show that
they mature in response to LPS and CD40 ligand and become capable of 6Ckine/MIP3b-mediated
chemotaxis and naive T cell activation. Immature dermal DC carry both TRANCE and RANK
on the cell surface, and the constitutive TRANCE-RANK ligation is responsible for high Bcl-2
levels and long-term cell survival. Dermal DC also promote the survival of RANK+ CD1a+-
derived Langerhans DC. These ®ndings provide evidence that, in addition to bone homeostasis,
TRANCE and RANK play a key role in the homeostasis of immature peripheral DC.
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The Role of Maturation and Caspase-Activation in UVB, Steroid, CD95 (FAS/APO-1)
and MHC-Class II Induced Cell Death in Murine Dendritic Cells
A. Eggert, A. D. McLellan, T. Mengling, E.-B. BroÈcker, M. Leverkus, and E. KaÈmpgen
Department of Dermatology and University of WuÈrzburg Medical School, WuÈrzburg, Germany
We have investigated potential pathways of dendritic cell (DC) death through a comparison of the
relative role of steroids, ultraviolet light, CD95 and class II in inducing DC apoptosis. Bone
marrow derived, mature DC were relatively resistant to a low level UVB treatment (50 mJ per
cm2) and only became susceptible as the dose was increased up to 100-250 mJ per cm2. In contrast,
immature DC showed complete sensitivity to low level (50 mJ per cm2) UVB doses. Though
much less effective than UVB, both hydrocortisone and dexamethasone induced apoptosis in sub-
populations of both immature and mature DC. All immature DC were highly susceptible to CD95
induced apoptosis but upon maturation became completely resistant. Crosslinking of class II with
the N22 or 2G9 anti-IA/IE monoclonal antibodies resulted in rapid onset of DC death, but only in
mature DC. Steroid, UVB and CD95 induced cell death was only partially (5-50%) inhibited by
caspase-inhibition with zVAD-fmk whilst class II-induced cell death was completely caspase-
independent. In spite of the low requirement for caspase activation in DC seen during CD95
induced apoptosis, we were able to detect strong activation of both caspase 8 and caspase 3 within
6h of CD95 crosslinking. In summary, although UVB and CD95 are highly effective agents for
induction of DC apoptosis, their ef®cacy is reduced upon DC maturation. Steroids are less effective
than UVB, but appear to act independently of DC maturation while class II crosslinking may be an
important signal for the removal of only mature DC in vivo.
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Localization of CD1e in Dendritic Cells
C. AngeÂnieux, J. Salamero,* D. Fricker, J.-P. Cazenave,² D. Hanau, and H. de la Salle
INSERM EP 99-08 and ²U 311, EFS-Alsace, Strasbourg, and *UMR CNRS 144, Institut Curie,
Paris, France
CD1e is expressed in monocytes derived dendritic cells (DCs) and Langerhans cells (LCs). In
constrast to other CD1, which are ®rst expressed on the surface of DCs and may then internalize
into early (EE) or late (LE) endosomal compartments, CD1e is mainly detected in the Golgi of
immature DCs or freshly isolated LCs, and never reachs the surface. Upon maturation CD1e is
mainly found in LE, cleaved into a soluble form. DCs were shortly incubated with LPS and/or
with ba®lomycin, known to block the transport between EE and LE/lysosomes, the acidi®cation
of LE and, consequently the cleavage of CD1e in a soluble form. Relocalization of CD1e after
these treatments was investigated by confocal microscopy using mAbs against the luminal or
cytoplasmic (VIIC7) domains of CD1e and Abs staining differents cellular compartments. After one
hour of LPS treatment, while HLA-DR compartments are not yet redistributed, CD1e+ vesicules
docking on MHCII+ compartments are observed, demonstrating a relocalization to compartments
implicated in processing and loading of antigens on CD1b, -c or HLA-DR. Absence of
colocalization with EE markers after treatment with both ba®lomycin and LPS suggests that CD1e
move directly from the Golgi to LE. Surprisingly, under these conditions, VIIC7 does not stained
endosomal compartments, supporting the idea that a post-traductional modi®cation or the
association with a partner, masking the VIIC7 epitope, is implicated in the transport of CD1e to
LE.
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Differentially Expressed Proteins in Immature and Mature Dendritic Cells
P. Verdijk, P. A. van Veelen, J. J. Neefjes, C. P. Tensen, F. Koning, and A. M. Mommaas
Depts of Dermatology, Immunoheamatology and Bloodtransfusion, and Center for Electron Microscopy,
LUMC, Leiden, The Netherlands
Upon activation, tissue residing immature dendritic cells (DC), such as Langerhans cells (LC), start
to migrate towards the draining lymph node and mature into ef®cient antigen presenting cells.
During maturation DC loose their capacity to endocytose antigens, change their surface expression
of adhesion molecules, chemokine receptors and costimulatory molecules, and their morphology.
We have now employed proteomics to identify additional differentially expressed proteins in
immature and mature DC. DC were obtained by culturing monocytes with IL-4 and GM-CSF for
6 days. LC were isolated and enriched from normal human skin. Maturation was induced by the
addition of LPS. Proteins were separated on 2-dimensional polyacrylamide gels and individual
protein spots were analysed by mass-spectrometry. Two of the proteins found to be differentially
expressed in immature and mature DC are involved in modulating actin dynamics: Co®lin, which
increases the rate of actin-depolymerisation, is highly expressed in immature DC and low in
mature DC, whereas pro®lin, which increases elongation of actin ®laments, is up-regulated in
mature DC compared to immature DC. Regulation of actin-®lament dynamics allows the cell to
respond to extracellular signals by moving, changing shape and translocating intracellular
organelles. The role of co®lin and pro®lin in migration of DC, formation of the typical dentritic
shape and/or transport of antigens towards the MHC class II rich compartment and of MHC class
II-peptide complexes towards the cell surface is currently under investigation.
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The Dendritic Cell Cytoskeleton is Critical for the Formation of the Immunological
Synapse
M. Al-Alwan,* G. Rowden,²³ P. Colp,² J. Bunker,² and K. West*²³
Department of *Microbiology & Immunology, ²Pathology and ³Medicine, Dalhousie University, Halifax,
Canada
Activation of T cells requires the formation of an immunological synapse between the interface of
the T cell and an APC. The T cell cytoskeleton plays an active role in this process; however, based
on studies using B cells, it has been widely believed that the APC cytoskeleton is not involved.
Using an allogeneic model, we evaluated whether the DC cytoskeleton is important for the ability
of DC to cluster and activate resting CD4+ T cells. DC were allowed to cluster with either resting
allogeneic or syngeneic CD4+ T cells. Confocal microscopy was used to evaluate the redistribution
of the cytoskeletal proteins F-actin and fascin. During clustering with allogeneic T cells, 87% of
DC polarized their F-actin and fascin toward the interface with the T cell compared with only 23%
of DC clustered with syngeneic T cells, indicating that these changes are antigen-dependent. The
cytoskeletal changes in DC are an active process since inhibition of DC actin polymerization using
Cytochalasin D (CytD) reduced their ability to cluster resting but not activated allogeneic CD4+ T
cells. In addition, pretreatment of DC with CytD prior to mixing with resting CD4+ T cells
reduced the MLR in a dose dependent manner. This novel ®nding provides strong evidence of the
DC cytoskeleton's dynamic involvement in the establishment of the immunological synapse with
resting T cells. This may partially explain why DC are unique at clustering and activating resting T
cells as compared to other APC.
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Dendritic Cells Form the Immunological Synapse at a Wide Range of MHC-Peptide
Concentrations
M. Al-Alwan,* G. Rowden,²³ P. Colp,² J. Bunker,² and K. West*²³
Department of *Microbiology & Immunology, ²Pathology and ³Medicine, Dalhousie University, Halifax,
Canada
We have demonstrated the active involvement of the DC cytoskeleton in the formation of the
immunological synapse with resting CD4+ T cells using an allogeneic system. In this study, we
examined these changes in a model that allows evaluation of DC cytoskeleton participation over a
wide range of MHC-peptide concentrations. We used the DO11.10 TCR transgenic system,
where the transgenic CD4+ T cells recognize an OVA speci®c peptide in the context of MHC class
II (IAd). Resting CD4+ T cells mixed with DC in the presence of agonist peptide (OVA323-339)
proliferate in a peptide dose dependent manner with an optimal proliferation at the dose range
300-3000 nM. In contrast, no proliferation was seen with no peptides or antagonist peptide
(OVA324-334). We used confocal microscopy to evaluate the redistribution of the cytoskeletal
protein, F-actin. In the presence of agonist peptide (300 nM), 96% of the DC clustering resting
CD4+ T cells polarize their F±actin at the interface with the T cell. However, only 39% and 13%
F-actin polarization is seen in DC clustering resting CD4+ T cells in the presence of antagonist
(300 nM) or no peptide, respectively. Pretreatment of DC with Cytochalasin A, an inhibitor of the
cytoskeletal rearrangement, prior to their mixing with resting CD4+ T cells and agonist peptide
signi®cantly reduced the MLR indicating that these cytoskeletal changes are a dynamic process.
This study demonstrates that the DC cytoskeleton plays a critical role in the formation of the
immunological synapse at a wide range of peptide doses.
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Erythrocytes Ef®ciently Deliver Tat Antigen to Human Dendritic Cells for Initiation of
Speci®c Type 1 Immune Responses In Vitro
S. Corinti, L. Chiarantini,* M. Magnani,* and G. Girolomoni
Laboratory of Immunology, IDI-IRCCS, Rome, Italy; *Giorgio Fornaini Institute of Biologic Chemistry,
University of Urbino, Urbino, Italy
Dendritic cells (DC) are an important target for vaccine development against viral infections. The
capacity of DC to induce CD4+ and CD8+ T cell responses is enhanced when antigens are
provided as particulates. Here, we analyzed human red blood cells (RBC) as a delivery system for
Tat protein, and studied whether IFN-g could improve the antigen-presenting functions of DC.
DC were generated from peripheral blood monocytes in human serum, and matured with
monocyte-conditioned medium (MCM) in the presence or not of IFN-g. Tat was conjugated to
RBC (RBC-Tat) through avidin-biotin links. DC ef®ciently and rapidly internalized RBC-Tat.
Compared to DC treated with soluble Tat, DC pulsed with RBC-Tat were much more ef®cient at
inducing speci®c CD4+ and CD8+ T cell responses. DC matured in the presence of MCM were
more effective than immature DC in inducing CD4+ and CD8+ T cell proliferation and IFN-g
release. Stimulation of DC with IFN-g inhibited the production of IL-10 but increased the release
of IL-12 and TNF-a. Moreover, IFN-g-treated DC markedly up-regulated the release of
CXCL10 (IP-10) and signi®cantly reduced the secretion of CCL17 (TARC) chemokines,
attracting preferentially Th1 and Th2 cells, respectively. Finally, immature or mature DC exposed
to IFN-g were better stimulators of allogeneic T cells, and induced a higher IFN-g production
from Tat-speci®c CD4+ and CD8+ T lymphocytes. In conclusion, RBC appear an effective tool
for Tat delivery into DC, and IFN-g could be advantageously used for augmenting the ability of
DC to induce Th1 responses.
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A Comparison of CTL Induction by Different Methods of Antigen Loading of
Monocyte-Derived Dendritic Cells
J. Galea-Lauri,* D. Darling,* and F. Farzaneh
Department of Molecular Medicine, The Rayne Institute, GKT School of Medicine and Dentistry, London,
UK
During this study we aimed to compare the ef®cacy of three different methods of antigen loading
of dendritic cells at inducing MHC-class I restricted antigen speci®c responses, using allogeneic
leukemic cells as a source of antigens for processing and presentation by the dendritic cells to
autologous T cells. Dendritic cells were pulsed with either whole cell tumor lysates prepared by
three freeze/thaw cycles or with apoptotic leukemic cell fragments, or were fused directly to the
leukemic cells to generate hybrid cells. Dendritic cell/leukemic hybrids and dendritic cells pulsed
with apoptotic leukemic cell fragments were both ef®cient at generating CTL responses when
tested against antigen-pulsed dendritic cells used as targets. However, the hybrid cells induced a
more potent CTL response as judged by a signi®cantly higher percentage of targets being lysed.
We also report that the CTL responses were MHC class I restricted and antigen-speci®c, as shown
by the inability of the CTL to lyse antigen-pulsed allogeneic dendritic cells or autologous dendritic
cells pulsed with different antigens, respectively. On the other hand, dendritic cells pulsed with
freeze/thaw lysates prepared from the leukemic cells induced very weak CTL responses. We thus
conclude that the method used for loading antigens into the dendritic cells is critical to the
outcome of the CTL response. Our data suggests that dendritic cells that express endogenously
synthesised antigens as is the case with the dendritic cell hybrids are better stimulators of MHC class
I restricted CTL responses to dendritic cells which acquire exogenous antigens, suggesting further
that the classical pathway of antigen presentation is more ef®cient than cross-presentation for the
induction of CTLs.
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UV-A Irradiation Inhibits the T-Cell Stimulatory Function of Mature Murine
Langerhans Cells
F. Koch, M. Blumthaler,* E. KaÈmpgen,² G. Schuler,³ P. Fritsch and N. Romani
Departments of Dermatology and *Medical Physics, University of Innsbruck, Innsbruck, Austria, and
Departments of Dermatology, ²University of WuÈrzburg, WuÈrzburg, and ³University of NuÈrnberg-Erlangen,
Erlangen, Germany
UV irradiation of Langerhans cells (LC) leads to different effects on their viability and their capacity
to stimulate T cells. This depends critically on the wavelength (i.e. UV-A vs. UV-B). UV-A has
been shown to inhibit LC function because CD54 and co-stimulatory molecules (CD80, CD86)
are not up-regulated any longer during subsequent culture. We tested the susceptibility of mature
LC, i.e. LC that already express high levels of CD54, 80, and 86, to UV-A. A pure UV-A source
(``Sellmair lamp''), which emits exclusively above 320 nm, was used to irradiate 2-day-cultured
mature LC. A clearcut dose-dependent reduction of T cell proliferation occurred, starting at 20 kJ
per m2 and leading to almost ``T cell only'' background at 60 kJ per m2. However, after two further
days in culture, about 60% of these LC had survived both in irradiated (60 kJ per m2) and
unirradiated control cultures. LC, that had been irradiated with 60 kJ per m2 on day 2, re-gained
their full ability to stimulate T cells by day 4. This is in sharp contrast to UV-B irradiation which is
not reversible and where LC eventually die. A similiar inhibitory effect could be seen with
``Sylvania F20 T12'' and ``Osram-Vitalux'' lamps that are commonly used as sources for UV-B.
These lamps also have a small emission window in the UV-A area which is energetically suf®cient
to cause an effect as shown in experiments where all the UV-B (< 320 nm) was ®ltered out, yet the
inhibitory effect still remained. We conclude that UV-A may not be as ``innocent'' as often
assumed, and further investigations seem warranted.
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Cross-Presentation of Vaccinal Lipopeptides Derived from HIV-1 Reverse
Transcriptase by Human Dendritic Cells
M. Andrieu, J. F. Desoutter, E. Loing,* D. Hanau,² J. G. Guillet, and A. Hosmalin
DeÂpartement d'Immunologie INSERM U445, ICGM, Paris, *SEDAC-Therapeutics, Lille, ²EPI 99-
08, ETS, Strasbourg, France
An ef®cient vaccine against HIV must induce good cellular immune responses and primary
stimulation of T CD8+ lymphocytes requires dendritic cells (DC) as presenting cells. Lipopeptides
are currently used in vaccine trials. We have already shown that a model lipopeptide containing a
short epitopic peptide from HIV-1 was endocytosed and presented in association with MHC class I
by human DC. To determine more precisely this cross-presentation pathway, we have used a
longer lipopeptide (Pol461-484), which requires processing to be presented. As the shorter model,
this lipopeptide was rapidly endocytosed into immature DC, as shown by co-localization of
Rhodamine-labeled analog and FITC-Dextran (by confocal microscopy). The lipopeptide induced
functional stimulation of HLA-A*0201-restricted Pol476-484 epitope-speci®c CD8+ T lympho-
cytes, as detected by intracellular IFN-g ¯ow cytometric analysis. The presentation was not
inhibited by monensine, which inhibits endosomal acidi®cation and therefore enzymatic
degradation. Conversely, it was inhibited by a proteasome speci®c inhibitor and by brefeldin A.
Therefore, the cross-presentation pathway followed by this long vaccinal lipopeptides in human
DC was endocytosis, then degradation in the cytoplasm before association with MHC I molecules.
These well-de®ned molecules are a good model for studying antigen processing in the cross-
presentation pathway, and the results will be useful for vaccine design and to address vaccines into
this particularly ef®cient pathway for protective CD8+ T lymphocyte induction.
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Cross Presentation of Cell-Associated Antigens by Dendritic Cells in the Steady State
Leads to Peripheral Tolerance In Vivo
K. Liu and R. Steinman
The Rockefeller University, New York, New York
Dendritic cells (DCs) serve as powerful adjuvants for the initiation of cell-mediated immunity, if
the DCs are charged with antigens ex vivo and then injected into mice or to humans. To probe the
function of DCs that are found in vivo in the steady state, i.e. in the absence of any ex vivo
manipulation, we injected mouse splenocytes charged with ovalbumin (OVA) according to the
method of Carbone et al (J Exp Med 171: 377-8, 1990). It is known that the OVA in the injected
splenocytes is ef®ciently cross-presented on the MHC class I products of the recipient DCs (J Exp
Med 192: 1685-96, 2000; J Immunol 166: 6099-103, 2001). We have obtained similar ®ndings
when we inject OVA-charged splenocytes from mice genetically depleted of the TAP transporters
(TAP±/±) into wild type C57BL/6 (TAP+/+) recipients. Speci®cally, when we isolate CD11c
positive (DC-enriched) and CD11c negative (DC-depleted) fractions from the recipients of OVA
charged splenocytes, only the DCs cross-present antigen to OT-I TCR transgenic, OVA-speci®c,
CD8+ T cells. When the OT-I T cells are injected into mice, followed by an intravenous infusion
of TAP±/± OVA splenocytes in the steady state, the T cells proliferate rapidly for 2 days ®rst in the
draining lymphoid tissue (spleen) and later reach distal lymph nodes. However the T cells are
ultimately deleted, because few can be found in spleen, lymph node or blood 10 days later.
Likewise, the OT-1 injected mice became unresponsive systemically to antigen rechallenge in situ
if the splenocytes are captured by DCs in the steady state, but immune if the OVA-splenocytes are
captured by DCs maturing in response to an agonistic anti-CD40 antibody. The tolerance to OVA
that is induced by DCs in the steady state is seen even with powerful adjuvants, i.e. rechallenge
with OVA in complete Freund's adjuvant or pulsed onto mature ex vivo derived DCs. The OT-I
cells from control mice given splenocytes charged with an irrelevant protein, Hen Egg Lysozyme
(HEL), remain strongly responsive to OVA, being able to proliferate and produce IFN gamma in
ELISPOT assays. We conclude that the capture of cell-associated antigens by DCs in vivo in the
steady state leads to peripheral tolerance. It is proposed that this is an essential role for DCs in vivo,
i.e. to induce tolerance to self-peptides so that subsequent immune responses to dying cells will
focus on microbial rather than self antigens. Without the establishment of peripheral tolerance to
those cell-associated self-peptides that can be presented by DCs, one would be at great risk of
developing autoimmunity whenever DCs are called upon to present infected self tissues.
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Effect of Dinitro-Fluorobencene in Amphibian Langerhans Cells
A. Castell, E. Sampedro, M. Herrera, B. HernaÂndez, and A. CastanÄoÂn
Depto. de BiologõÂa Celular y Tisular, Fac. de Medicina, Universidad Nacional AutoÂnoma de MeÂxico, MeÂxico
D.F., MeÂxico
Recently, we demonstrated two subsets of amphibian epidermal dendritic cells (DC) similar to
mammalian Langerhans cells. One was located suprabasally and was ATPase+/class II± whereas the
other had a basal location and was ATPase+/class II+. Both subsets had ultrastructural pattern of
Langerhans cells except for the Birbeck granule. The objective of these work was to search the
modi®cations in the amphibian DC with an hapten. Ten Rana pipiens were painted with 50 ml of
DNFB at 0.1% 0.5, 1, 1.5 and 2 hrs. Epidermal sheets were obtained and treated to demonstrate
ATPase and class II molecules. Other samples were processed for electron microscopy. We
observed a diminution of ATPase+/class II± and an increase in the ATPase+/class II+ subset
densities. We appreciated too an increased number of class II+ DC in the underlying connective
tissue. At ultrastructural level we observed that DC had numerous vesicles with some myelinic
bodies, but no evidence of Birbeck granules was shown. Results suggest that ATPase+/class II± dc
diminished as a result of depletion of the enzyme caused by the continuous endocytosis process,
whereas ATPase+/class II+ dc increased by the ampli®ed synthesis and membrane expression of
class II molecules for antigen presentation. We considered that both subsets are the same type but
in a different functional state. On the other hand, the lack of Birbeck granules is not an evidence
that these cells do not represent the homology of langerhans cells in amphibians, because they have
all the other morphological characteristics of mammalian Langerhans cells.
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Cholera Toxin and its B Subunit Differentially Modulate Antigen Presentation by
Mucosal Dendritic Cell Subsets
F. AnjueÁre, M. Lebens, J. Holmgren, C. Ardavin, and C. Czerkinsky
INSERM U364, Nice, France; Department of Microbiology, GoÈteborg University, Sweden and Faculty of
Biology, University Complutense, Madrid, Spain
Mucosal administration of antigens linked to cholera toxin B subunit (CTB) can induce peripheral
T cell tolerance whereas co-administration of cholera toxin (CT) breaks it. The mechanisms that
govern induction or abrogation of tolerance in that system remain unknown. We examined the
phenotypical and functional properties of DC subsets in the gut-associated lymphoid tissues from
mice fed either CT or CTB. Two CD11c+ DC subsets were identi®ed in both Peyer's patches
(PP) and mesenteric lymph nodes (MLN), based on expression or not of CD8a. A third and
predominant subset with intermediate levels of expression of CD8 was exclusively disclosed in
MLN. Further, a discrete subset of CD11c+ but CD8± DCs was identi®ed in the intestinal wall
and could constitute the muco-epithelial equivalent of LCs. Feeding mice with CT led to the
selective increase of the CD8int DCs in MLN and of intestinal wall DCs whereas CTB had no
apparent effect. Thus, this MLN DC subset may play a major role in the induction of mucosal
immune responses to gut luminal antigens adjuvantized by CT. Adoptive transfer studies are now
underway to examine the potential role of these APCs in the induction or abrogation of oral
tolerance (EC Biotech IV).
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Effective Treatment of Established Melanoma Tumors with Antigen Loaded Dendritic
Cells Generated Under FCS-Free Conditions Requires IL-2
A. Eggert, J. Becker, M. Ammon, A. McLellan, E.-B. BroÈcker, and E. KaÈmpgen
Department of Dermatology, University of WuÈrzburg Medical School, WuÈrzburg, Germany
Melanoma, despite its aggressive growth characteristics, is an immunogenic tumor expressing
several characterized neo- and differentiation antigens. Dendritic cells (DC) when pulsed with
de®ned peptides induce tumor speci®c T cell responses and protect animals from challenge with
melanoma. However, DC treatment of metastatic disease so far has failed to induce signi®cant
tumor regressions. We therefore set up a therapeutic model using C57BL/6J mice and the
immunogenic melanoma cell line B78-D14. To produce skin and lung tumors groups of mice
received s.c. or i.v. injections of 2 3 106 tumor cells. After 1 and 2 wks mice were vaccinated with
20.000 DC, either bone marrow derived DC or epidermal Langerhans cells (LC), loaded with the a
TRP2 peptide. Generally, DC cultured with FCS proved to induce a dominant unspeci®c
response. This was not seen using LC cultured in 1% mouse serum, however, vaccination with
TRP2 loaded FCS-free LC alone failed to in¯uence the growth of established B16 tumors. A
reproducible reduction of tumors in size and weight was only obtained, if LC vaccinations with
TRP2 were followed by a 5 d treatment of mice with IL-2, 200.000 IU i.p. twice/d. Omitting the
TRP2 peptide abolished the ef®cacy of this combined treatment, demonstrating the crucial role of
priming a melanoma speci®c T cell response. Collectively our data suggest that a DC based T cell
priming needs an IL-2 mediated expansion of T cells to become effective and that this combined
treatment might be helpful in melanoma patients with metastatic disease.
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Long Lasting Immunity in DNA-Vaccinated Mouse is Maintained by Antigen-Pulsed
Spleen Dendritic Cells
Sk. Md. Fazle Akbar, Y. Oka, N. Horiike, K. Joko, and M. Onji
3rd Department of Internal Medicine, Ehime University School of Medicine, Japan
The mechanism underlying the long-lasting humoral and cellular immunity due to a single
injection of DNA vaccine was studied. Plasmid pCAGGS(S) constructed by inserting the genes of
hepatitis B surface antigen (HBsAg) into the multiple cloning site of the parental plasmid,
pCAGGS, was injected (100 mg per mouse) once into the regenerating anterior tibialis muscle of
C57BL/6 mouse. HBsAg-speci®c memory T cells were isolated from C57BL/6 mouse injected
twice with 10 mg of HBsAg. Spleen dendritic cell (DC) were isolated by density centrifugation.
In®ltration of DC and expression of HBsAg were studied at the site of injection by
immunohistochemistry. A single injection of pCAGGS(S) induced antibody to HBsAg and
HBsAg-speci®c T cells in C57BL/6 mouse, which persisted for as long as 48 weeks. In®ltrating
cells including DC were detected at the site of DNA injection and some injection of pCAGGS(S)
induced proliferation of HBsAg-speci®c memory lymphocytes without addition of HBsAg,
indicating that the spleen DC from these mouse were pulsed with HBsAg in situ. Existence of
HBsAg-pulsed DC in the spleen may have a critical role in the persistence of long-lasting
immunity due to a single injection of DNA vaccine.
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p38 MAPK is Activated by the Chemical Sensitizer DNFB in a Fetal Skin Dendritic Cell
Line
T. J. Matos, C. B. Duarte, A. P. Carvalho, and M. C. Lopes
Center for Neuroscience of Coimbra, University of Coimbra, Coimbra, Portugal
Dendritic cells (DC) play a pivotal role in the induction of cutaneous immune response, namely in
the sensitization phase of allergic contact dermatitis (ACD). However, the intracellular mechanisms
involved in the activation of these antigen presenting cells (APCs) remain unclear. We investigated
the effect of a strong skin sensitizer, 2,4-dinitro¯uorobenzene (DNFB), and its inactive analogue,
2,3-dicloronitrobenzene (DNCB), on the activity of mitogen activated protein kinases (MAPKs)
in a dendritic cell (DC) line generated from fetal mouse skin (FSDC), precursors of Langherhans
cells. DNFB (5 mg per ml) increased signi®cantly the phosphorylation (activity) of p38 high
osmolarity glycerol protein kinase (p38/HOG), but not the phosphorylation of extracellular
regulated kinase (ERK), or stress-activated protein kinase/c- jun NH2- terminal kinase (SAPK/
JNK). Maximal phosphorylation of p38 was observed after 30-45 min incubation with DNFB, as
determined by Western blot, using phospho-speci®c antibodies. The results indicating that
stimulation with the strong sensitizer DNFB, at low concentration, activates p38 MAPK suggest
that this kinase may be involved in the activation of APCs during the sensitization process of ACD.
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Characterisation of CD11c/CD1a Positive Dendritic Cells for Identi®cation of Contact
Sensitisers
N. Gilmour, Z. Wright, and D. Basketter
SEAC, Unilever Research Colworth House, Sharnbrook, Bedfordshire, UK
In vitro alternatives for the identi®cation of contact sensitisers have examined the use of human
blood derived dendritic cell (DC) cultures. Cultures exposed to the allergen 2,4-dinitrochlor-
obenzene (DNCB) have shown up-regulation of certain markers, although with variability and not
always with evidence of speci®city. We aimed to derive a puri®ed DC population (CD11c+ cells),
a cell type more relevant for identi®cation of skin allergens. Pure populations of DC were isolated
from human peripheral blood using BCDA-1 magnetic bead separation. The cells were cultured
for 5 days in a combination of granulocyte-macrophage colony stimulating factor (GM-CSF),
interleukin-4 (IL-4) and transforming growth factor±beta (TGF-b), which generates ``Langerhans
cell like'' cells. This approach produced a population which was 95% CD11c/CD1a positive as
determined by ¯ow cytometry. The cells expressed HLA-DR but not CD86 or CD83,
demonstrated endocytic ability (FITC-dextran uptake), were weak stimulators of the mixed
lymphocyte reaction and thus could be regarded as an ``immature'' phenotype. Exposure of these
cells to subtoxic doses of DNCB resulted in elevated expression of HLA-DR (6-7 fold increase in
mean ¯uorescence intensity [MFI]) and CD86 (15-20 fold increase in MFI) compared with control
cells. Concurrent treatment with subtoxic doses of the irritant sodium lauryl sulphate or 0.1%
DMSO (vehicle control) did not induce up-regulation of HLA-DR or CD86. Culture of blood
derived CD11c+ dendritic cells may provide a population of Langerhans like cells for evaluation of
potential future in vitro approaches to the identi®cation of skin sensitisers.
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Reactivity of Langerhans Cells in Reconstructed Human Epidermis to Exposure to
Allergens and UV Radiation
V. Facy, M. ReÂgnier, and R. Schmidt
L'OreÂal, Life Sciences Research, Clichy, France
To study the behavior of Langerhans cells in reconstructed human epidermis, we have analyzed
their density, dendricity, and the expression of IL-1b and CD86 mRNA after exposure to known
allergens or Solar Simulated Radiation (SSR). CD34+ cord blood progenitors were cultured for
7 days in StemBio A medium in the presence of SCF (replaced by TGF-b at day 4), GM-CSF and
TNF-a to generate a differentiated dendritic cell population. These cells together with human
keratinocytes and melanocytes were seeded onto human de-epidermized dermis or the Episkinq
support. After 2 weeks of culture, the resulting reconstructed epidermis containing the Langerhans
cells was exposed to topically applied allergens or SSR. The reactivity of the Langerhans cells was
analyzed 24 h later. The number of Langerhans cells and their morphology were analyzed after
Langerin immunostaining. Changes in IL-1b and CD86 mRNA expressions were evaluated by
RT-PCR. Exposure of the reconstructed epidermis to allergens resulted in a dose-dependent
decrease in the number of Langerhans cells and an over-expression of IL-1b and CD86 mRNA.
Exposure of the reconstructed epidermis to SSR caused a decrease in the number of the
Langerhans cells and a reduction in dendricity of the remaining Langerhans cells. The SSR-
induced changes, which resemble very much in vivo observations attributed to the phenomena of
immunosuppression, were prevented by the topical application of a sunscreen before irradiation.
We propose this model to predict the sensitizing potential of new chemicals and to evaluate the
protective effect of sunscreens against UV-induced immunodamages.
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Reduced Susceptibility of Human Immature Dendritic Cells (iDC) to NK Cell Lysis
After Interaction with the Opportunistic Yeast Malassezia furfur (Mf)
E. Buentke, L. C. Hef¯er, J. Wilson,* R. P. A. Wallin,* C. LoÈfman,² B. J. Chambers,* H. G.
Ljunggren* and A. Scheynius
Unit of Clinical Allergy Research, *Microbiology and Tumor Biology Center, Karolinska Institutet and
Hospital, Stockholm, ²Department of Animal Development and Genetics, Uppsala University, Sweden
The yeast Mf, normally present in the human skin micro¯ora, is nevertheless a factor contributing
to the severity of the chronic in¯ammatory skin disease atopic dermatitis (AD). The aim of this
study was to assess whether co-culture of Mf and human iDCs would affect subsequent interactions
of DCs with autologous NK cells. iDCs pre-incubated with Mf showed a reduced susceptibility to
NK cell killing when compared to untreated iDCs. Moreover, also when iDCs were treated with
Mf-iDC co-culture supernatant, a reduced susceptible to killing was observed, indicative of the
presence of soluble factors. The numbers of CD40, CD80, CD83 and CD86+ DCs increased and
HLA-DR expression was up-regulated after supernatant treatment. NK (CD56+/CD3±) cells were
found in the dermis of skin biopsy specimens from healthy individuals and AD patients. However,
in the AD patients CD56+ cells were also found in the epidermis. These data suggest that NK cells
and iDCs can interact, that Mf affects this interaction and that NK cells may play a role in regulating
DCs. Furthermore, the data imply that DCs and NK cells can meet in the skin.
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Study of the Phenotype and Function of Langerhans Cell Histiocytosis Cells
F. Geissmann, Y. Lepelletier, S. Fraitag, J. Valladeau,* C. Bodemer, M. DebreÂ, M. Leborgne, S.
Saeland,* and N. Brousse
Pathology, Dermatology, Haematology and Immunology Departments and UMR CNRS 8603, IFR
Necker-Enfants Malades, Paris, France; *Schering Plough Laboratory for Immunology Research, Dardilly,
France
Langerhans cell histiocytosis (LCH) consists of lesions composed of cells with characteristics of
Langerhans cells (LC). The clinical course of LCH ranges from spontaneous resolution to a chronic
and sometimes lethal disease. We studied 25 patients with various clinical forms of the disease. In
bone and chronic lesions, LCH cells had immature phenotype and function. They coexpressed LC
antigens CD1a and Langerin together with monocyte antigens CD68 and CD14. Class II antigens
were intracellular and LCH cells almost never expressed CD83, CD86 or DC-Lamp despite their
CD40 expression. Consistently, LCH cells sorted from bone lesions (eosinophilic granuloma)
poorly stimulated allogeneic T-cell proliferation in vitro. Strikingly, however, in vitro treatment
with CD40L induced the expression of membrane class II and CD86 and strongly increased LCH
cell allostimulatory activity, to a level similar to that of mature DC. Numerous IL-10+, Langerin±,
CD68+ macrophages were found within bone and lymph node lesions. In patients with self-healing
and/or isolated cutaneous disease, LCH cells had a more mature phenotype. LCH cells were
frequently CD14±/CD86+ and macrophages were rare or absent, as were IL-10 expressing cells.
We conclude that LCH cells in the bone/chronic forms of the disease accumulate within tissues in
an immature state, that most probably results from extrinsic signals, and may be induced to
differentiate towards mature DC after CD40 triggering. Drugs that enhance the in vivo maturation
of these immature DC, or that induce their death may be of therapeutic bene®t.
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Cholera Toxin Induces Activation of Langerhans Cells In Vivo
M. E. Baca-Estrada, C. Ewen, D. Wilkie,* D. Mahony, and M. Foldvari²
Veterinary Infectious Disease Organization, *Department of Animal Science and ²College of Pharmacy and
Nutrition, University of Saskatchewan, Saskatoon, Canada
The development of non-invasive methods for the delivery of proteins through the permeability
barriers, such as the intact skin, will greatly facilitate the administration of human and veterinary
vaccines. Our studies have demonstrated that topical application of antigens formulated in lipid-
based delivery systems induces antigen-speci®c immune responses. These responses can be
signi®cantly enhanced by coadministration of antigens with cholera toxin (CT). The mechanism
by which CT exerts its immunoadjuvant effect is not known but it is likely related to its ability to
activate dendritic cells (DC). In this study we sought to evaluate the effect of CT on epidermal
dendritic cells (Langerhans cells; LC) following topical application to intact skin. Our results
indicate that within 8 h of application of CT, epidermal LC cells become round and exhibit
enhanced expression of MHC class II and costimulatory molecules. These changes are
accompanied by increased ICAM-1 expression in the skin and increased migration of ¯uorescent
labeled cells from the skin to the draining lymph nodes. Taken together, these ®ndings suggest that
CT induces activation of LC and stimulates the migration of cells to the lymph nodes. These results
provide important information for the development of effective and safe transcutaneous vaccines.
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Factors Affecting the Differentiated State of Langerhans Cells in Epidermis
L. Pieri, L. Domenici, and P. Romagnoli
Department of Anatomy, Histology and Forensic Medicine, University of Florence, Viale Pieraccini 6,
Firenze, Italia
Cytokines, in particular GM-CSF and TNF-a, together with serum factors, are known to
in¯uence the differentiation of precursors into Langerhans cells (LC) and of the latter into
``mature'' dendritic cells. This research has addressed the role of serum separately from that of
cytokines in maintaining the differentiated state of LC within epidermis. Epidermal sheets isolated
from human skin biopsies were incubated without supplements or with either 10% fetal calf serum
or cytokines (TNF-a, 0.25-25 ng per ml; GM-CSF, 0.05-0.5 ng per ml; or a combination of the
two at highest doses). Upon labeling for CD1a, the mean cell surface area (an estimate of cell
volume) and perimeter length (an estimate of dendriticity) decreased signi®cantly (p < 0.01, anova)
within 48 h culture without supplements. These decreases were almost entirely prevented by
addition of serum (p < 0.01 vs. without serum), but not by any cytokine or their combination, at
variance with previous results with serum. Upon labeling for major histocompatibility complex
class II molecules, all parameters analyzed exhibited inconsistent, not signi®cant variations among
experiments and among experimental conditions. The results suggest that CD1a varies in
distribution upon culture, without changes in cell shape and size, and that the two antigens
analyzed are differentially regulated in LC within epidermis. The distribution of CD1a seems to be
in part dependent on serum factors, therefore the previously recognized effects of cytokines in the
presence of serum may depend on concomitant factors acting on LC, or be mediated by
keratinocytes whose response to cytokines possibly depends on trophic stimuli given by serum.
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Expression and Function of Histamine Receptors in Human Dendritic Cells
M. Idzko, A. la Sala,* D. Ferrari,² E. Panther, F. Di Virgilio,² G. Girolomoni,* and J. Norgauer
Department of Experimental Dermatology, Freiburg, Germany; *Laboratory of Immunology, Istituto
Dermopatico dellIÁmmacolata, IRCCS, Rome, Italy; ²Department of Experimental and Diagnostic Medicine,
Section of General Patholog; and the Center of Biotechnology, University of Ferrara, Ferrara, Italy
Dendritic cells (DC) are antigen-presenting cells specialized in the activation of naive T
lymphocytes and the initiation of immune responses. Immature DC resides in most tissues, where
they are adapted to capture antigens and alert for danger signals such as microorganisms,
in¯ammatory cytokines and cell necrosis. Histamine is a well-known mediator eliciting different
responses in immune and non immune cells. Here we show that immature and mature dendritic
cells (DCs) express the mRNA for H1, H2 and H3 histamine receptors. Histamine induced
intracellular Ca2+ transients, actin polymerization and chemotaxis in immature human DC.
Maturation of DC resulted in the loss of histamine-induced chemotaxis, actin polymerization and
Ca2+ responses. However, in maturing DC histamine dose-dependently enhanced intracellular
cAMP levels and stimulated interleukin (IL)-10 secretion, while it inhibited production of IL-12.
As a consequence, the ability of mature DC to generate allogeneic type 1 responses was impaired
by histamine. The use of speci®c histamine receptor agonists or antagonists revealed that Ca2+
transients, actin polymerization and chemotaxis of immature DC were prevalently due to
stimulation of H1 and H3 receptors receptor subtypes. Modulation of IL-12 and IL-10 secretion by
histamine involved exclusively the H2 and H3 receptors. Our study suggests that histamine has
important and complex biological effects on DC activities, opening the possibility that histamine
released during in¯ammatory or immune responses could regulate DC functions and ultimately
favor type 2 lymphocytes-dominated immunity.
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Neuropeptide Y and Cutaneous Immunity
K. Seiffert, I. Friedman, R. Lambert, K. Campton, and R. D. Granstein
Weill Medical College of Cornell University, New York, New York
Epidermal Langerhans cells (LC) reportedly can be stained with antibodies to neuropeptide Y
(NPY) in the setting of atopic dermatitis. Therefore, our laboratory examined expression of NPY
and the related factor peptide YY (PYY) by the epidermis-derived dendritic cell line XS52
(BALB/c) and highly-enriched populations of BALB/c LC. While both populations of cells were
found to contain mRNA for NPY and PYY by RT-PCR, radioimmunoassay of supernatants
conditioned by these populations of cells revealed the presence of detectable levels of PYY
secretion only from XS52 cells. The effects of NPY are mediated by at least 6 G protein-coupled
receptors termed Y1, Y2, Y3, Y4, Y5 and Y6. By RT-PCR, Y1, Y2, Y4, Y5 and Y6 receptors
could not be detected on XS52 cells or on highly-enriched populations of murine LC. In order to
examine whether production of these factors by cells in the epidermis may have immunologic
consequences, naõÈve mice were injected intradermally with 500 pmol of NPY, PYY or diluent
alone. Fifteen minutes later 5 mice from each group were immunized by topical application of 5 mL
of 1% dinitro¯uorobenzene (DNFB) at the injected site. One week later all mice as well as non-
immunized negative control animals were challenged on the ears by application of 5 mL of 0.2%
DNFB to each side of earch ear and 24 h ear swelling was assessed. Mice immunized at NPY
injected sites exhibited a signi®cantly decreased contact hypersensitivity response compared to the
diluent and PYY groups. The locus of action of NPY in this activity remains unknown. NPY may
have a regulatory role for immune reactions within the skin.
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The Adenosine Receptors A2a and A3 are Differentially Expressed During Dendritic
Cell Maturation
S. Hofer, L. Ivarsson, S. Neyer, and C. Heu¯er
Dept. of Dermatology, University of Innsbruck, Innsbruck, Austria
In an attempt to characterize dendritic cell (DC) functional stages we performed a gene array of
immature vs. mature monocyte derived DC. One group of differentially regulated molecules were
the adenosine receptors A2a and A3. The mRNA levels were ~4 fold up-regulated and ~10 fold
down-regulated during maturation, respectively. We found little expression of mRNA coding for
the other known adenosine receptors, A1 and A2b in immature DC only. To collect information
on the possible involvement of adenosine and it`s receptors in DC function we added the stable
adenosine-agonist 5¢-N-ethylcarboxyamidoadenosine (NECA) to maturing DC. Like adenosine,
NECA binds to all adenosine receptors. Using untreated and treated DC we compared T-cell
activating capacity (mixed leukocyte reaction), surface marker expression (FACS analysis), T-cell
cytokine pro®le (ELISA) and transcription of genes coding for a pannel of DC function related
molecules (quantitative PCR analysis). Preliminary results show an induction of mRNA
transcription coding for proin¯ammatory cytokine receptors (CXCR4, CCR7) in immature
DC. These receptors are known to be up-regulated during maturation. To ®nd out whether these
changes are mediated by the A2 or the A3 receptors we are currently using speci®c receptor
antagonists in similar experiments.
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Are Extracellular Nucleotides Danger Signals for Dendritic Cell Activation?
D. Ferrari, A. la Sala,* M. Idzko,² G. Bolognesi, S. Corinti,* G. Girolomoni,* S. Dichmann,² J.
Norgauer,² A. Cavani,* and F. Di Virgilio
Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; *Laboratory of
Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy; ²Department of Experimental
Dermatology, Freiburg, Germany
Factors released at sites of tissue damage, or during the early phases of in¯ammation can have a role
in shaping the immune response. Thus, it has been postulated that cells undergoing stress or
necrotic cell death release factors that trigger immune cells, in particular dendritic cell (DC)
activation, and initiate primary immune response. Identity of such factors is largely unknown, but
for a few examples such as CD40L, TNFa, IL-1b. Substances already present in the cell cytoplasm
(constitutive danger signals) may alert the immune system when released into the extracellular
environment. We provide evidence for a role of intracellular nucleotides (in particular ATP) as
endogenous danger signals. ATP is normally present at a 5±10 mM concentration in the cytosol of
all cells. Its concentration in the extracellular milieu is negligible. Release of ATP occurs following
cell membrane stretching or injury, or upon stimulation with in¯ammatory agents such as LPS.
Once in the extracellular medium, ATP stimulates in a autocrine/paracrine fashion speci®c plasma
membrane receptors, named purinergic P2, and triggers an increase in the intracellular Ca2+
concentration, MAPK activation, cytoskeletal rearrangement, chemotaxis, IL-1b and TNFa
secretion. In DC, low ATP concentrations may also drive maturation. Sustained exposure to high
ATP concentrations on the contrary causes DC apoptosis. We conclude that extracellular ATP is a
powerful activator of DC and other immune cells and suggest that this nucleotide may have an
important role as a trigger and modulator of the early phases of the immune response.
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Dehydroepiandrosterone Sulfate Regulates Cortisol-Induced Suppression of Epidermal
Langerhans Cells
J. Hosoi, M. Tanida, and T. Tsuchiya
Shiseido Life Science Research Center, Yokohama, Japan
Dehydroepiandrosterone (DHEA) which decreases as people are aged is considered as an
antagonizing factor to aging and stress. Effects of DHEA sulfate and cortisol on Langerhans cells
were examined. Epidermal cells were prepared from Balb/c mouse skin. Langerhans cells were
enriched by I-A antibody-bound magnetic beads. Langerhans cell population was determined by
¯ow cytometry. Mixed epidermal cell lymphocyte reaction (MELR) was performed with T cells
prepared from C57BL mice by nylon wool. Langerhans cell population decreased after incubation
with cortisol for 24 h. The down-regulation was blocked by DHEA sulfate. DHEA sulfate alone
did not affect the population. MELR was suppressed by pretreatment of epidermal cells with
cortisol. The suppression was not observed in the presence of DHEA sulfate. Addition of cortisol
to the mixed culture caused more suppression and the suppression was blocked by DHEA sulfate
little. DHEA was suggested to antagonize the suppressive effect of cortisol on Langerhans cells.
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Identi®cation of Genes Speci®cally Modulated in Dendritic Cells During Maturation
F. Granucci, C. Vizzardelli, M. Persico, N. Pavelka, and P. Ricciardi-Castagnoli
University of Milano-Bicocca, Department of Biotechnology and Bioscience, Milano, Italy
The application of high density DNA array technology to monitor gene expression transcription
has been responsible of a paradigm shift in biology and we have now the ability to measure the
expression of a signi®cant proportion of the genome in single experiment. In the ®eld of
immunology the analysis of gene expression pro®les has revealed that cells respond to an activation
signal with waves of coordinated gene expression pro®les. DCs represent the professional antigen
presenting cells which uptake, process and present antigens to naive T cells inducing their priming.
In order to acquire this ability DC have to undergo a process of maturation that involve the
activation of hundreds of genes. Global expression pro®les of DCs stimulated with Gram-negative
bacteria at different time points has been performed using microarrays representing 11000 known
genes and ESTs. Gene expression data have been organized using two different type of clustering,
the hierarchical clustering and the self-organizing maps. Approximately 30% of the genes displayed
on the chips were called present at each time point after bacteria stimulation. Using stringent
conditions, we identi®ed about 1500 gene differentially expressed during DC maturation: 800
ESTs and 700 known genes. These genes mostly encoded enzymes and proteins involved in the
control of cell cycle, apoptosis, cytoskeleton rearrangements and activation and control of
in¯ammation.
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Crosslinking of Leukosialin (CD43) with Monoclonal Antibody 6F5 Induces Apoptosis
in Dendritic Cells
N. Selenko, O. Majdic, L. Deszcs, E. Tschachler, J. Stoeckl, and W. Knapp
Institute of Immunology, Institute of Medical Biochemistry, Division of Biocemistry, Department of
Dermatology, Division of Immunology, Allergy, and Infectious Diseases, University of Vienna Medical
School, Vienna, Austria
Dendritic cells (DC) play a central role in the induction and regulation of immune responses. This
capacity has to be controlled in order to avoid overwhelming immune reactions. One of these
potential control mechanisms is programmed cell death of DC. Here we report that a monoclonal
antibody (mAb) against CD43 generated in our laboratory induces apoptosis in DC. CD43 is
broadly expressed on peripheral blood leukocytes. Yet, we observed that CD43 triggered apoptosis
is speci®c for DC, since engagement of CD43 on monocytes, lymphocytes, granulocytes or cell
lines did not result in apoptosis. CD43 induced DC death is rapid and ef®cient and occurs in
immature as well as mature monocyte-derived DC, which is in contrast to apoptosis observed after
HLA-DR triggering. Interestingly, also peripheral blood DC (LIN-, HLA-DR+) were driven into
apoptosis upon CD43 triggering with 6F5mAb. Cross-linking of the CD43 epitope was found to
be mandatory, since Fab-fragments of 6F5 failed to induce apoptosis. DC apoptosis appears to be
speci®c for the epitope recognized by the 6F5 mAb, since an antibody against a different epitope
showed no such effects. We conclude from these data that the mAb 6F5 recognizes an epitope of
CD43 which represents a potential target structure via which DC can be selectively eliminated.
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Stimulation of Blood-Derived Dendritic Cells by Ultraviolet B Radiation During
Apoptosis
S. Nakagawa, S. Aiba, and H. Tagami
Department of Dermatology, Tohoku University School of Medicine, Aoba-ku Sendai, Sendai, Japan
UVB is considered to suppress skin immune system by killing or altering LC function. However,
we have previously demonstrated that some LC subpopulations showed enhanced expression of
costimulatory molecules and increased proin¯ammatory cytokine production after UVB,
proposing the possibility that UVB partly potentiates skin immune reactions. In this study, we
examined the mechanism of the stimulation or apoptosis of LC induced by UVB using blood-
derived dendritic cells (BDC). BDC, which were obtained from CD14-selected PBMC by
culturing them with GM-CSF and IL-4 for 6 days, were irradiated with various doses of UVB (25-
200 J per m2). Flow cytometry was used to detect cell surface molecules on BDC. RT-PCR and
ELISA were utilized for the analysis of cytokines. UVB caused apoptotic cell death on BDC in a
dose-dependent manner, while simultaneously stimulated BDC to up-regulate CD86 surface
expression, and mRNA or protein synthesis of proin¯ammatory cytokines such as IL-1b, IL-6, IL-
8, and TNF-a. Inhibition experiments using p38 MAPK inhibitor, SB203580 showed that p38
MAP kinase cascade was largely involved only in the former process. These results suggest that
UVB exerts contradictory effects on BDC which involve the complex intracellular pathways.
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A Clinically Approved Oral Vaccine Against Urinary Tract Infections Induces the
Terminal Maturation of CD83+ Immunostimulatory Dendritic Cells
R. Ramoner, S. Schmidhammer, C. Zelle-Rieser, G. Bartsch, and M. Thurnher
Department of Urology, University of Innsbruck, Innsbruck, Austria
Dendritic cells (DCs) are important antigen-presenting cells of the immune system, which have
attracted interest as cellular adjuvants to induce immunity in clinical settings. We have investigated
the effects of Uro-Vaxomq, an oral vaccine composed of different E. coli strains on human
monocyte-derived dendritic cells (moDCs). Uro-Vaxomq induced the terminal maturation of
CD83+ moDCs. MoDCs stimulated with Uro-Vaxomq displayed a phenotype of activated DCs
with high levels of major histocompatibility complex (MHC) molecules and increased levels of
adhesion and co-stimulatory molecules. In addition, moDCs activated with Uro-Vaxomq
exhibited enhanced T cell-stimulatory capacity in the allogeneic mixed leukocyte reaction. Uro-
Vaxomq at 100 mg per ml was as potent as TNF-a at 1000 U per ml in activating human moDCs.
In DC-based immunotherapy, Uro-Vaxomq could be used as a stimulus of DC maturation, which
meets the standards of good manufacturing practice (GMP). In addition, vaccination with Uro-
Vaxomq-loaded moDCs may be an attractive treatment option in preventing recurrent urinary
tract infections in predisposed individuals.
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Direct Transfection and Activation of Human Langerhans Cells In Situ Using Biolistic
Delivery of Naked DNA
A. T. Larregina, S. C. Watkins, G. Erdos, L. A. Spencer, D. Beer Stolz, W. J. Storkus, and L. D.
Falo Jr
Department of Dermatology, Cell Biology and Surgery. University of Pittsburgh, School of Medicine,
Pittsburgh, Pennsylvania
Delivery of antigens to Langerhans cells (LC) in order to induce speci®c immune responses against
tumors represents a challenge for vaccine development and for this purpose genetic immunization
strategies have emerged as an attractive approach. In the present work, to address the possibility of
``in situ'' transfection of human Langerhans cells (LC), we used the gene gun to transduce human
skin organ cultures with plasmid DNA encoding the reporter green ¯uorescent protein (pEGFP) or
®re¯y luciferase (pLuc). To analyze the function of transfected LC we used a plasmid DNA
encoding melanoma antigen MART-1 under the control of the hIE-CMV promoter. Gold
delivery to LC and the expression EGFP was analyzed in situ in the population of CD1a+ cells in
epidermal sheets by confocal microscopy and in cytospin preparations of epidermal cell
suspensions. The quanti®cation of transgenic proteins was determined in epidermal or dermal
cell suspensions as well as in puri®ed CD1a+ cells, from skin samples transfected with pLuc. The
viability of CD1a+ LC and skin migratory dendritic cells was analyzed after gene delivery in
cytospin preparations and by transmission electron microscopy. Activation and migration of LC
from transfected epidermis was determined 1, 3, 6, 12, 24 and 48 h after transfection of skin samples
with pEGFP and pLuc, or after delivery of empty plasmid backbones or unloaded gold particles.
The possibility of direct transfection of skin dendritc cells (DC) was analyzed by RT-PCR in the
population of migratory DC from skin samples transfected with genes under the control of the
hIE-CMV or the keratinocyte speci®c promoter K14. The ability of transfected LC to process and
present transgenic peptides in MHC-I restricted manner was analyzed in co-cultures of LC
transfected with a plasmid DNA encoding the human melanoma antigen MART-1 with a speci®c
CTL clone HLA-A2 restricted. We conclude that: i) LC can be directly transfected using a gene
gun, ii) the viability of LC is not compromised by the transfection method employed iii) biolistic
gene delivery is suf®cient to stimulate the activation and migration of epidermal LC and iv) LC can
ef®ciently process transgenic proteins and present the resulting peptides to a MART-1 speci®c
CTL.
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Entrapment and Antigen Loading of Langerhans Cells In Situ by an Arti®cial
Chemokine Gradient
T. Kumamoto, E. K. Huang,* R. F. Valentini,* and A. Takashima
UT South-western, Dallas, Texas; *Brown University, Providence, Rhode Island
Many dendritic cell (DC)-based vaccine protocols have been developed for the treatment of cancer
patients. However, time- and cost-consuming ``customizing'' processes are required in the current
format, e.g. isolation, expansion, and antigen-pulsing of DC. Here we report a novel format that
requires no ex vivo DC manipulation. We sought to entrap migratory Langerhans cells (LC) by
creating an arti®cial chemokine gradient in their homing path. We formulated ethylene-vinyl-
acetate (EVA) polymer rods releasing MIP-3b (LC-attracting chemokine) in a controlled fashion.
When MIP-3b rods were implanted subcutaneously into mouse abdomen and DNFB was applied
over the implantation sites, marked LC accumulation was observed around the rods. FITC-
triggered LC homing to draining lymph nodes (LN) (assessed by counting IA+/FITC+ LN cells)
was markedly inhibited by MIP-3b rod implantation at 24 hr. Recovery of IA+/FITC+ LN cells
increased thereafter to the normal level at 72 hr, indicating that LC can be entrapped transiently
without affecting their homing potential. As an attempt to load migratory LC with tumor-
associated antigens (TAA) at the entrapment sites, we co-implanted MIP-3b rods together with the
second EVA rods releasing ovalbumin (OVA) and applied DNFB 24 hr later. These mice
developed potent CTL activities to lyse the OVA-transduced E.G7-OVA tumor target, and
exhibited almost full protection against subsequent challenge with the same tumor cells. Thus,
tumor-speci®c protective immunity is readily inducible by combining MIP-3b-mediated LC
entrapment and EVA polymer-based LC loading with relevant TAA. Our in situ LC vaccine
strategy represents a major breakthrough moving the DC-based vaccine concept toward practical
medicine.
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Role of Matrix Metalloproteinases in Migration of In Vitro Generated Langerhans Cells
and Epidermal Langerhans Cells, Implication of TNFa
N. Noirey, M.-J. Staquet, M.-J. Gariazzo, M. Serres, C. AndreÂ, D. Schmitt, and C. Vincent
INSERM U346, Lyon, France and STALLERGENES SA, Antony, France
Langerhans cells (LC) are potent dendritic cells for induction of primary T cell-mediated immune
responses. The implication of matrix metalloproteinase-9 (MMP-9) in the migration was suggested
by Kobayashi et al in mouse model and by Lebre et al in human skin explants. In our in vitro model
using Langerhans like dendritic cells derived from CD34+ cord blood cells (LLDC), we
investigated the role of MMP-9 and other MMPs on human cell migration.
Immature LLDC, as epidermal LC, are activated with Bandrowski' Base (BB) a chemical
allergen or with recombinant Birch pollen allergen 1 (rBet v 1). Non-speci®c activation is obtained
by addition of TNFa. Contact of LLDC or LC with BB or rBet v 1 triggers migration in 10
experiments over 10, migration is maximum at 24 h of contact with allergens. Migration is
preceded by a production of MMP-2 and ±9, part of the molecules is recovered as pro-MMPs in
cell culture supernatant and part is associated to cell membrane proteins. MMP-1, ±3, ±7 and ±13
as MT1- and MT3-MMP are also identi®ed at the cellular level. Addition of TNFa in the upper
compartment of migration chambers with non-activated LLDC or freshly isolated LC initiates
MMP-2 and MMP-9 production then cell migration with a dose dependent effect. These data
imply that TNFa is a key molecule for MMPs production and cell migration. Furthermore,
activation of LLDC with BB induces a synthesis of TNFa and expression of TNF-R2 on the cell
membrane suggesting an autocrine loop. In conclusion, membrane associated MMP-2 and ±9
rather than soluble ones are implicated in the cell migration, however, the system is probably more
complex, other MMPs being implicated either in the migration or in MM-2 or ±9 activation.
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Adhesion of Dendritic Cells Derived from CD34+ Progenitors to Resting Human
Dermal Microvascular Endothelial Cells is Down-Regulated Upon Maturation and
Depends on CD11a, CD11b and CD36
V. A. Nguyen, S. Ebner, C. FuÈrhapter, N. Romani, D. KoÈlle, P. Fritsch, and N. Sepp
Departments of Dermatology and Obstetrics (DK), University of Innsbruck, Austria
Dendritic cells (DC) function as sentinels of the immune system. In order to reach their target
tissue, bone marrow-derived DC precursors need to bind and migrate speci®cally through
microvascular endothelial cells. Binding of DC to primary endothelial cells of the skin has not been
investigated. We therefore determined adhesion of DC at different stages of development to
human dermal microvascular endothelial cells (HDMEC). DC were generated from human cord
blood-derived CD34+ hematopoietic progenitors by culture in the presence of GM-CSF, TNF-a
and hSCF. To enhance DC maturation, cells were additionally exposed to a de®ned cocktail of IL-
1b/IL-6/TNF-a/PGE2 (``cocktail DC''). Adhesion was quanti®ed by phase contrast microscopy
and by a ¯uorimetric adhesion assay. Signi®cantly more DC progenitors on day 5 (37.8 6 9.7%)
than mature DC on day 13 (13.8 6 6.3% for conventionally matured DC and 2.5 6 0.87% for
``cocktail DC``) bound to unstimulated HDMEC. Pretreatment of HDMEC with TNF-a and
IFN-g resulted in an enhanced attachment of both DC progenitors and mature DC by 50±160%.
Mature DC lacked expression of CD31, CD36, CD45RA and CLA and expressed lower levels of
CD11a, CD11b and CD49d as compared to day 5 progenitors. MAb's against CD11a, CD11b, and
CD36 markedly inhibited DC binding (mean inhibition 65-70%), whereas anti-CLA, anti-DC-
SIGN and anti-CD49 Ab's did not. Our data support the hypothesis of immunosurveillance with
selective recruitment of blood DC progenitors (including langerhans cell progenitors) to resting,
and, more so, to in¯amed skin. They have potential relevance for anti-cancer immunotherapy
strategies favouring the intracutaneous application of mature DC.
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A Three-Dimensional View on Langerhans Cell Migration ± A Scanning
Electronmicroscopic Study
P. Stoitzner, K. Pfaller,* H. StoÈssel, and N. Romani
Departments of Dermatology and *Histology, University of Innsbruck, Innsbruck, Austria
Langerhans cells and dermal dendritic cells initiate primary immune responses after migrating from
sites of antigen uptake to lymphoid organs. The skin is a feasible model to study the morphology
and regulation of dendritic cell migration. Both features are incompletely known and understood.
We used murine skin explant cultures for tracking the pathways of dendritic cell migration by
scanning electronmicroscopy and noted the following ultrastructural features. (1) In 48-h cultures
of epidermal sheets we observed numerous Langerhans cells migrating out between keratinocytes
in a time-dependent manner. These cells appeared mature as judged by their expression of thin
cytoplasmic processes (``veils''). They also possessed pseudopodia that appeared to be actively
involved in migration. (2) The basement membrane represented a tightly packed and dense
network of ®brils which seemed to leave no space for emigrating dendritic cells unless they actively
digested the meshwork by proteinases. (3) Inspection of the dermal compartments in 48-h cultures
of whole skin revealed dendritic cells ``struggling'' through the collagen lattice and extending their
cytoplasmic processes, apparently to pull themselves along the collagen ®brils until they reach a
lymph vessel. These observations visualize the cumbersome pathway that dendritic cells have to
take when they generate immunity (or tolerance). They thereby emphasize the need to better
understand the cellular and molecular events that regulate this migration in order to be able to
improve it in vaccination approaches.
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How Migrating Langerhans Cells Cross Physical Borders ± A Transmission Electron
Micrososcopic Study
H. StoÈssel, P. Stoitzner, K. Pfaller, and N. Romani
Departments of Dermatology and Histology (KP), University of Innsbruck, Innsbruck, Austria
On their way from the epidermis to the lymph node, Langerhans cells must cross some solid
physical barriers, ®rst the basement membrane and then the endothelial cells of the lymphatic
vessels. We were interested in the morphology of these processes. A murine skin explant culture
system was used. Explants were cultured on medium for 48 h, ®xed and further processed for
transmission electronmicroscopy. On rare occasions could we observe Langerhans cells that were
just leaving the epidermis. They seem to ®rst extend a pseudo-pod. Then they penetrate the
basement membrane, presumably with the help of matrix metallo-proteinases. Disruption of the
basement membrane (lamina densa) was only seen where a Langerhans cell was actively pushing
out of the epidermis, emphasizing the spatially focussed action of these enzymes. Entry into dermal
lymph vessels appeared to occur through (sometimes wide) gaps in the thin endothelial lining of
the vessels. This very moment was indeed caught by EM, although very rarely. Transmigration
between adjacent endothelial cells is also conceivable, even more so since cell-cell contacts in the
lymph endothelial lining appeared loose; cell endings often overlapped to some degree. The clear
physical separation of the electron-dense ground substance of the connective tissue and the
electron-lucent lumen of the vessel in the gaps suggests that there is still a molecular border (e.g.
barely visible lamina lucida materials) that needs to be surmounted by migrating Langerhans cells
with the help of known (e.g. matrix metalloproteinases) and still unknown molecular tools.
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Verapamil Inhibits Murine Epidermal Langerhans Cell Migration In Vitro and In Vivo
M. Cumberbatch, R. J. J. Dearman, and I. Kimber
Syngenta Central Toxicology Laboratory, Alderley Park, Maccles®eld, Cheshire, UK
Verapamil (VPM) has been found previously to compromise the migration of Langerhans cells
(LC) from human skin explants through a mechanism believed to be dependent upon inhibition of
multi-drug resistance protein (MDR1) activity. More recently, it was suggested that murine
dendritic cells (DC) do not express substantial levels of MDR1 but that both human and murine
DC express the multidrug resistance associated protein 1 (MRP1), a transporter of leukotriene C4
(LTC4). It is known that VPM inhibits both MDR1 and MRP1 activity and also resultant LTC4
release. We have now examined the in¯uence of VPM on LC migration in mice, both in skin
explants and in vivo. Early (4 hr) migration of MHC class II+ LC from murine skin explants was
inhibited completely by addition of VPM to culture medium. Subsequently, mice were exposed
topically on the dorsum of both ears to VPM 2 hr prior to application of the contact allergen
oxazolone (Ox). VPM inhibited the decrease in epidermal LC densities observed 4 hr following
exposure to Ox and compromised also the accumulation of DC in draining lymph nodes 18 hr
later. Identical pre-treatment of mice with VPM attenuated LC migration and DC accumulation
provoked by intradermal injection of tumour necrosis factor a (TNF-a), but was without effect on
either response stimulated by exogenous interleukin 1b (IL-1b). It is proposed that one function of
VPM is to regulate the secretion by LC of IL-1b either directly through inhibition of MDR1/
MRP1 activity or through a mechanism involving LTC4 transport.
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Macrophage In¯ammatory Protein (MIP)-3a Expression is Increased in Human
In¯ammatory Bowel Disease: Role in Crohn's Disease
A. Kaser, O. Ludwiczek, and H. Tilg
Division of Gastroenterology, Department of Medicine, University Hospital Innsbruck, Austria
MIP-3a, the ligand of CC chemokine receptor 6 (CCR6), has recently been identi®ed the key
chemokine attracting Langerin+ Langerhans cell-like dendritic cells (DCs) to in¯amed epithelial
cell surfaces. In¯ammatory bowel disease (IBD), constituting Crohn's disease (CD) and ulcerative
colitis (UC), are chronic in¯ammatory disorders characterized by in®ltration of Th1 and Th2
lymphocytes, respectively, in the lamina propria of the gut. The role of DCs in IBD is barely
de®ned. In the current study, we asked whether MIP-3a expression is altered in IBD. Colonic
biopsies were obtained from IBD patients. Control biopsies were obtained from patients
undergoing routine colonoscopy for tumor screening, which were found normal. MIP-3a mRNA
levels in colonic biopsies were determined by real-time PCR analysis. Furthermore, whole tissue
cultures of colonic biopsies were performed and MIP-3a secreted into supernatant determined by
speci®c enzyme-linked immunosorbent assay. We demonstrate that MIP-3a mRNA levels are
signi®cantly elevated in both, lesional and non-lesional colonic biopsies in CD compared to
controls. MIP-3a mRNA levels varied widely in UC patients, and were not statistically different
from controls. MIP-3a levels secreted from colonic biopsies cultured for 24 h were elevated in
both, lesional and non-lesional CD compared to controls. In UC, non-lesional cultured biopsies
secreted MIP-3a comparable to controls, while MIP-3a secretion was signi®cantly elevated in
lesional UC. MIP-3a has a predominant role in the migration of LC-like DC precursors to
in¯amed epithelial surfaces, thus in directing DCs to sites of antigen-uptake. Enhanced expression
of MIP-3a in human CD might therefore attract DCs to epithelial surfaces, and thus could play a
role in the initiation of the Th1 immune response ®nally resulting in bowel in¯ammation. Another
important function of enhanced MIP-3a expression in CD might be the direct attraction of T
lymphocytes, since CCR6 expression has also been reported on gut-dedicated a4a7-expressing
memory T lymphocytes.
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Inhibition by Lactoferrin of Mechanical Trauma-Induced Langerhans Cell Migration in
Humans
M. Bhushan, S. Camus,* M. Cumberbatch,* R. J. Dearman,* I. Kimber,* and C. E. M. Grif®ths
Dermatology Centre, University of Manchester, Hope Hospital, Salford, UK; *Syngenta Central Toxicology
Laboratory, Alderley Park, Maccles®eld, Cheshire, UK
Topical exposure of volunteers to the sensitising chemical diphencyprone, or intradermal
administration of homologous recombinant tumour necrosis factor a (TNF-a) or interleukin (IL)-
1b, each provokes signi®cant reductions (approximately 30%) in CD1a+/HLA-DR+ Langerhans
cells (LC) in epidermal sheets prepared from punch biopsies. Furthermore, lactoferrin (LF), a
protein believed to inhibit TNF-a production, compromises both allergen- and IL-1b-induced
LC migration but is without effect on responses provoked by TNF-a. We have now investigated
the utility of epidermal LC measurements in blister roofs taken following suction blister formation;
a technique that permits the concomitant measurement of locally produced cytokines. We
demonstrate that CD1a+ LC numbers in blister roofs taken from suction blisters (12mm) formed on
photoprotected buttock skin were reduced by 31 6 3% (6 volunteers) compared with those
derived from concurrent punch biopsy (6 mm) material. Treatment of sites with LF prior to
induction of suction blisters inhibited almost completely the loss in LC numbers observed as a
result of this manipulation (3 volunteers). Injection of IL-1b (50U) prior to formation of suction
blisters, conditions shown previously to induce signi®cant LC migration in humans, failed to
provoke further decreases in LC densities (4 volunteers). Taken together these data suggest that
although the suction blister technique may represent a potentially useful tool for analysis of soluble
cutaneous mediators, this process is itself traumatic. The suggestion is that this procedure induces
local cytokine release, including THF-a, with concomitant loss of responsive LC from the
epidermis; a response that may be prevented by pre-treatment with LF.
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HIV Capture by Langerhans Cells
A. Amara, T. Delaunay,* F. Arenzana-Seisdedos, and J.-L. Virelizier
UniteÂ d'Immunologie Virale, Institut Pasteur, Paris, France; *INRA Villenave d'Ornon, France
DC-SIGN is a C-type lectin expressed on the surface of dendritic cells (DCs) that ef®ciently binds
and transmits human immunode®ciency viruses (HIV) to T cells in trans. It was postulated that
DC-SIGN allows HIV to divert mucosal DCs from their immunological function and to use them
as transporters for the virus to reach lymphoid organs, where DCs transmit a vigorous infection to
T cells. The recent discovery of DC-SIGN as a speci®c and ef®cient HIV receptor raises the
possibility that other attachment factors expressed on relevant cell types may exist and could have
profound consequences on the transmission of HIV infection. By their localization in mucosal
epithelium, Langerhans cells (LCs) are likely to be the initial HIV targets and are thought to play an
important role in the early steps of viral dissemination. In this work, we found that LCs do not
express DC-SIGN but can still bind envelope glycoproteins of different HIV strains. This
interaction is inhibited by mannan (a mannose polymer), suggesting the participation of a lectin
receptor in the capture of viral envelopes by LCs. We hypothesize that LCs may express speci®c
HIV attachment receptor(s), allowing these cells to capture virus in mucosa and transport HIV
virions to lymph nodes, the major site of HIV replication in vivo.
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Expression of Functional HIV CXCR4, CCR5, and CD4 Receptors on Fresh and
Cultured Human Langerhans Cells
I. Tchou, L. Misery, O. Sabido, P. Moja, H. Hamzeh, J. Peguet-Navarro,* D. Schmitt* and C.
Genin
GIMAP/Immunologie, FaculteÂ de MeÂdecine, Saint-Etienne, France; *INSERM UniteÂ 346, HoÃpital
Edouard Herriot, Lyon, France
HIV can cross the intact epithelium of genital mucosae via Langerhans cells. Fresh Langerhans cells
are known to express CD4 and CCR5. The presence of CXCR4 has been described on the surface
of cultured but not freshly isolated Langerhans cells. In the present study, we demonstrate that
CXCR4 was expressed by fresh Langerhans cells isolated and puri®ed from epidermis. However,
the percentage of Langerhans cells expressing CXCR4 or CCR5 increased during maturation of
the cells in culture, especially in the presence of exogenous GM-CSF. To determine if CXCR4
was functional, freshly isolated Langerhans cells were infected with HIV-LAI, a T-cell tropic strain
and P24 production was measured in culture supernatants. A P24 production was observed when
infected Langerhans cells were cocultured with SupT1 cells. However, the presence of HIV
provirus DNA was evidenced within the infected Langerhans cells by nested PCR. Ultrastructural
studies con®rmed that there was the formation of syncytia when Langerhans cells were cocultured
with SupT1 cells. Preincubation of Langerhans cells with AZT or SDF1-a, a natural ligand for
CXCR4, prevented infection. These data demonstrate that CXCR4 is present on the surface of
Langerhans cells, freshly isolated from human skin epidermis, and that this expression is functional.
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Extracellular-Matrix Environment Favors HIV-1 Transmission by Setting Dendritic
Cells as Replicative Reservoirs
S. Dumont, N. Bechetoille, S. MareÂchal, S. Gof¯o, E. Gentilhomme,* D. Schmitt, and C.
Dezutter-Dambuyant
UniteÂ INSERM U346, HoÃpital E. Herriot, Pavillon R, Lyon, France; *CRSSA Service de SanteÂ des
ArmeÂes, La Tronche, France
In primary HIV-1 infection, dendritic cells (DC) are used by the virus to traverse the epithelial
barrier of the female genital tract. In vitro, the replication of monocyte (M)-tropic strains is
hypothesized to be ef®cient in immature DC but not in cultured mature DC although infectious
virus can be ef®ciently transmitted to CD4+ T cells. We focused our interest on the susceptibility
of human interstitial DC (IntDC) to be infected after M- and T lymphocyte (T)-tropic strains
exposure when they were integrated in a reconstructed lamina propria. For this purpose, CD34
precursors were cultured in presence of GM-CSF+ TNFa and generated more than 80% of IntDC
(Langerine± or CD207±) and less than 5% of Langerhans cells (LC) (Langerine+ or CD207+). The
mixed DC subpopulations were either cultured in ®broblasts-retracted collagen lattices or in
suspension. Infection of both culture models was performed after 7 or 13 days of culture of CD34+
cells by a T- (LaõÈ) or a M- (BaL) tropic strain. Virus replication was controled by measuring p24 in
supernatants. Detection of provirus was carried out by in situ PCR. Although DC were infected by
both virus strains when they were integrated or not in lattices, only the M-tropic strain was
ef®ciently replicated by immature DC (infected on day 7 of the CD34 culture). Integrated in
lattices, DC ef®ciently replicated virus when they were infected on day 13 of the culture whereas
their counterparts lost this capacity in suspension. These results suggest that sustained capacity of
DC to replicate M-tropic strains is correlated to the delay of DC maturation induced by their
integration into a 3D-reconstructed lamina propria. In this 3D model, the productive infection of
IntDC may contrast with the ability of DC-SIGN to capture the virus and not to mediate its entry,
unless migrating LC act as viral vectors by enhancing the infection of IntDC in trans.
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Inhibition of HIV Infection in a Reconstructed Mucosa Integrating Langerhans Cells
P. Sivard, O. DeleÂzay, J. Kanitakis,* J.-F. Mosnier,² C. Genin and L. Misery
``Group Mucosal Immunity and Pathogen Agents'', ²Department of Pathology, University of Saint-Etienne;
*Department of Dermatology, Edouard Herriot Hospital, Lyon, France
We have performed a reconstructed in vitro mucosa integrating Langerhans cells (LC), and we have
investigated the infection of this model by HIV-1. Our epithelium consists of vaginal keratinocytes
cultured on de-epidermized dermis in submerged medium for two weeks. LC precursors, obtained
by differentiation of CD34+ cord blood progenitor cells in presence of GM-CSF, TNFa, TGFb
and Flt3L, are added in the reconstituted epithelium after 4±6 days of culture. Immuno-
histochemical and ultrastructural studies showed that LC were detected in a physiological location
in the well-strati®ed, differentiated epithelium. T-tropic (LAI, NL4-3) and M-tropic (BaL) HIV-1
strains were added 1° on a epithelium of vaginal cells, 2° on isolated fresh LC, and 3° on the model
of the reconstructed mucosa. Nested PCR revealed the presence of proviral DNA of the three
HIV-1 strains in cultured LC as in LC integrated in vaginal mucosa. In contrast, we could not
detect any HIV-1 proviral DNA in epithelial cells. NL4-3 infection of LC included in our model
could be totally inhibited by 100 ng per ml of SDF-1 (the natural ligand of CXCR4) or by AZT.
LAI infection was also inhibited by these drugs (SDF-1 and AZT) but less ef®ciently. Then, in our
experiments, LC could be infected by both M and T-tropic HIV isolates in this in vitro vaginal
model. Moreover, T-tropic HIV infection could be speci®cally inhibited by SDF-1 con®rming the
presence of a functional CXCR4 on LC. Such model seems to be a useful tool for the study of the
mechanisms involved in heterosexual transmission of HIV.
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Langerhans Cells in Human Periodontal Diseases
S. SeÂguier,*² G. Godeau,* E. Kahn,³ N. Brousse,² and J. C. Kaqueler*
*Laboratoire d'Anatomie Pathologique et de Physiopathologie des Tissus non MineÂraliseÂs, FaculteÂ de
Chirurgie Dentaire-Paris V, Montrouge, ²Service d'Anatomie et de Cytologie Pathologiques, HoÃpital
Necker-Enfants Malades, UniversiteÂ Paris V, Paris, ³Inserm U494, Imagerie MeÂdicale Quantitative, CHU
PitieÂ-SalpeÃtrieÁre, Paris, France
Gingival Langerhans cells (LC) are strongly implicated in the initiation and maintenance of
in¯ammatory periodontal diseases. In order to initiate the immune response LC migrate towards
lymph nodes and present pathogenic antigens to T lymphocytes. Their migration and the crossing
of the epithelial basement membrane probably need the release of metalloproteinases (MMPs)
leading to the local degradation of matrix macromolecules. Our works were focused on
quantitative and morphological studies as well as MMPs expression by gingival LC in periodontal
diseases. Fixed or frozen gingival samples of control, gingivitis or periodontitis patients were
stained by single or double immunohistochemical method using antibodies directed against CD1a
(LC), CD45, CD3, CD8, CD20, TIA-1, GrB, MMP-1, MMP-2 and MMP-9. Quantitative and
morphological studies were performed by morphometric and automated image analysis. MMPs
expression of gingival LC was studied with a confocal microscope on sections stained by double
immuno¯uorescence method. Results of these studies showed (1) a signi®cant decrease in the
CD1a + LC number correlated with the severity of the in¯ammatory phenomenon evaluated by
the quantitative study of cellular and collagen ®bres components; (2) a signi®cant decrease of the
surface, perimeter and equivalent diameter of CD1a + LC in periodontitis when compared with
controls and within the basal epithelial layer when compared with the upper layers; (3) an
expression of the collagenase MMP-1 and the gelatinases MMP-2 and MMP-9 by LC in healthy
and diseased gingival tissues. In conclusion, during periodontal diseases LC contribute to the
extracellular matrix degradation.
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Different Behavior of Mycobacterium Tuberculosis in Human Macrophages and
Dendritic Cells
L. Tailleux, O. Neyrolles,* S. Bouakline-HonoreÂ,* E. Perret,² M.-C. PreÂvost,² P. H. Lagrange,*
J.-C. Gluckman, M. Rosenzwajg, and J.-L. Herrmann*
Institut National de la Recherche Scienti®que EPI-0013 and Laboratoire d'Immunologie Cellulaire et
Immunopathologie de l'Ecole Pratique des Hautes Etudes, Paris, France; *Service de Microbiologie, HoÃpital
Saint-Louis, Assistance Publique-HoÃpitaux de Paris, UniversiteÂ Paris VII, Paris, France; ²Institut Pasteur,
Paris, France
The interaction of Mycobacterium tuberculosis (Mtb) with dendritic cells (DCs) is likely to have a
strong impact on the initiation of the immune response, the host's capacity to control primo-
infection, and possible further reactivation of latent infection. Here, we compared the interaction
of virulent Mtb H37Rv with human monocyte-derived DCs and macrophages (MFs) generated in
vitro from the same donors. As reported by others, Mtb infection induced DC activation and
maturation, with up-regulation of CD83, HLA-class II and costimulatory molecules, whereas it
resulted in only limited activation of MFs. Unexpectedly, the ability of Mtb to multiply in DCs
over a 7-day period was markedly reduced relative to its growth in MFs. Confocal microscopy
analysis revealed differential traf®cking of Mtb in the two cell types: although the mycobacterial
phagosome did not acidify nor fuse with host cell lysosomes in both DCs and MFs, in DCs the
bacterial vacuoles appeared to be disconnected from endocytic and recycling pathways, as
demonstrated by the absence of Rab5a and Rab11 markers on the vacuole membrane and the
inability of this compartment to accumulate and recycle exogeneously administered transferrin.
Such a segregation may be responsible for impaired access of the bacteria to essential nutrients.
Altogether, our ®ndings suggest that human DCs may have evolved special mechanisms to control
the growth of intracellular mycobacteria, a property that could allow safe and ef®cient priming of
naive T cells in secondary lymphoid organs without contributing to spreading the pathogen.
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The Effects of Treponema Pallidum on Human Dendritic Cells
J. L. Shin, T. H. Lee, J. M. Kang, and M.-G. Lee
Department of Dermatology, Yonsei University, College of Medicine, Seoul, Korea
Cell mediated immune responses play a prominent role in the syphilis, which is caused by
Treponema pallidum (TP). TP enters human body through skin or mucous membrane, where
dendritic cells (DC) may be important antigen presenting cells to present treponemal antigens to
the lymphocytes. The role of DC in the syphilitic infection is not well understood in human. In
the present study, we studied interaction of TP with DC, generated from human peripheral blood
mononuclear cells with GM-CSF and IL-4. After adding TP to DC culture at day 7 for 16 h, the
change of surface antigens on DC was checked with ¯ow cytometry and the amount of IL-12 in
culture supernatant of DC was checked by ELISA. We have observed an ef®cient phagocytosis of
TP by electron microscopy as early as 2 h after addition of TP to DC. Interaction of DC with TP
resulted in increased surface expression of CD83 which was proportionally increased according to
the number of TP. Addition of normal rabbit serum, normal rabbit testicular tissue, and media,
which served as negative controls, did not induce any change of CD83 on DC. CD80, CD86
expressions on DC were slightly increased and HLA-DR was not changed. The amount of IL-12
in the culture supernatant of DC was increased (1099 pg per ml) after the addition of TP which was
similar (1191 pg per ml) in the supernatant of mature DC. However, there was no secretion of IL-
12 from DC after adding normal rabbit testicular tissue and serum. From the above results, we
found that TP can stimulate DC to mature by showing increased expression of surface molecules
and production of IL-12.
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Human Melanoma Cells with Different Invasive Properties Inhibit the Earliest Steps of
Differentiation of Langerhans Cell Precursors, but Fail to Affect the Functional
Maturation of Epidermal Langerhans Cells
O. Berthier-Vergnes, M. Gaucherand, J. PeÂguet-Navarro, J. Plouet,* J. F. Pageaux,² D. Schmitt,
and M.-J. Staquet
INSERM U346, E.Herriot hospital, Lyon, France; *UPR CNRS 9062 IPBS, Toulouse, France;
²INSERM U352 ± INSA, Villeurbanne, France
This study addressed the question of whether invasive and non invasive human melanoma cells
may affect the generation and/or functional maturation of human epidermal Langerhans cells (LC).
LC were generated in vitro from CD34+ cord blood progenitors under GM-CSF/TNF-a/TGF-
b1. CD34+ cells were co-cultured with or without melanoma cells from a metastatic and invasive
clone (T1C3) or a non-metastatic and non-invasive clone (IC8) using transwell dishes. After 7 or
11 days of co-culture, CD34+-derived cells displayed a non-adherent undifferentiated morphology,
high level of monocytic CD14 marker, low level of LC markers (CD1a, E-cadherin) and DC
markers (CD40, CD80, CD54, CD58, CD83, CD86, HLA-DR, HLA-class I), and were less
potent than control LC in inducing allogeneic T cell proliferation. The generation of a CD14+
population was correlated with a decrease in CD1a+ population, without any statistical differences
between the two clones. Interestingly, melanoma cells affect differentiation of CD34+ cells only
during their proliferation stage (day 0±day 6), and the earlier the co-culture was started, the more
the CD14+ population was enhanced. This effect was not the result of factors including IL-10,
TGF-b1 and VEGF, as assessed by using blocking antibodies. By contrast, a 2-day coculture of
melanoma cells from both clones with fresh LC isolated from healthy epidermis did not affect their
phenotype and function. Collectively, our data demonstrate that melanoma cells produce factor(s)
that block(s) the earliest steps of LC differentiation, but fail(s) to affect the functional maturation of
LC, thus highlighting the differential sensitivity of LC and their precursors to melanoma-derived
factor(s). We suggest that melanoma cells might participate in their own escape from
immunosurveillance by preventing LC generation in the local cutaneous microenvironment.
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Breast Carcinoma Cell Lines Favor the Differentiation of CD34+ Cells into Two
Different Subpopulations (CD1a+Lang±CD86±, CD1a+Lang+CD86+)
M. C. Thomachot, J.-Y. Blay, and C. MeÂneÂtrier-Caux
Equipe Cytokines et Cancers, INSERM U-453, Centre LeÂon BeÂrard, Lyon, France
It has been reported that breast carcinoma (BCC) tumors are in®ltrated by immature dendritic cells
(DC) (CD1a+CD83±CCR6+). The aim of this study was to investigate the effect of BCC
conditioned media (BCC CM) as well as irradiated BCC cell lines on the differentiation of CD34+
progenitors into DC in presence of GM-CSF+ TNFa. In contrast with renal cell carcinoma,
previously described to block DC differentiation through IL-6 and M-CSF production, BCC CM
as well as irradiated cell lines favored DC differentiation towards a speci®c phenotype in this
model: BCC CM promoted the differentiation of CD34+ into CD1a+ DC as early as day 6, in
particular strongly enhanced CD34+ cell differentiation into Langerhans cells at day 6; at day 12,
cells cultured in the presence of BCC CM showed a long ®ne shape with long dendrites and were
loosely adherent. In addition, a speci®c subpopulation of cells expressing high levels of the CD1a
Ag among those Langerin+ and CD86± subpopulations were obtained in the presence of BCC CM.
Similar results were observed in presence of rhTGFb, known to favor the differentiation of CD34+
progenitors into Langerhans cells. Pan TGFb polyclonal antibody decreased the MFI of CD1a+
cells, blocked the appearance of the CD1a+Lang+CD86+ population and diminished by 50% the
CD86±CD1a+ population. These results strongly suggest the involvement of TGFb in the effects of
BCC CM. The functional consequences of this shift of DC phenotype induced by BCC CM will
be discussed.
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Generating the Optimal Dendritic Cell for Immunotherapy
E. Scandella, S. Gillessen, Y. Men, and M. Groettrup
Research department, Cantonal Hospital St. Gall, St. Gallen, Switzerland
Dendritic cells (DCs) have the unique ability to initiate an immune response in vivo. Therefore
DCs became a major tool in cancer immunotherapy. Recently, it has been shown that mature DCs
are more potent in eliciting an immune response than immature DCs. Nonetheless, not all mature
DCs induce optimal T cell responses. The secretion of IL-12p70 by DCs seems to play a central
role in the stimulation of Th1 cells providing essential help for the activation of cytotoxic T cells.
In this study we are aiming to optimize the maturation conditions for human DCs with respect to
clinical applicability. For this reason we investigate the effect of different stimuli, like soluble
CD40L, polyI:C or a cytokine mixture of TNF-a, IL-1b, IL-6 and PGE2 on DC maturation, IL-
12p70 production and T cell stimulatory capacity of the DCs. ``Clinical grade'' DCs where
generated under serumfree conditions and treated with different maturation stimuli. Mature DCs
were analyzed by FACScan or used as stimulators in mixed lyphocyte reactions. We found that all
of the stimuli mentioned above induce maturation but do not elicit IL-12p70 production of DCs
when given alone. However the combination of the cytokine mixture with soluble CD40L or
polyI:C leads to production of considerable amounts of IL-12p70. Furthermore this IL12p70
production could be enhanced by the addition of IFN-g. DCs which were matured with the
cytokine mixture showed the best T cell stimulatory capacity which could not be enhanced by the
addition of soluble CD40L, polyI:C or IFN-g. So far our experiments show that proin¯ammatory
cytokines are necessary that DCs stimulate Th cells ef®ciently, but are not suf®cient to induce IL-
12p70 production of DCs. Currently we are investigating the cytokine pro®le of Th cells activated
by these DCs.
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Alteration of Peripheral Blood Dendritic Cells in Connective Tissue Disease
Y. Ozaki, T. Ito, K. Tajima, K. Uehira, S.-I. Mori, R. Amakawa, and S. Fukuhara
First Dept. Int. Med. Kansai Medical University, Moriguchi-City, Japan
The pathogenesis of connective tissue diseases has remained unclear. Dendritic cells (DCs) are
specialized APC and play central roles in eliciting primary immune responses. Thus, it is possible
that DCs are involved in breakdown of self tolerance, resulting in the genesis of connective tissue
diseases. We recently identi®ed 3 fractions of human peripheral blood DCs including the
monocyte-associated fraction 1 and 2 (CD1a+/CD11c+ and CD1a±/CD11c+) and the lymphoid-
associated fraction 3 (CD1a±/CD11c±). Here, we attempted to determine whether these fractions
were altered in connective tissue disease including primary Sjogren's syndrome (pSS), systemic
lupus erythematosus (SLE), systemic sclerosis (SSc), and polymyositis/dermatomyositis (PM/DM).
We analyzed peripheral blood DCs from 23 pSS, 10 SLE, 11 SSc, 5 PM/DM untreated with
immunosuppressant, and 22 normal volunteers as control. Total amount (/total PBMC) of fraction
1 DC was decreased in pSS, SLE and PM/DM. Fraction 3 DC were also decreased in only SLE
patients' peripheral blood. In SSc patients, neither fraction of circulating DC was altered.
Furthermore, immunohistochemical staining of the small salivary gland from pSS patients indicated
that CD11c+ myeloid DCs scattered among the in®ltration of CD4+ T cells. These ®ndings suggest
the selective traf®cking of DCs into the focal in¯ammatory sites in pSS. Amount of circulating DCs
and their fractions were reduced in some connective tissue disease in different patterns, suggesting
that DCs participate in the pathogenesis of these diseases in different ways.
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Gangliosides Puri®ed from Human Melanoma Tumors Alters the Phenotypic and
Functional Differentiation of Monocyte-Derived Dendritic Cells
J. PeÂguet-Navarro, M. Sportouch, H. El Garch, O. Berthier-Vergnes, D. Schmitt, and J.
Portoukalian
INSERM UniteÂ 346, HoÃpital Edouard Herriot, Lyon, France
Gangliosides are membrane-associated sialic acid-containing glycosphingolipids which may be
involved in the suppression of the antitumor immune response. Indeed, tumor cells synthetize and
shed large amounts of gangliosides into their microenvironment and several studies have unravelled
the immunosuppressive properties of these compounds. In the present study, we analyzed the
effects of total or puri®ed ganglioside fractions derived from human melanoma tumors on the
differentiation of dendritic cells (DC). To this aim, monocytes were puri®ed from normal
peripheral blood and cultured for 6 days with GM-CSF and IL-4 in the presence or not of
gangliosides at different concentrations, before phenotypic and functional studies were carried out.
Gangliosides were prepared from human melanoma tumors and, as described earlier, the total
ganglioside fraction mostly contained GM3 and GD3 gangliosides. At the concentration of 25 mg
per ml, the total ganglioside fraction did not alter the cell yield but substantially altered the
phenotype of monocyte-derived cells. HLA-DR, CD1a, CD54, CD80 and CD40 antigens were
strongly down-regulated while the percentage and mean ¯uorescence intensity of CD86 was
dramatically increased. CD14 and CD83 expression remained negative. At 50 mg per ml, the viable
cell yield was decreased by about 30-40% and the phenotypic alterations were even more
pronounced. Furthermore, the allostimulatory capacity of viable monocyte-derived cells was
signi®cantly decreased. GM3 and GD3 were puri®ed by high pressure liquid chromatography in
order to analyze their respective effects on DC differentiation. Both fractions were found to induce
the above mentioned phenotypic and functional changes. In conclusion, the results demonstrate an
inhibitory effect of gangliosides on phenotypic and functional DC differentiation, which may be an
additional mechanism of human melanoma escape.
P57
Increased Tumor Necrosis Factor Family Signaling Elements in Peripheral Blood
Lymphocytes of patients with Langerhans Cell Histiocytosis
Y.-H. Cai, B. G. Darnay,* B. B. Aggarwal,* and K. L. McClain
Baylor College of Medicine, Texas Children's Cancer Center; *Cytokine Research Laboratory, Department
of Bioimmunotherapy, M.D. Anderson Cancer Center; Houston, Texas
Langerhans Cell Histiocytosis (LCH) is a reactive/proliferative disease characterized by increased
numbers of CD1a+ Langerhans cells (LCs), lymphocytes (lym), eosinophils and CD1a±
macrophages in®ltrate in single or multiple organs. Cytokines up-regulated in LC include tumor
necrosis factor alpha (TNF-a) and CD40L by an unknown mechanism. RANK and its ligand
RANKL in¯uence T cells and dendritic cells interactions. OPG (osteoprotegerin) a decoy receptor
of RANKL may be involved. We have studied peripheral blood lymphocytes from 7 children with
active LCH and compared them with normal controls to determine if changes in CD40/CD40L,
RANK/RANKL or OPG relate to systemic aberrations of the immune system accompany
localized or diffuse disease. Results: by ¯ow cytometric analysis CD19+ peripheral blood B cells
had a marked increase in CD40, but no increase in CD80, CD86, CD40L or rank expression. We
did not ®nd any increase in myeloid dendritic cells (CD11c+/11b +) or lymphoid dendritic cells
(CD11c+/llb-) or their expression of CD40. RT-PCR analysis of mRNA content in lym showed
increased amounts for RANKL and OPG. Conclusions: unlike the classical T-cell±antigen
presenting cell interaction it appears that in LCH patients the CD40 is up-regulated in B cells and
that mRNA for RANKL and its decoy receptor opg are increased. The CD40/CD40L interaction
between T and B cells may be preferentially used instead of CD28/CD80 in LCH lymphocytes.
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Langerhans Cell-Related Dendritic Cells Expand in a Virally Induced Mouse Model of
Histiocytosis
P. J. M. Leenen, M. Melis, B. den Broeder, K. HaÈhlen,* and R. M. Egeler²
Department of Immunology, Erasmus University Rotterdam, *Pediatric Hematology-Oncology, Sophia
Children's Hospital, Rotterdam, ²Department of Pediatrics, Leiden University Medical Center, Leiden, The
Netherlands
The malignant histiocytosis sarcoma virus (MHSV) induces a proliferative disease in mice involving
cells characterized initially as malignant macrophages. Therefore, this disease was suggested to
represent a mouse model for malignant histiocytosis (MH). Upon infection, virally affected cells
®rst appear in spleen and bone marrow and later metastasize to visceral organs. To investigate the
speci®city of the virus in affecting distinct subsets of mononuclear phagocytes, we further
characterized the virally transformed cells in this model. Immunohistochemical and ¯ow
cytometric analysis showed that distinct MHSV-infected subpopulations expand simultaneously.
These populations include CD11c/CD13-positive DC, MOMA-1-positive metallophilic Mj and
ER-MP58-positive myeloid precursor cells. DC represent the major subset of transformed cells in
both primarily and secondarily affected organs. Early in viral infection, all affected splenic DC
express CD8a, whereas affected DC in other peripheral organs virtually lack CD8a expression. In
later stages, also transformed DC in spleen show heterogeneous CD8 expression. In the mouse,
CD8a is expressed by lymphoid-related DC as well as by Langerhans cells which have been
activated immunologically in vivo or in vitro. Similarly activated myeloid DC, however, do not
express CD8a. Since MHSV only affects myeloid cells and CD8a is expressed by MHSV-
transformed DC in a non-constitutive manner, we conclude that affected DC in this mouse model
are most likely related to Langerhans cells.
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Methotrexate and 6-Mercaptopurine in the Treatment of Langerhans Cell Histiocytosis
(LCH)
H. Carstensen
Paediatric Department, Paediatric Haematology/Oncology unit, Copenhagen University Hospital,
Rigshospitalet, Copenhagen, Denmark
We present results and experiences of treating children with LCH with methotrexate (MTX) and
6-mercaptopurine (6MP) after unsuccessful previously administered therapy. Eleven children (7_
and 4_) was diagnosed with LCH in the period of 1983-2000 and had a median age at onset of 1.8
ys. (range 0.4-12.0). In nine cases the diagnosis was de®nite (CD1-pos./Birbecks granules), and in
other two cases presumptive. At onset seven patients had multisystem, and four had single system
disease. Ten children had bone involvement among those seven had multiosseous LCH, and one
child only skin involvement. Three children received MTX and 6MP together with prednisone
and/or vinblastine, while the other eight received the two drugs after recurrent disease (1-7
recurrences) with a median period of 0.9 yr. (range 0.6-8.3) from diagnosis of LCH. In all cases,
previous therapy included, i.e. prednisone, cytostatics and/or immunomodulating agents. Six
patients also got other therapy, but in all cases tapered off before MTX and 6MP were stopped.
The dose of MTX was 20 mg per m2 per week and 6MP 50 mg per m2 per day. In all cases
improvement occurred along the treatment as judged by resolvement of clinical symptoms, e.g.
pain, limp, fever, regression of skin elements, imaging studies showing healing of lytic lesions.
Side-effects were limited to transient myelosuppression, reversible liver affection, and to a mild
degree loss of appetite. All patients seem to bene®t from the treatment with MTX and 6MP,which
were given in all but one case after recurrence of LCH, and in all cases led to remission.
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Fascin and Langerhans Cells: Function, Regulation and Langerhans Cell Manipulation
R. Ross, M. Bros, X. L. Ross, J. Beissner, and A. B. Reske-Kunz
Clinical Research Unit Allergology, Department of Dermatology, University of Mainz, Mainz, Germany
Maturation of Langerhans cells (LC) into fully mature dendritic cells (DC), capable of primary
stimulation of naive T cells, can be mimicked by in vitro culture of epidermal cell suspensions for
three days. Applying a differential screening approach we recently discovered that the actin-
bundling protein fascin is up-regulated during this maturation process. Furthermore, we showed
that fascin expression is induced during maturation of human monocyte-derived dendritic cells as
well. Inhibition of fascin expression by antisense oligonucleotides inhibits formation of numerous
dendrites, indicating that fascin is pivotal for dendrite formation in DC. Here we report on the
isolation of the human und the murine fascin genes and characterization of the corresponding
promoters. Promoter fragments were subcloned to drive the expression of the reporter genes
enhanced green ¯uorescence protein (EGFP) and luciferase. Deletion contructs were used to
characterize the active promoter. Several cell lines were transfected and analysed for reporter gene
expression, indicating that cell type speci®city of fascin promoter re¯ects expression pattern of
fascin in vivo. The murine EGFP reporter construct was used to restrict expression to LC following
bioballistic transfer of expression constructs to murine epidermis by gene gun transfection.
Compared with transfections of antigens under control of ubiquitously expressed promoters the
LC-targeted expression of transgenes will allow for analysis of the importance of the route of
antigen delivery for the outcome of the immune response.
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In Situ Characterisation of Dendritic Cells in Human Placenta and Decidua
U. KaÈmmerer, A. Eggert,* M. Kapp, A. McLellan,* T. Geijtenbeek,² Y. van Kooyk,² J. Dietl,
and E. KaÈmpgen*
Departments of Gynecology and *Dermatology, University of WuÈrzburg, Germany; ²Department of Tumor
Immunology, University Medical Center St. Radboud, Nijmegen, The Netherlands
Dendritic cells (DC) are sentinel cells of the immune system and located in surface tissues such as
skin and mucosa, where the organism is threatened by infectious agents. The human decidua,
despite its proposed immunosuppressive function, hosts a variety of immunocompetent CD45 cells
such as natural killer cells, macrophages, T cells and, as recently described by us, CD83+ DC. We
have now undertaken a more detailed immunhistochemical characterization of the HLA-DR+
antigen presenting cells (APC) present in fetal placenta and maternal decidua. Using mAbs against
the monocyte/macrophage markers CD14 and CD68, the DC marker CD83 as well as the novel
lectin type molecule DC-SIGN we found that HLA-DR positive APC in decidua can be divided
into 3 populations: a majority of undetermined CD14+/CD68±/CD83±/DC±SIGN+ cells, a
minority of CD14+/CD68+/CD83±/DC±SIGN± macrophages and few CD14±/CD68±/
CD83+/DC±SIGN+ DC. In contrast to maternal decidua, CD14+ cells within early placental
villi were generally negative for DC±SIGN as well as for CD83. Interestingly, in mature placenta at
term most of the CD14+ cells expressed DC±SIGN, but still were CD83 negative. In summary,
this is the ®rst identi®cation of CD83±/CD14+ APC at the feto±maternal interface that express the
HIV-binding lectin DC±SIGN. Expression of DC±SIGN on fetal APC seems to be up-regulated
during pregnancy. The functional role of DC-SIGN+ APC not belonging to the CD14±/
CD83+ DC lineage awaits further analysis.
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In Vitro and In Vivo Analysis of RelB-De®cient Dendritic Cells
T. Herrmann, C. Stoll, M. Pech, D. Weih, and F. Weih
Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, Karlsruhe, Germany
The Rel/NF-kB family member RelB is expressed in speci®c regions of lymphoid organs. RelB-
de®cient mice (relB±/±) have a complex phenotype including multiorgan in¯ammation, myeloid
hyperplasia, and multifocal defects in immune responses. Interdigitating dendritic cells (DCs)
express high levels whereas Langerhans cells (LCs) express only very low levels of RelB, correlating
with reduced DC populations in lymphoid organs but normal numbers of LCs in the skin of relB±/±
mice. RelB expression increases during DC maturation and strong kB-binding activity can be
induced by different stimuli triggering terminal differentiation of DCs in vitro. To investigate the
role of RelB in DCs we compared DCs generated in vitro from wild-type and relB±/± bone marrow
(BMDCs). So far, BMDCs from control and relB±/± mice did not reveal clear differences in
maturation, antigen uptake, and MLRs. Also, PKH26-labeled relB±/± BMDCs injected into wild-
type mice were able to migrate to the draining lymph node. We previously demonstrated that
relB±/± mice show poor CHS responses. Since the development of lymph nodes is impaired in
relB±/± mice we injected BMDCs after haptenization with TNBS into wild-type recipients. In these
adoptive transfer experiments, both control and relB±/± BMDCs showed a similar capacity to
induce an ear swelling response. Experiments to test the ability of freshly isolated LCs from relB±/±
mice to migrate and to induce immune responses will be presented.
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Two Subsets of Spleen DC in Rat: Phenotype and Function
C. Voisine, B. Trinite, M. Heslan, and R. Josien
INSERM U437, 30 bd J. Monnet, Nantes, France
We previously shown that freshly extracted OX62+ DC from rat spleen contain two subsets, one
CD4+ and one CD4±. The CD4±, but the not the CD4+ subset of spleen DC exhibited a
cytotoxic activity against selected tumoral targets cells. Here we extended our study on the
function of rat spleen DC subsets. Three color FACS analyses of unsorted low density cells showed
a CD4+ DC:CD4± DC ratio of 1.5:1±1:1. Unlike CD4± cells, CD4+ spleen DC co-express CD5,
SIRP and Thy1, express higher levels of CD11c and lower levels of the OX62 integrin than CD4±
DC. Giemsa staining of cytospun revealed a myeloid and lymphoid-related morphology of CD4±
and CD4+ DC, respectively. However, cell morphology heterogeneity was observed in the CD4+
subset of spleen DC. CD4± DC exhibited an extremely short half life in vitro but could be rescue
from cell death by CD40 cross linking, GMCSF, IL-3 or PolyI:C. These stimuli had no effects on
in vitro survival of CD4+ DC. Moreover, unlike CD5 and SIRP, the expression of CD4 seems to
be lost in culture by at least a subset of CD4+ spleen DC. Upon stimulation by CD40L of LPS,
very low levels of IL-10 and IFNg was detected in the supernatant of both CD4+ and CD4± DC.
In contrast, IL12p40 production was strictly restricted to CD4± DC in vitro. The in¯uence of these
two spleen DC subsets on Th and CD8+ T cells differentiation in vitro and in vivo is currently under
investigation.
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Differentially Expressed Molecules in Dendritic Cells: Integrin Adhesion Dependent
Membrane Translocation of CYTIP-1, an Up-Regulated Novel Cytohesin-1 Interacting
Protein
L. Ivarsson,* P. Winklehner,*§ A. Trockenbacher,²§ S. Neyer,* H. Fiegl,* S. Hofer,* S. Ebner,*
T. BoÈhm,³ W. Kolanus,³ R. Schneider,² and C. Heu¯er*
*Department of Dermatology, ²Institute of Biochemistry, University of Innsbruck, ³Laboratory for Molecular
Biology, Gene Center, University of Munich
Dendritic cells grown from CD14+ precursors to both stages of maturation were used in a
differential display of mRNA to identify molecules differentially expressed during DC maturation.
A novel cytoplasmic molecule, CYTIP-1 (Cytohesin-Interacting Protein) was up-regulated during
DC maturation. Sequence analyses reveales two protein±protein interaction domains: a coiled-coil
domain and a PDZ domain. We show that CYTIP-1 speci®cally interacts with cytohesins. DC
express only cytohesin-1, which is simultaneously up-regulated during maturation of DC and is the
putative binding partner of CYTIP-1 in DC. Immunoprecipitation studies con®rm binding of
cytohesin-1 to CYTIP-1. Mapping of the binding sites reveals the coiled-coil domain of
cytohesin-1 to interact with the coiled-coil domain of CYTIP-1. Cytohesin-1 after translocation
to the plasma membrane interacts with the aLb2 chain of LFA-1 to strengthen its adhesiveness to
ICAM-1. Speci®cally after integrin ligand binding CYTIP-1 also localizes to the plasma
membrane, suggesting a role for CYTIP-1 in the integrin adhesion dependent functions of
cytohesin-1. LFA-1 ± ICAM-1 binding is one of the interactions of mature DC to interact with T-
cells in an immune response. Up-regulation of CYTIP-1 therefore may be involved in the
regulation of this interation.
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Molecular Identity and Function of Langerhans Cell-Associated Ecto-ATPase/ADPase
Activities
N. Mizumoto, T. Kumamoto, S. C. Robson,* and A. Takashima
UT South-western, Dallas, Texas; *Harvard University, Boston, Massachusetts
Although ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) activities have been
widely used as useful markers of epidermal Langerhans cells (LC), the molecular identity or
physiological function of these activities remain unknown. CD39, which was originally described
as an obscure activation marker expressed by B cells, dendritic cells, and endothelial cells, has been
recently identi®ed as a vascular NTPDase. We detected CD39 mRNA and/or protein expression
almost exclusively within the IA+ population in mouse epidermis and in LC-derived XS52 and
XS106 lines, but not in keratinocyte or epidermal gd T cell lines. Moreover, CD39-de®cient mice
showed normal surface densities of IA+/DEC205+ LC, whereas these CD39±/± LC lacked apparent
ecto-NTPDase activities. Thus, we conclude that CD39 is responsible for LC-associated ecto-
NTPDase activities. With respect to function, CD39±/± mice developed signi®cantly (p < 0.01,
n = 10) exacerbated in¯ammatory responses to topically applied croton oil, benzalkonium chloride
(BAC), and ethyl phenylpropiolate (EPP) than did CD39+/+ mice. Local administration of soluble
NTPDase reduced the extent of croton oil-induced ear swelling in CD39±/± mice to the normal
level, supporting the anti-in¯ammatory role for CD39. Exposure of Pam 212 keratinocytes to the
same chemicals released biologically relevant ATP and ADP into culture media. Addition of
CD39-expressing XS52 cells in keratinocyte cultures signi®cantly reduced ATP levels in the
media. These results reveal a novel pathogenic mechanism of irritant contact dermatitis, as well as a
previously unrecognized protective role for LC-associated CD39 against environmental insults via
phosphohydrolysis of otherwise pro-in¯ammatory nucleotides released by neighboring keratino-
cytes.
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Phenotypic and Functional Characterisation of DC in Afferent Lymph Draining Ovine
Skin
K. Walsh,*² P. Cameron,³ W. Kimpton,* R. Cahill,* and P. Chaplin§
*Laboratory for Foetal and Neonatal Immunology, School of Veterinary Science, University of Melbourne,
Parkville Victoria, Australia; ²Cooperative Research Centre for Vaccine Technology, ³Department of
Microbiology and Immunology, University of Melbourne, Parkville, Victoria Australia; §Bavarian Nordic
GmbH, Martinsried, Germany
We have used a pseudoafferent lymphatic cannulation model, draining the skin of sheep, to
characterise dendritic cells (DC) within this compartment into two major populations. The major
subpopulations are CD11c+, MYD-1+, CC81±, WC10± or CD11c±, MYD-1±, CC81+,
WC10+ and can be further subdivided by the expression of CD4 and CD8. These distinct
phenotypic DC populations express high levels of the maturation markers CD83, CD80/CD86,
CMRF-56 and MHC II and are capable of stimulating naõÈve allogeneic lymphocytes. Differences
between the populations are unlikely to be due simply to stages of maturation in the afferent
lymphatics. Antigen uptake studies in vitro showed that all DC populations retained phagocytic
functions normally associated with immaturity including receptor mediated phagocytosis of FITC-
dextran and latex beads, but not uptake of Lucifer Yellow by ¯uid phase endocytosis. Within 24 h
of intra-dermal injection of particulate antigen (1 mm latex beads), DC carrying beads were found
in the afferent lymph. A variable number of beads were found in each of the DC populations
suggesting none are specialised for ef®cient multiple bead uptake. To determine the kinetics of
migration of the blood DC precursors through skin, a cohort of whole blood was labelled with a
long-term tracking label, CFSE, in vitro and reinfused. The number and phenotype of labelled cells
migrating into afferent lymph was monitored daily by ¯ow cytometry. Labelled DC of each subset
migrating into afferent lymph peaked within 24-72 h of labelling, which is in keeping with rapid
turnover of DCs within the different subpopulations.
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Role of Langerhans Cells in Corneal Graft Rejection
I. Dekaris, N. Gabriñ, and M. R. Dana*
Lions Croatian Eye Bank, Department of Ophthalmology, General Hospital ``Sveti Duh'', Zagreb,
Croatia; *Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
Antigen-presenting cells in the cornea are Langerhans cells (LC), normally present at corneal
periphery. Centripetal migration of LCs toward graft seams to be crucial in graft rejection, and
TNF-a might induce this migration. We aimed to determine whether LC activity suppression by
sTNFRI might improve corneal graft success rate. To check whether TNF-a can induce
centripetal LC migration, mice corneas (n = 10 per group) were centrally injected with 10 ng
per ml or 1 mg per ml of TNF-a LS in the central cornea were counted by immuno¯uorescence
assay after 1 week. Secondly, donor corneas (2 mm) from C57Bl/6 mice were grafted into naive
and presensitized Balb/c recipients. LS number at donor/recipient junction was determined
14 days after surgery. Balb/c (fully disparate) and B10.D2 (minor disparate) eyes bearing C57Bl/6
corneal grafts were topically treated (4 3 day) with placebo or TNF-antagonist ± soluble TNF
receptor I. Grafts were considered rejected as already described (Sonoda, Transpl 92). Graft success
rate was compared during 8 postoperative weeks. Intracorneal TNF-a injection induced dose-
dependent centripetal LS migration (42 LC per mm2, 55 LC per mm2). Number of LCs at graft rim
was signi®cantly lower in naive corneal graft recipients (48 per mm2) as compared to sensitised
corneal graft recipients (98 per mm2, p < 0.05). Topical sTNFRI treatment improved corneal graft
success rate in minor-only disparate graft recipients (60% vs. 30% in placebo, p < 0.05). Corneal
Langerhans cells are activated both by TNF-a injection and corneal transplantation. sTNFRI has
suppressive effect on corneal LCs and can attenuate immune response to minor H alloantigens.
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Langerhans Cells in Corneal Graft Rejection
I. MravieÁiñ, N. Gabriñ, L. SÏuman,* G. Lackoviñ,² R. Laziñ, A. Tomljenoviñ,² and I. Dekaris
Lions Croatian Eye Bank, Ophthalmology Dep GH ``Sveti Duh'', Zagreb, Croatia, *``Ruer BosÏkoviñ''
Institute, Zagreb, Croatia, ²Fasculty of Natural Sciences and Mathematics, Zagreb, Croatia
The aim of this study was to evaluate the role of donor Langerhans Cells (LC) in allorecognition of
corneal grafts. We used mice in which minor HYA was involved (C57BL/Go female recipients-
C57BL/Go male donors. The median survival times (MSTs) of test skin grafts were estimated in
recipients that were three weeks earlier pretreated with fresh cornea graft or super®cially cauterized
cornea graft. The presence of conglomerates of LCs were correlated with skin graft survival. The
human corneo-scleral rings (remnant after excision of the corneal transplant) were analysed for the
number of donor LC conglomerats, and they were correlated with survival of corneal grafts in
human patients. In central part of intact mice corneas we did not found LC conglomerats while
they appeared in cauterized corneas. C57BL/Go female rejected faster test graft after senzitization
with cauterized cornea graft (MST 10 days) comparing with sensitization with normal cornea
(MST 17 days). In experiment with human corneas we did not ®nd correlation between number of
donor LC cells in corneo-scleral ring and rejection rate of transplanted corneas, instead
in¯ammation and neovascularisation of recipient eye were predominant reason for corneal
rejection. Although donor derived Langerhans cells can induce corneal allograft rejection (direct
pathway) it is most probable that the majority of corneal graft rejection is in conjunction with
recipient derived LC which are mobilized in the presence of risk factor of the recipient eye
(indirect pathway).
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IL-12 Production of Mouse Langerhans Cells: Regulation by TGF-b for the Induction of
TH1 Cells
Y. Tada, A. Asahina, K. Nakamura, S. Hachimura,* S. Kaminogawa,* and K. Tamaki
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan; *Department of
Applied Biological Chemistry, University of Tokyo, Tokyo, Japan
IL-12 is a cytokine known to serve as a powerful mediator for Th1-type differentiation of T helper
cells both in vitro and in vivo. We have previously shown that TGF-b enhances IL-12 production of
anti-CD40 mAb-stimulated LC. In this study, we investigated the ability of anti-CD40 mAb/
TGF-b-treated LC to prime antigen-speci®c T cells in vitro, and examined the cytokines that they
induced in naive T cells. A highly puri®ed population of LC (> 95%) was prepared from BALB/c
mouse skin by the panning method using anti-I-Ad mAb. LC were incubated overnight in the
presence of OVA peptide [323-339] 1) with anti-CD40 mAb or 2) with anti-CD40 mAb plus
TGF-b. LC were then washed and co-cultured with naive CD4+ CD62Lhigh T cells isolated from
the spleen of OVA323-339-speci®c TCR-transgenic BALB/c mice (OVA23-3). The culture
supernatants were collected after 24 h for measurement of IL-2 and after 72 h for measurement of
IL-4 and IFN-g. Anti-CD40 mAb/TGF-b-treated LC induced in T cells greater levels of IFN-g
and lower levels of IL-4 than anti-CD40 mAb-treated LC did. However, there were no signi®cant
differences in IL-2 production of T cells primed by either LC. Thus, our in vitro data provide
further evidence that TGF-b, together with CD40 ligation, induces Th1 responses in the skin.
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Polarized Dendritic Cells Mediate CD8 help for CD4+ T cells: Helper Function of CD8+
T Cells in the Development of Th1 Responses
R. B. Mailliard, S. Egawa, Q. Cai, A. Kalinska, M. T. Lotze, M. L. Kapsenberg, W. J. Storkus, and
P. Kalinski
University of Pittsburgh, Pittsburgh, Pennsylvania; GlaxoSmithKline Inc., King of Prussia, Pennsylvania;
University of Amsterdam, The Netherlands
Th1 responses are essential in resistance against most intracellular pathogens and cancer. We show
that the induction of IL-12 production in DC during the priming of naive T cells and the resulting
development of Th1 cells critically depend on the cooperation between CD40L-expressing naive
CD4+ T cells and IFN-g-producing naive CD8+ T cells. The interaction of DC with CD8+ T cells
activates DC and results in their development into type-1-polarized effector DC that produce
elevated amounts of IL±12 upon subsequent interaction with CD4+ T cells and induce strongly-
polarized Th1 responses. In contrast, DC maturation induced by either bacterial LPS or stromal-
type in¯ammatory cytokines, such as TNFa and IL-1b, exhausts their IL-12-producing capacity.
The currently described helper function of CD8+ T cells helps to explain preferential induction of
Th1 responses against intracellular pathogens and contact allergens, which are effectively presented
in context of MHC class I. The ability of DC to receive imunomodulatory signals from CD8+ T
cells, a classical effector T cell subset, represents a novel mechanism of immunoregulation and may
help in designing improved DC-based immunotherapeutic strategies.
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Antigen-Presenting Function Perturbation by UVB Irradiation of Human Epidermal
and Monocyte-Derived Langerhans Cells
M. F. Aries, C. VaissieÁre, F. Dodeller, G. Riffet, M. Charveron, and Y. Gall
Institut de Recherche Pierre FABRE, Laboratoire de Biologie Cellulaire CutaneÂe, FaculteÂ de MeÂdecine de
Rangueil, Toulouse, France
Exposure of the human skin to UV radiation causes an imbalance of its homeostasis and a reduced
cutaneous immunity. The immunosuppression brought about by UVB is assumed to result in
particular from the direct effects of UVB on the antigen-presenting function of the Langerhans
cells (LCs), adhesion and co-stimulatory molecules being of crucial importance for the interaction
of antigen-presenting cells with immune cells, especially T lymphocytes. The aim of the present
study was to determine the differential effects of UVB on Langerhans cells antigen-presenting
function by means of two models: a human skin explant model irradiated with increasing levels of
UVB (312 nm; 0.5±1 J per cm2): after irradiation, LCs freshly isolated were tested for their
allostimulating capacity in mixed lympho-epidermal culture (MLEC). UVB inhibited the
lymphocyte proliferating response which was evaluated in the presence of 3H thymidine : 0.75 J per
cm2 caused a 43% inhibition of the response; a human monocyte-derived Langerhans cells
(MoLCs) model: monocytes were cultured for 6 days in supplemented RPMI-1640, containing 50
ng per ml IL4, 100 ng per ml GM-CSF, 4 ng per ml TGFb. In vitro UVB irradiation of MoLCs to
increasing doses (0.005±0.03 J per cm2) perturbed their allostimulating capacity in MLEC (0.03 J
per cm2 caused a 34% inhibition of the response) and modulated their functional expression of
HLA-DR, CD54 and CD86: MoLCs were stained for four-color analysis with the corresponding
different monoclonal antibodies and analyzed on a double laser equipped FACSCalibur ¯ow
cytometer. Better knowledge of mechanisms involved in UV-induced immune suppression is
essential for developing new strategies aimed at photoprotection and cancer prevention. Our
results can be used and expanded to quantify UV-mediated Langerhans cell damage and the degree
of immune photoprotection provided by various agents or sunscreens.
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Comparative Determination of Sunscreen Immune Protection Factors by Using Either
Human Skin Explants, Langerhans Cell or Monocyte-Derived Dendritic Cell
Suspensions
J. PeÂguet-Navarro, C. Dalbiez-Gauthier, B. Le Varlet,* P. Courtellemont,* and D. Schmitt
INSERM U346, Pavillon R, HoÃpital E. Herriot, Lyon, France; *LVMH Branche Parfums et
CosmeÂtiques, Saint-Jean de Braye, France
The immunosuppressive effect of UVB has long been recognized and is thought to predispose to
the development of skin cancers. Sunscreens are generally accepted to protect the skin against
erythema and photoaging but their ability to protect against immunosuppressive effects is still
debated and the need to determine sunscreen immune protection factors (IPF) is increasing. In the
present study, three in vitro models have been developed to determine sunscreen IPF. First, human
skin explants were treated or not with sunscreens with different sun protecting factors (SPF 4 and
15) and irradiated with increasing doses of UVB before epidermal cells were recovered by
trypsinization. Alternatively, human enriched Langerhans cell (LC) or day 6 monocyte-derived
dendritic cell (DC) suspensions were irradiated through a piece of translucent strip recovered or
not with the sunscreens. The allostimulatory function of the different cell suspensions was then
analysed in a 5-day mixed lymphocyte reaction. Results showed that in any experimental
conditions, the UVB dose providing 50% (D50%) immunosuppression in the presence of
sunscreens was signi®cantly higher than that obtained with their respective vehicles, thus
demonstrating the sunscreen immunoprotective effect. IPF were determined by the ratio of the
D50% value in the presence of sunscreen to that of vehicle alone. IPF values for SPF 4 and 15
sunscreens were: 5.1 6 2.7 and 9.8 6 5.6; 6.2 6 2.5 and 10.5 6 2.9; 4.0 6 1.0 and 10.5 6 3.4 using
human skin explants, LC or monocyte-derived DC, respectively. In conclusion, IPF values for
sunscreens were very similar whether we used human skin explants or reduced the model to either
LC or monocyte-derived DC suspensions. Furthermore, IPF ranked according to the sunscreen
SPF values. Although investigating only one aspect of immunosuppression, i.e. the inhibition of
DC allostimulatory function, these models proved to be very useful in determining sunscreen IPF.
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IL-4 Mediated Suppression of Prostaglandin E2 Production in Human Monocyte-
Derived Dendritic Cells: Transcellular Arachidonic Acid Metabolism Enhances Priming
of Th2 T cells
C. Zelle-Rieser, R. Ramoner, E. Artner-Dworzak,* A. Casari,* G. Bartsch, and M. Thurnher
Department of Urology and *Institute of Medical Biochemistry, University of Innsbruck, Innsbruck, Austria
Prostaglandin E2 (PGE2) is a member of the eicosanoid family of arachidonic acid derivatives
which is liberated from membrane phospholipids by phospholipases. Eicosanoids have been
implicated in the regulation of in¯ammatory responses and T helper (TH) cell development. We
show here that IL-4, which is required for dendritic cell development from monocytes, suppresses
PGE2 production by human monocyte-derived dendritic cells (moDCs). MoDCs, however,
ef®ciently converted exogenous arachidonic acid into PGE2. PGE2 production from exogenous
arachidonic acid further reduced IL-12 biosynthesis in LPS-matured, ``exhausted'' moDCs in
response to CD40 ligation and enhanced their ability to induce IL-4 producing Th cells in mixed
leukocyte reactions at a low moDC:T cell ratio. Our data together with previous reports suggest
that cytokine exhaustion, declining availability of antigen and accumulation of free arachidonic
acid followed by ``transcellular'' metabolism are important for Th2 development. These conditions
all apply for the late phase of in¯ammatory and immune responses.
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Interleukin-3 Modi®es the Capacity of Human Monocyte-Derived Dendritic Cells to
Induce Helper T Cell Responses: Shift Towards a TH2 Cytokine Secretion Pattern
S. Ebner, V. A. Nguyen, C. FuÈrhapter, M. Herold, and N. Romani
Departments of Dermatology and Internal Medicine (MH), University of Innsbruck, Innsbruck, Austria
Human monocyte-derived dendritic cells (DC1) were described to induce TH1 differentiation,
whereas dendritic cells (DC2) derived from plasmacytoid cells induce TH2 differentiation. We
wondered whether human monocyte-derived dendritic cells cultured in different cytokine
microenvironments display different TH-inducing patterns. The standard method to generate
dendritic cells from monocytes is culture with GM-CSF + IL-4; standard approach to obtain DC2
is culture in the presence of IL-3. Human CD14+ monocytes (pDC1) express not only GM-CSF-
receptors (CD116) but also IL-3-receptors (CD123). Therefore, we cultured dendritic cells with
IL-3 (i.e. instead of GM-CSF) and IL-4. Maturation of both subpopulations (i.e. control GM-
CSF + IL-4 DCs and experimental IL-3 + IL-4 DCs) was induced with a cytokine cocktail of
TNFa, IL-1b, IL-6 and PGE2. Yields of these two populations were almost identical; they showed
similar morphology (``veils'') and phenotype. Only CD1a was differentially expressed: ``GM-CSF
cells'' expressed high levels whereas ``IL-3 cells'' were negative. Also, the immunostimulatory
capacity in the mixed leukocyte reaction was equal. When these two mature dendritic cell
populations were stimulated with CD154 and IL-12 p70 was measured by ELISA, ``IL-3 cells''
produced signi®cantly less IL-12 than ``GM-CSF cells''. In co-culture experiments with naive
allogeneic CD4+ T cells these ``IL-3 cells'' induced T cells to produce signi®cantly more IL-5 and
IL-4 and less IFN. as compared to stimulation with conventional ``GM-CSF cells''. These results
indicate that a different cytokine environment during differentiation of pDC1 can change the
nature of dendritic cells from a TH1-inducing antigen-presenting cell to a TH2-inducing antigen-
presenting cell.
P75
Differential Regulation of Human Blood Dendritic Cell Subsets by Interferons
T. Ito,* R. Amakawa,* M. Inaba,² S. Ikehara,² K. Inaba,³ and S. Fukuhara*
*First Department of Internal Medicine; ²First Department of Pathology, Kansai Medical University;
³Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University;
*²10-15 Fumizono-cho Moriguchi, Osaka, ³Kitashirakawa-Oiwake-cho Sakyo-ku, Kyoto, Japan
Based on the relative expression of CD11c, two types of DC precursors have identi®ed in human
peripheral blood. A CD11c+ population is myeloid-DCs, whereas a CD11c± population,
sometimes called type I interferon-producing cells but better known as plasmacytoid DCs, is
lymphoid-DCs. Here, we investigate the effects of IFN-a/b and IFN-g, as well as other cytokines,
on CD11c+ and CD11c± DC subsets, directly isolated from the peripheral blood. Both IFN-g and
IFN-a, rather than GM-CSF, were the most potent cytokines for enhancing the maturation of
CD11c+ DCs. Incubation of CD11c+ DCs with IFN-g also resulted in increased IL-12 production,
and this IL-12 allowed DCs to increase Th1 responses by alloreactive T cells. In contrast, IFN-a
did not induce IL-12 but rather augmented IL-10 production. IFN-a-primed matured CD11c+
DCs induced IL-10-producing regulatory T cells; however, this process was independent of the
DC-derived IL-10. On the other hand, IFN-a, by itself, neither matured CD11c± DCs nor altered
the polarization of responding T cells, although this cytokine was a potent survival factor for
CD11c± DCs. Unlike IFN-a, IL-3 was a potent survival factor and induced the maturation of
CD11c± DCs. The IL-3-primed CD11c± DCs activated T cells to produce IL-10, IFN-g and IL-4.
Thus, CD11c+ and CD11c± DC subsets play distinct roles in the cytokine-network, especially their
responses to interferons. In exerting the unique and integral roles to prime naive T cells, DC
system not only shows heterogeneity in terms of cellular lineage, but also has plasticity to induce
different Th cell development depending on the cytokine milieu
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